["If a patient with Non-Small Cell Lung Cancer cancer has araf s214c, one recommended therapy is sorafenib. entry url: https://civicdb.org/links/evidence_items/17", "If a patient with Acute Myeloid Leukemia cancer has dnmt3a r882, one recommended therapy is idarubicin. entry url: https://civicdb.org/links/evidence_items/18", "If a patient with Polycythemia Vera cancer has jak2 v617f, one recommended therapy is peginterferon alfa-2b. entry url: https://civicdb.org/links/evidence_items/19", "If a patient with Polycythemia Vera cancer has jak2 v617f, one recommended therapy is fedratinib. entry url: https://civicdb.org/links/evidence_items/20", "If a patient with Melanoma cancer has nras g13d, one recommended therapy is tanespimycin. entry url: https://civicdb.org/links/evidence_items/21", "If a patient with Melanoma cancer has nras q61l, one recommended therapy is temozolomide. entry url: https://civicdb.org/links/evidence_items/22", "If a patient with Melanoma cancer has nras q61r, one recommended therapy is temozolomide. entry url: https://civicdb.org/links/evidence_items/23", "If a patient with Neuroblastoma cancer has alk f1174l, one recommended therapy is alectinib. entry url: https://civicdb.org/links/evidence_items/37", "If a patient with Neuroblastoma cancer has alk f1174l, one recommended therapy is crizotinib. entry url: https://civicdb.org/links/evidence_items/38", "If a patient with Cancer cancer has alk r1275q, one recommended therapy is alk inhibitor tae684. entry url: https://civicdb.org/links/evidence_items/39", "If a patient with Non-Small Cell Lung Cancer cancer has araf s214c, one recommended therapy is sorafenib. entry url: https://civicdb.org/links/evidence_items/40", "If a patient with Non-Small Cell Lung Cancer cancer has araf s214c, one recommended therapy is trametinib. entry url: https://civicdb.org/links/evidence_items/41", "If a patient with Melanoma cancer has kit l576p, one recommended therapy is dasatinib. entry url: https://civicdb.org/links/evidence_items/42", "If a patient with Gastrointestinal Stromal Tumor cancer has pdgfra d842i, one recommended therapy is crenolanib. entry url: https://civicdb.org/links/evidence_items/43", "If a patient with Gastrointestinal Stromal Tumor cancer has pdgfra d842v, one recommended therapy is crenolanib. entry url: https://civicdb.org/links/evidence_items/44", "If a patient with Gastrointestinal Stromal Tumor cancer has pdgfra d842y, one recommended therapy is crenolanib. entry url: https://civicdb.org/links/evidence_items/45", "If a patient with Gastrointestinal Stromal Tumor cancer has pdgfra i843del, one recommended therapy is crenolanib. entry url: https://civicdb.org/links/evidence_items/46", "If a patient with Gastrointestinal Stromal Tumor cancer has pdgfra d842_i843delinsvm, one recommended therapy is crenolanib. entry url: https://civicdb.org/links/evidence_items/47", "If a patient with Melanoma cancer has kit exon 11 mutation, one recommended therapy is imatinib. entry url: https://civicdb.org/links/evidence_items/58", "If a patient with Melanoma cancer has braf v600e, braf v600m, one recommended therapy is dabrafenib. entry url: https://civicdb.org/links/evidence_items/73", "If a patient with medullary thyroid cancer has ret m918t, one recommended therapy is jak2 inhibitor azd1480. entry url: https://civicdb.org/links/evidence_items/77", "If a patient with Colorectal Cancer cancer has braf v600e, one recommended therapy is panitumumab + sorafenib. entry url: https://civicdb.org/links/evidence_items/89", "If a patient with Melanoma cancer has braf v600, one recommended therapy is trametinib + dabrafenib. entry url: https://civicdb.org/links/evidence_items/93", "If a patient with Melanoma cancer has braf v600d, one recommended therapy is dabrafenib. entry url: https://civicdb.org/links/evidence_items/94", "If a patient with Melanoma cancer has braf v600e, one recommended therapy is trametinib + dabrafenib. entry url: https://civicdb.org/links/evidence_items/95", "If a patient with Colorectal Cancer cancer has braf v600e, one recommended therapy is plx4720 + pictilisib bismesylate. entry url: https://civicdb.org/links/evidence_items/96", "If a patient with Melanoma cancer has braf v600e, one recommended therapy is nutlin-3 + plx4720. entry url: https://civicdb.org/links/evidence_items/97", "If a patient with Colorectal Cancer cancer has braf v600e, one recommended therapy is capecitabine + bevacizumab + vemurafenib. entry url: https://civicdb.org/links/evidence_items/98", "If a patient with Colorectal Cancer cancer has braf v600e, one recommended therapy is vemurafenib. entry url: https://civicdb.org/links/evidence_items/99", "If a patient with Non-Small Cell Lung Cancer cancer has eml4::alk fusion, alk l1196m, one recommended therapy is alectinib. entry url: https://civicdb.org/links/evidence_items/141", "If a patient with Neuroblastoma cancer has alk f1174l, one recommended therapy is alk inhibitor tae684. entry url: https://civicdb.org/links/evidence_items/142", "If a patient with Neuroblastoma cancer has alk r1275q, one recommended therapy is crizotinib. entry url: https://civicdb.org/links/evidence_items/143", "If a patient with nan cancer has fgfr3::baiap2l1 fusion, one recommended therapy is pd173074. entry url: https://civicdb.org/links/evidence_items/144", "If a patient with Colorectal Cancer cancer has kras g13d, one recommended therapy is cetuximab. entry url: https://civicdb.org/links/evidence_items/145", "If a patient with Acute Myeloid Leukemia cancer has npm1 exon 11 mutation, one recommended therapy is tretinoin. entry url: https://civicdb.org/links/evidence_items/146", "If a patient with Acute Myeloid Leukemia cancer has npm1 exon 11 mutation, one recommended therapy is daunorubicin. entry url: https://civicdb.org/links/evidence_items/147", "If a patient with Acute Myeloid Leukemia cancer has npm1 exon 11 mutation, one recommended therapy is valproic acid. entry url: https://civicdb.org/links/evidence_items/148", "If a patient with Acute Myeloid Leukemia cancer has npm1 exon 11 mutation, one recommended therapy is tretinoin + nsc348884. entry url: https://civicdb.org/links/evidence_items/149", "If a patient with Acute Myeloid Leukemia cancer has npm1 exon 11 mutation, one recommended therapy is anti-cd123 + anti-cd33. entry url: https://civicdb.org/links/evidence_items/150", "If a patient with Acute Myeloid Leukemia cancer has npm1 exon 11 mutation, one recommended therapy is anti-cd33. entry url: https://civicdb.org/links/evidence_items/151", "If a patient with Acute Myeloid Leukemia cancer has npm1 w288fs, one recommended therapy is nsc348884. entry url: https://civicdb.org/links/evidence_items/152", "If a patient with Acute Myeloid Leukemia cancer has npm1 w288fs, one recommended therapy is daunorubicin + cytarabine + etoposide. entry url: https://civicdb.org/links/evidence_items/153", "If a patient with Non-Small Cell Lung Cancer cancer has tsc1 frameshift truncation, one recommended therapy is sirolimus. entry url: https://civicdb.org/links/evidence_items/154", "If a patient with nan cancer has tsc1 loss-of-function, one recommended therapy is everolimus. entry url: https://civicdb.org/links/evidence_items/155", "If a patient with Ovarian Cancer cancer has brca1 loss-of-function, one recommended therapy is olaparib. entry url: https://civicdb.org/links/evidence_items/211", "If a patient with Ovarian Cancer cancer has brca2 loss-of-function, one recommended therapy is olaparib. entry url: https://civicdb.org/links/evidence_items/212", "If a patient with Non-Small Cell Lung Cancer cancer has egfr l858r, one recommended therapy is erlotinib + gefitinib. entry url: https://civicdb.org/links/evidence_items/229", "If a patient with Acute Myeloid Leukemia cancer has bcr::abl1 fusion, one recommended therapy is imatinib. entry url: https://civicdb.org/links/evidence_items/259", "If a patient with Chronic Myelogenous Leukemia cancer has bcr::abl1 fusion, one recommended therapy is imatinib. entry url: https://civicdb.org/links/evidence_items/260", "If a patient with Chronic Myelogenous Leukemia cancer has bcr::abl1 fusion, one recommended therapy is dasatinib + nilotinib. entry url: https://civicdb.org/links/evidence_items/261", "If a patient with Lung Adenocarcinoma cancer has eml4::alk fusion, one recommended therapy is crizotinib. entry url: https://civicdb.org/links/evidence_items/262", "If a patient with nan cancer has ccnd3 loss, one recommended therapy is palbociclib. entry url: https://civicdb.org/links/evidence_items/263", "If a patient with nan cancer has cdk4 expression, one recommended therapy is alpelisib. entry url: https://civicdb.org/links/evidence_items/264", "If a patient with Cancer cancer has ddr2 g253c, one recommended therapy is dasatinib. entry url: https://civicdb.org/links/evidence_items/266", "If a patient with Non-Small Cell Lung Cancer cancer has ddr2 g505s, one recommended therapy is dasatinib. entry url: https://civicdb.org/links/evidence_items/267", "If a patient with Non-Small Cell Lung Cancer cancer has ddr2 g774v, one recommended therapy is dasatinib. entry url: https://civicdb.org/links/evidence_items/268", "If a patient with Non-Small Cell Lung Cancer cancer has ddr2 i638f, one recommended therapy is dasatinib. entry url: https://civicdb.org/links/evidence_items/269", "If a patient with Non-Small Cell Lung Cancer cancer has ddr2 l239r, one recommended therapy is dasatinib. entry url: https://civicdb.org/links/evidence_items/270", "If a patient with Non-Small Cell Lung Cancer cancer has ddr2 l63v, one recommended therapy is dasatinib. entry url: https://civicdb.org/links/evidence_items/271", "If a patient with Non-Small Cell Lung Cancer cancer has ddr2 s768r, one recommended therapy is dasatinib + erlotinib. entry url: https://civicdb.org/links/evidence_items/272", "If a patient with Non-Small Cell Lung Cancer cancer has egfr exon 19 deletion, one recommended therapy is gefitinib. entry url: https://civicdb.org/links/evidence_items/273", "If a patient with Non-Small Cell Lung Cancer cancer has egfr g719s, one recommended therapy is gefitinib. entry url: https://civicdb.org/links/evidence_items/274", "If a patient with Non-Small Cell Lung Cancer cancer has egfr l858r, one recommended therapy is erlotinib + gefitinib. entry url: https://civicdb.org/links/evidence_items/275", "If a patient with Non-Small Cell Lung Cancer cancer has egfr l858r, one recommended therapy is gefitinib. entry url: https://civicdb.org/links/evidence_items/276", "If a patient with Non-Small Cell Lung Cancer cancer has egfr t790m, one recommended therapy is erlotinib + pemetrexed. entry url: https://civicdb.org/links/evidence_items/277", "If a patient with Non-Small Cell Lung Cancer cancer has egfr t790m, one recommended therapy is staurosporine. entry url: https://civicdb.org/links/evidence_items/278", "If a patient with Breast Cancer cancer has erbb2 d769h, one recommended therapy is neratinib + lapatinib. entry url: https://civicdb.org/links/evidence_items/279", "If a patient with Breast Cancer cancer has erbb2 d769y, one recommended therapy is neratinib. entry url: https://civicdb.org/links/evidence_items/280", "If a patient with Breast Cancer cancer has erbb2 l755_t759del, one recommended therapy is neratinib. entry url: https://civicdb.org/links/evidence_items/281", "If a patient with Breast Cancer cancer has erbb2 g309a, one recommended therapy is neratinib. entry url: https://civicdb.org/links/evidence_items/282", "If a patient with Breast Cancer cancer has erbb2 l755s, one recommended therapy is neratinib. entry url: https://civicdb.org/links/evidence_items/283", "If a patient with Breast Cancer cancer has erbb2 l755w, one recommended therapy is neratinib. entry url: https://civicdb.org/links/evidence_items/284", "If a patient with Breast Cancer cancer has erbb2 g778_p780dup, one recommended therapy is neratinib. entry url: https://civicdb.org/links/evidence_items/285", "If a patient with Breast Cancer cancer has erbb2 r678q, one recommended therapy is neratinib + lapatinib. entry url: https://civicdb.org/links/evidence_items/286", "If a patient with Breast Cancer cancer has erbb2 r896c, one recommended therapy is neratinib. entry url: https://civicdb.org/links/evidence_items/287", "If a patient with Breast Cancer cancer has erbb2 v777l, one recommended therapy is neratinib. entry url: https://civicdb.org/links/evidence_items/288", "If a patient with Breast Cancer cancer has erbb2 v842i, one recommended therapy is neratinib. entry url: https://civicdb.org/links/evidence_items/289", "If a patient with Breast Cancer cancer has esr1 l536q, one recommended therapy is tamoxifen + fulvestrant. entry url: https://civicdb.org/links/evidence_items/290", "If a patient with Breast Cancer cancer has esr1 d538g, one recommended therapy is fulvestrant + tamoxifen. entry url: https://civicdb.org/links/evidence_items/291", "If a patient with Breast Cancer cancer has esr1 y537c, one recommended therapy is fulvestrant + tamoxifen. entry url: https://civicdb.org/links/evidence_items/292", "If a patient with Breast Cancer cancer has esr1 y537n, one recommended therapy is tamoxifen + fulvestrant. entry url: https://civicdb.org/links/evidence_items/293", "If a patient with Breast Cancer cancer has esr1 y537s, one recommended therapy is fulvestrant + tamoxifen. entry url: https://civicdb.org/links/evidence_items/294", "If a patient with Cholangiocarcinoma cancer has fgfr2::oga fusion, one recommended therapy is ponatinib. entry url: https://civicdb.org/links/evidence_items/295", "If a patient with Cholangiocarcinoma cancer has fgfr2::tacc3 fusion, one recommended therapy is pazopanib + ponatinib. entry url: https://civicdb.org/links/evidence_items/296", "If a patient with Acute Myeloid Leukemia cancer has flt3 itd, one recommended therapy is lestaurtinib. entry url: https://civicdb.org/links/evidence_items/297", "If a patient with Acute Myeloid Leukemia cancer has flt3 itd, one recommended therapy is sorafenib. entry url: https://civicdb.org/links/evidence_items/298", "If a patient with Acute Myeloid Leukemia cancer has flt3 itd, one recommended therapy is tyrphostin ag 1296. entry url: https://civicdb.org/links/evidence_items/299", "If a patient with Lung Adenocarcinoma cancer has gata2 expression, one recommended therapy is bortezomib + fasudil. entry url: https://civicdb.org/links/evidence_items/301", "If a patient with nan cancer has kit internal duplication, one recommended therapy is imatinib. entry url: https://civicdb.org/links/evidence_items/302", "If a patient with Non-Small Cell Lung Cancer cancer has kit l576p, one recommended therapy is dasatinib + nilotinib + imatinib. entry url: https://civicdb.org/links/evidence_items/303", "If a patient with Gastrointestinal Stromal Tumor cancer has kit v654a, one recommended therapy is sunitinib. entry url: https://civicdb.org/links/evidence_items/304", "If a patient with Non-Small Cell Lung Cancer cancer has kras g12d, one recommended therapy is selumetinib + dactolisib. entry url: https://civicdb.org/links/evidence_items/305", "If a patient with Colorectal Cancer cancer has kras g13d, one recommended therapy is cetuximab. entry url: https://civicdb.org/links/evidence_items/306", "If a patient with Glioblastoma cancer has mgmt promoter methylation, one recommended therapy is temozolomide. entry url: https://civicdb.org/links/evidence_items/307", "If a patient with Glioblastoma cancer has mgmt promoter methylation, one recommended therapy is carmustine. entry url: https://civicdb.org/links/evidence_items/308", "If a patient with Glioblastoma cancer has mgmt promoter methylation, one recommended therapy is o6-benzylguanine. entry url: https://civicdb.org/links/evidence_items/309", "If a patient with Breast Cancer cancer has pik3ca e542k, one recommended therapy is izorlisib. entry url: https://civicdb.org/links/evidence_items/310", "If a patient with Breast Cancer cancer has pik3ca e542k, one recommended therapy is sirolimus. entry url: https://civicdb.org/links/evidence_items/311", "If a patient with Breast Cancer cancer has pik3ca h1047r, one recommended therapy is izorlisib. entry url: https://civicdb.org/links/evidence_items/314", "If a patient with nan cancer has pml::rara fusion, one recommended therapy is tretinoin. entry url: https://civicdb.org/links/evidence_items/316", "If a patient with Breast Cancer cancer has pten r233*, one recommended therapy is mtor inhibitor. entry url: https://civicdb.org/links/evidence_items/317", "If a patient with Breast Cancer cancer has tp53 r175h, one recommended therapy is doxorubicin. entry url: https://civicdb.org/links/evidence_items/319", "If a patient with nan cancer has tsc1 frameshift truncation, one recommended therapy is everolimus. entry url: https://civicdb.org/links/evidence_items/320", "If a patient with Chronic Myelogenous Leukemia cancer has bcr::abl1 fusion, one recommended therapy is imatinib. entry url: https://civicdb.org/links/evidence_items/344", "If a patient with Breast Cancer cancer has tp53 r249, one recommended therapy is doxorubicin. entry url: https://civicdb.org/links/evidence_items/399", "If a patient with nan cancer has mef2d::csf1r fusion, one recommended therapy is gw-2580 + imatinib. entry url: https://civicdb.org/links/evidence_items/403", "If a patient with Non-Small Cell Lung Cancer cancer has egfr exon 19 deletion, one recommended therapy is gefitinib + erlotinib. entry url: https://civicdb.org/links/evidence_items/413", "If a patient with Prostate Cancer cancer has igf2 overexpression, one recommended therapy is cabazitaxel + linsitinib + docetaxel. entry url: https://civicdb.org/links/evidence_items/414", "If a patient with nan cancer has apc mutation, one recommended therapy is jw55. entry url: https://civicdb.org/links/evidence_items/445", "If a patient with Colorectal Cancer cancer has apc mutation, one recommended therapy is g007-lk. entry url: https://civicdb.org/links/evidence_items/446", "If a patient with Glioblastoma cancer has atm mutation, one recommended therapy is temozolomide. entry url: https://civicdb.org/links/evidence_items/452", "If a patient with Melanoma cancer has atm mutation, one recommended therapy is temozolomide. entry url: https://civicdb.org/links/evidence_items/453", "If a patient with Cancer cancer has atm underexpression, one recommended therapy is ku-0060648 + nu7441. entry url: https://civicdb.org/links/evidence_items/454", "If a patient with hematologic cancer has atm mutation, one recommended therapy is olaparib. entry url: https://civicdb.org/links/evidence_items/455", "If a patient with nan cancer has aurka amplification, one recommended therapy is cisplatin + alisertib. entry url: https://civicdb.org/links/evidence_items/456", "If a patient with Thymic Carcinoma cancer has kit v560del, one recommended therapy is imatinib. entry url: https://civicdb.org/links/evidence_items/486", "If a patient with Prostate Cancer cancer has pten loss, one recommended therapy is temsirolimus. entry url: https://civicdb.org/links/evidence_items/507", "If a patient with nan cancer has erbb2 amplification, one recommended therapy is trastuzumab. entry url: https://civicdb.org/links/evidence_items/528", "If a patient with nan cancer has erbb2 amplification, one recommended therapy is trastuzumab. entry url: https://civicdb.org/links/evidence_items/529", "If a patient with nan cancer has cdk12 loss-of-function, one recommended therapy is olaparib. entry url: https://civicdb.org/links/evidence_items/623", "If a patient with Chronic Myelogenous Leukemia cancer has bcr::abl1 fusion, abl1 f317l, one recommended therapy is ponatinib. entry url: https://civicdb.org/links/evidence_items/638", "If a patient with Chronic Myelogenous Leukemia cancer has bcr::abl1 fusion, abl1 t315i, one recommended therapy is ponatinib. entry url: https://civicdb.org/links/evidence_items/639", "If a patient with Non-Small Cell Lung Cancer cancer has egfr t790m, one recommended therapy is rociletinib. entry url: https://civicdb.org/links/evidence_items/646", "If a patient with Prostate Cancer cancer has atm s2289*, one recommended therapy is olaparib. entry url: https://civicdb.org/links/evidence_items/647", "If a patient with Prostate Cancer cancer has atm n2875h, one recommended therapy is olaparib. entry url: https://civicdb.org/links/evidence_items/648", "If a patient with Prostate Cancer cancer has brca2 loss-of-function, one recommended therapy is olaparib. entry url: https://civicdb.org/links/evidence_items/650", "If a patient with Gastrointestinal Stromal Tumor cancer has pdgfra v561a, one recommended therapy is imatinib. entry url: https://civicdb.org/links/evidence_items/652", "If a patient with Gastrointestinal Stromal Tumor cancer has kit exon 11 mutation, one recommended therapy is imatinib. entry url: https://civicdb.org/links/evidence_items/654", "If a patient with Non-Small Cell Lung Cancer cancer has xrcc1 r194w, one recommended therapy is docetaxel + vinorelbine + gemcitabine. entry url: https://civicdb.org/links/evidence_items/659", "If a patient with nan cancer has gstp1 deletion, one recommended therapy is carboplatin + paclitaxel + cisplatin. entry url: https://civicdb.org/links/evidence_items/660", "If a patient with nan cancer has mthfr a222v, one recommended therapy is fluorouracil. entry url: https://civicdb.org/links/evidence_items/669", "If a patient with Colorectal Cancer cancer has gstp1 i105v, one recommended therapy is folfox regimen. entry url: https://civicdb.org/links/evidence_items/670", "If a patient with Cervical Cancer cancer has xrcc1 q399r, one recommended therapy is cisplatin + carboplatin. entry url: https://civicdb.org/links/evidence_items/673", "If a patient with Ovarian Cancer cancer has abcb1 s893t, one recommended therapy is paclitaxel. entry url: https://civicdb.org/links/evidence_items/674", "If a patient with Non-Small Cell Lung Cancer cancer has abcb1 i1145i, one recommended therapy is cisplatin + carboplatin. entry url: https://civicdb.org/links/evidence_items/675", "If a patient with Non-Small Cell Lung Cancer cancer has ercc2 k751q, one recommended therapy is carboplatin + paclitaxel. entry url: https://civicdb.org/links/evidence_items/677", "If a patient with Lung Squamous Cell Carcinoma cancer has fgfr1 amplification, one recommended therapy is pd173074. entry url: https://civicdb.org/links/evidence_items/680", "If a patient with Lung Cancer cancer has fgfr1 expression, one recommended therapy is ponatinib. entry url: https://civicdb.org/links/evidence_items/681", "If a patient with Non-Small Cell Lung Cancer cancer has fgfr1 amplification, one recommended therapy is pd173074. entry url: https://civicdb.org/links/evidence_items/686", "If a patient with Non-Small Cell Lung Cancer cancer has v::ros1 fusion, one recommended therapy is crizotinib. entry url: https://civicdb.org/links/evidence_items/688", "If a patient with gastric adeno cancer has met amplification, one recommended therapy is onartuzumab. entry url: https://civicdb.org/links/evidence_items/689", "If a patient with Non-Small Cell Lung Cancer cancer has egfr overexpression, one recommended therapy is epidermal growth factor receptor tyrosine kinase inhibitor. entry url: https://civicdb.org/links/evidence_items/693", "If a patient with Lung Adenocarcinoma cancer has kif5b::ret fusion, one recommended therapy is vandetanib. entry url: https://civicdb.org/links/evidence_items/698", "If a patient with Cancer cancer has hras mutation, one recommended therapy is selumetinib + mtor kinase inhibitor azd8055 + everolimus + mirdametinib + binimetinib. entry url: https://civicdb.org/links/evidence_items/700", "If a patient with Melanoma cancer has cd274 expression, one recommended therapy is pembrolizumab + nivolumab. entry url: https://civicdb.org/links/evidence_items/704", "If a patient with nan cancer has mtor mutation, one recommended therapy is pazopanib + everolimus. entry url: https://civicdb.org/links/evidence_items/705", "If a patient with Breast Cancer cancer has akt2 expression, one recommended therapy is trastuzumab. entry url: https://civicdb.org/links/evidence_items/706", "If a patient with Melanoma cancer has akt1 e17k, one recommended therapy is uprosertib. entry url: https://civicdb.org/links/evidence_items/707", "If a patient with Melanoma cancer has pten loss, one recommended therapy is uprosertib. entry url: https://civicdb.org/links/evidence_items/708", "If a patient with Breast Cancer cancer has akt1 e17k, one recommended therapy is capivasertib. entry url: https://civicdb.org/links/evidence_items/709", "If a patient with Breast Cancer cancer has pik3ca e545k, one recommended therapy is akt inhibitor mk2206 + pictilisib. entry url: https://civicdb.org/links/evidence_items/710", "If a patient with Breast Cancer cancer has pten loss, one recommended therapy is pi3kbeta inhibitor azd8186. entry url: https://civicdb.org/links/evidence_items/711", "If a patient with Melanoma cancer has mtor h1968y, one recommended therapy is capivasertib + pi3k/bet inhibitor ly294002. entry url: https://civicdb.org/links/evidence_items/713", "If a patient with Cancer cancer has pten loss, one recommended therapy is paclitaxel + buparlisib + carboplatin. entry url: https://civicdb.org/links/evidence_items/714", "If a patient with Breast Cancer cancer has nf2 k159fs, one recommended therapy is temsirolimus. entry url: https://civicdb.org/links/evidence_items/715", "If a patient with Melanoma cancer has mtor p2213s, one recommended therapy is capivasertib + pi3k/bet inhibitor ly294002. entry url: https://civicdb.org/links/evidence_items/722", "If a patient with Melanoma cancer has agk::braf fusion, one recommended therapy is sorafenib. entry url: https://civicdb.org/links/evidence_items/723", "If a patient with Melanoma cancer has papss1::braf fusion, one recommended therapy is trametinib. entry url: https://civicdb.org/links/evidence_items/726", "If a patient with Melanoma cancer has trim24::braf fusion, one recommended therapy is trametinib. entry url: https://civicdb.org/links/evidence_items/727", "If a patient with Melanoma cancer has braf l597r, one recommended therapy is vemurafenib. entry url: https://civicdb.org/links/evidence_items/728", "If a patient with Colorectal Cancer cancer has nt5e overexpression, one recommended therapy is cetuximab. entry url: https://civicdb.org/links/evidence_items/730", "If a patient with Acute Myeloid Leukemia cancer has idh1 r132c, one recommended therapy is gsk321. entry url: https://civicdb.org/links/evidence_items/732", "If a patient with Non-Small Cell Lung Cancer cancer has met amplification, one recommended therapy is crizotinib. entry url: https://civicdb.org/links/evidence_items/735", "If a patient with Cancer cancer has met exon 14 skipping mutation, one recommended therapy is crizotinib. entry url: https://civicdb.org/links/evidence_items/736", "If a patient with Non-Small Cell Lung Cancer cancer has egfr overexpression, one recommended therapy is epidermal growth factor receptor tyrosine kinase inhibitor. entry url: https://civicdb.org/links/evidence_items/737", "If a patient with Merkel Cell Carcinoma cancer has pik3ca p471l, one recommended therapy is idelalisib. entry url: https://civicdb.org/links/evidence_items/739", "If a patient with Breast Cancer cancer has ret overexpression, one recommended therapy is vandetanib. entry url: https://civicdb.org/links/evidence_items/740", "If a patient with Lung Adenocarcinoma cancer has rit1 mutation, one recommended therapy is pictilisib + selumetinib. entry url: https://civicdb.org/links/evidence_items/742", "If a patient with Non-Small Cell Lung Cancer cancer has cd274 expression, one recommended therapy is pembrolizumab + nivolumab. entry url: https://civicdb.org/links/evidence_items/743", "If a patient with Neuroblastoma cancer has mycn amplification, one recommended therapy is fact complex-targeting curaxin cbl0137. entry url: https://civicdb.org/links/evidence_items/744", "If a patient with Basal Cell Carcinoma cancer has smo mutation, one recommended therapy is arsenic trioxide + psi. entry url: https://civicdb.org/links/evidence_items/747", "If a patient with Medulloblastoma cancer has ptch1 mutation, one recommended therapy is sonidegib. entry url: https://civicdb.org/links/evidence_items/748", "If a patient with Medulloblastoma cancer has ptch1 loh, one recommended therapy is vismodegib. entry url: https://civicdb.org/links/evidence_items/749", "If a patient with Prostate Cancer cancer has stk11 underexpression, one recommended therapy is sb202190. entry url: https://civicdb.org/links/evidence_items/751", "If a patient with Head And Neck Squamous Cell Carcinoma cancer has cdkn2a p16 expression, one recommended therapy is panitumumab. entry url: https://civicdb.org/links/evidence_items/753", "If a patient with nan cancer has pik3ca amplification, one recommended therapy is pictilisib. entry url: https://civicdb.org/links/evidence_items/756", "If a patient with Melanoma cancer has braf v600e, one recommended therapy is pictilisib. entry url: https://civicdb.org/links/evidence_items/757", "If a patient with Breast Cancer cancer has erbb2 amplification, one recommended therapy is akti-1/2. entry url: https://civicdb.org/links/evidence_items/760", "If a patient with nan cancer has erbb2 amplification, one recommended therapy is neratinib. entry url: https://civicdb.org/links/evidence_items/761", "If a patient with Non-Small Cell Lung Cancer cancer has egfr t790m, one recommended therapy is rociletinib. entry url: https://civicdb.org/links/evidence_items/762", "If a patient with Melanoma cancer has erbb4 mutation, one recommended therapy is lapatinib. entry url: https://civicdb.org/links/evidence_items/770", "If a patient with Colorectal Cancer cancer has pik3ca mutation, one recommended therapy is cabozantinib. entry url: https://civicdb.org/links/evidence_items/771", "If a patient with Glioblastoma cancer has egfr viii, one recommended therapy is epidermal growth factor receptor tyrosine kinase inhibitor. entry url: https://civicdb.org/links/evidence_items/772", "If a patient with Glioblastoma cancer has egfr amplification, egfr egfrviii, one recommended therapy is afatinib. entry url: https://civicdb.org/links/evidence_items/773", "If a patient with Glioblastoma cancer has pten expression, one recommended therapy is epidermal growth factor receptor tyrosine kinase inhibitor. entry url: https://civicdb.org/links/evidence_items/774", "If a patient with Glioblastoma cancer has pten expression, one recommended therapy is dacomitinib. entry url: https://civicdb.org/links/evidence_items/775", "If a patient with Head And Neck Squamous Cell Carcinoma cancer has nrg1 expression, one recommended therapy is lapatinib. entry url: https://civicdb.org/links/evidence_items/776", "If a patient with Ovarian Cancer cancer has nrg1 expression, one recommended therapy is seribantumab. entry url: https://civicdb.org/links/evidence_items/778", "If a patient with Non-Small Cell Lung Cancer cancer has nrg1 expression, one recommended therapy is gemcitabine + cisplatin + paclitaxel + carboplatin. entry url: https://civicdb.org/links/evidence_items/779", "If a patient with Colorectal Cancer cancer has egfr g724s, one recommended therapy is cetuximab. entry url: https://civicdb.org/links/evidence_items/786", "If a patient with Colorectal Cancer cancer has egfr g719s, one recommended therapy is cetuximab. entry url: https://civicdb.org/links/evidence_items/787", "If a patient with Colorectal Cancer cancer has areg expression, one recommended therapy is cetuximab. entry url: https://civicdb.org/links/evidence_items/788", "If a patient with Colorectal Cancer cancer has ereg expression, one recommended therapy is cetuximab. entry url: https://civicdb.org/links/evidence_items/789", "If a patient with Head And Neck Squamous Cell Carcinoma cancer has mapk1 e322k, one recommended therapy is erlotinib. entry url: https://civicdb.org/links/evidence_items/791", "If a patient with Non-Small Cell Lung Cancer cancer has kras a146v, one recommended therapy is abemaciclib. entry url: https://civicdb.org/links/evidence_items/794", "If a patient with Non-Small Cell Lung Cancer cancer has kras g12v, one recommended therapy is palbociclib. entry url: https://civicdb.org/links/evidence_items/795", "If a patient with Papillary Renal Cell Carcinoma cancer has met mutation, one recommended therapy is foretinib. entry url: https://civicdb.org/links/evidence_items/796", "If a patient with Lung Adenocarcinoma cancer has met exon 14 skipping mutation, one recommended therapy is crizotinib. entry url: https://civicdb.org/links/evidence_items/797", "If a patient with Head And Neck Squamous Cell Carcinoma cancer has fgfr1 expression, one recommended therapy is infigratinib. entry url: https://civicdb.org/links/evidence_items/799", "If a patient with gastric adeno cancer has fgfr1 expression, one recommended therapy is infigratinib. entry url: https://civicdb.org/links/evidence_items/800", "If a patient with nan cancer has fgfr1 expression, one recommended therapy is dovitinib + pd173074. entry url: https://civicdb.org/links/evidence_items/801", "If a patient with nan cancer has fgfr3 overexpression, one recommended therapy is tyrosine kinase inhibitor su5402 + dovitinib + pd173074. entry url: https://civicdb.org/links/evidence_items/803", "If a patient with head and neck cancer has ptprd mutation, one recommended therapy is jsi-124. entry url: https://civicdb.org/links/evidence_items/807", "If a patient with Prostate Cancer cancer has defa1 expression, one recommended therapy is docetaxel. entry url: https://civicdb.org/links/evidence_items/808", "If a patient with Colorectal Cancer cancer has notch1 amplification, one recommended therapy is notch1 antibody (pf-06293622). entry url: https://civicdb.org/links/evidence_items/811", "If a patient with Non-Small Cell Lung Cancer cancer has nrg1 expression, one recommended therapy is patritumab. entry url: https://civicdb.org/links/evidence_items/813", "If a patient with Non-Small Cell Lung Cancer cancer has wee1 rs3910384, one recommended therapy is platinum compound + gemcitabine. entry url: https://civicdb.org/links/evidence_items/814", "If a patient with Head And Neck Squamous Cell Carcinoma cancer has ptprt promoter hypermethylation, one recommended therapy is jsi-124 + stattic. entry url: https://civicdb.org/links/evidence_items/817", "If a patient with Colorectal Cancer cancer has vegfa decreased peri-therapeutic expression, one recommended therapy is bevacizumab + levoleucovorin + irinotecan + fluorouracil. entry url: https://civicdb.org/links/evidence_items/818", "If a patient with Ovarian Cancer cancer has dnmt1 expression, one recommended therapy is decitabine. entry url: https://civicdb.org/links/evidence_items/819", "If a patient with Ovarian Cancer cancer has kras mutation, one recommended therapy is decitabine. entry url: https://civicdb.org/links/evidence_items/820", "If a patient with Lung Cancer cancer has pdcd4 expression, one recommended therapy is paclitaxel. entry url: https://civicdb.org/links/evidence_items/821", "If a patient with Glioblastoma cancer has mgmt rs16906252, one recommended therapy is temozolomide. entry url: https://civicdb.org/links/evidence_items/822", "If a patient with Breast Cancer cancer has tff3 expression, one recommended therapy is tamoxifen + aminoglutethimide. entry url: https://civicdb.org/links/evidence_items/823", "If a patient with Cancer cancer has cd44 cd44s expression, one recommended therapy is rg7356. entry url: https://civicdb.org/links/evidence_items/825", "If a patient with nan cancer has casp8 overexpression, one recommended therapy is conatumumab. entry url: https://civicdb.org/links/evidence_items/831", "If a patient with Lung Adenocarcinoma cancer has met amplification, one recommended therapy is crizotinib. entry url: https://civicdb.org/links/evidence_items/836", "If a patient with Non-Small Cell Lung Cancer cancer has smarca4 underexpression, one recommended therapy is cisplatin + vinorelbine. entry url: https://civicdb.org/links/evidence_items/837", "If a patient with Non-Small Cell Lung Cancer cancer has eml4::alk fusion, alk c1156y, one recommended therapy is lorlatinib. entry url: https://civicdb.org/links/evidence_items/842", "If a patient with Non-Small Cell Lung Cancer cancer has eml4::alk fusion, alk l1198f, alk c1156y, one recommended therapy is crizotinib. entry url: https://civicdb.org/links/evidence_items/844", "If a patient with Prostate Cancer cancer has brca1 loss-of-function, one recommended therapy is olaparib. entry url: https://civicdb.org/links/evidence_items/845", "If a patient with gastric adeno cancer has tp53 mutation, one recommended therapy is chemotherapy. entry url: https://civicdb.org/links/evidence_items/850", "If a patient with Breast Cancer cancer has tp53 mutation, one recommended therapy is doxorubicin. entry url: https://civicdb.org/links/evidence_items/851", "If a patient with Colorectal Cancer cancer has egfr amplification, one recommended therapy is panitumumab + cetuximab. entry url: https://civicdb.org/links/evidence_items/854", "If a patient with Breast Cancer cancer has ar overexpression, one recommended therapy is dactolisib. entry url: https://civicdb.org/links/evidence_items/859", "If a patient with Cancer cancer has nrg1 expression, one recommended therapy is anti-erbb3 monoclonal antibody av-203. entry url: https://civicdb.org/links/evidence_items/861", "If a patient with nan cancer has erbb3 expression, one recommended therapy is pertuzumab + 9f7-f11. entry url: https://civicdb.org/links/evidence_items/865", "If a patient with Colorectal Cancer cancer has slfn11 expression, one recommended therapy is 7-ethyl-10-hydroxycamptothecin. entry url: https://civicdb.org/links/evidence_items/870", "If a patient with Non-Small Cell Lung Cancer cancer has birc5 nuclear expression, one recommended therapy is platinum compound + taxane compound. entry url: https://civicdb.org/links/evidence_items/874", "If a patient with Colorectal Cancer cancer has tp53 wildtype, one recommended therapy is cetuximab + capecitabine + oxaliplatin. entry url: https://civicdb.org/links/evidence_items/875", "If a patient with Endometrial Cancer cancer has mre11 loss, one recommended therapy is talazoparib. entry url: https://civicdb.org/links/evidence_items/876", "If a patient with gastric adeno cancer has atm underexpression, one recommended therapy is olaparib. entry url: https://civicdb.org/links/evidence_items/878", "If a patient with Lung Adenocarcinoma cancer has egfr l858r, one recommended therapy is afatinib. entry url: https://civicdb.org/links/evidence_items/879", "If a patient with Lung Adenocarcinoma cancer has egfr exon 19 deletion, one recommended therapy is afatinib. entry url: https://civicdb.org/links/evidence_items/880", "If a patient with Non-Small Cell Lung Cancer cancer has egfr exon 19 deletion, one recommended therapy is afatinib. entry url: https://civicdb.org/links/evidence_items/881", "If a patient with Lung Adenocarcinoma cancer has egfr exon 19 deletion, one recommended therapy is afatinib. entry url: https://civicdb.org/links/evidence_items/882", "If a patient with Lung Adenocarcinoma cancer has egfr l858r, one recommended therapy is afatinib. entry url: https://civicdb.org/links/evidence_items/883", "If a patient with Non-Small Cell Lung Cancer cancer has egfr exon 19 deletion, one recommended therapy is erlotinib. entry url: https://civicdb.org/links/evidence_items/884", "If a patient with Non-Small Cell Lung Cancer cancer has egfr l858r, one recommended therapy is erlotinib. entry url: https://civicdb.org/links/evidence_items/885", "If a patient with nan cancer has erbb2 amplification, one recommended therapy is afatinib. entry url: https://civicdb.org/links/evidence_items/886", "If a patient with nan cancer has erbb2 amplification, one recommended therapy is afatinib + trastuzumab + lapatinib. entry url: https://civicdb.org/links/evidence_items/887", "If a patient with Colorectal Cancer cancer has top1 amplification, one recommended therapy is irinotecan. entry url: https://civicdb.org/links/evidence_items/888", "If a patient with Head And Neck Squamous Cell Carcinoma cancer has cdkn1b expression, one recommended therapy is fluorouracil + cisplatin. entry url: https://civicdb.org/links/evidence_items/889", "If a patient with Lung Squamous Cell Carcinoma cancer has met amplification, one recommended therapy is crizotinib. entry url: https://civicdb.org/links/evidence_items/890", "If a patient with Colorectal Cancer cancer has fgfr1 expression, one recommended therapy is infigratinib. entry url: https://civicdb.org/links/evidence_items/896", "If a patient with Cancer cancer has naprt promoter hypermethylation, one recommended therapy is gne-617. entry url: https://civicdb.org/links/evidence_items/897", "If a patient with Non-Small Cell Lung Cancer cancer has egfr exon 18 overexpression, one recommended therapy is erlotinib + bevacizumab. entry url: https://civicdb.org/links/evidence_items/898", "If a patient with Mantle Cell Lymphoma cancer has zeb1 expression, one recommended therapy is doxorubicin + salinomycin. entry url: https://civicdb.org/links/evidence_items/900", "If a patient with Colorectal Cancer cancer has ptp4a3 overexpression, one recommended therapy is cetuximab. entry url: https://civicdb.org/links/evidence_items/902", "If a patient with esophageal cancer has tp53 wildtype, one recommended therapy is chemotherapy. entry url: https://civicdb.org/links/evidence_items/906", "If a patient with Non-Small Cell Lung Cancer cancer has tyms underexpression, one recommended therapy is pemetrexed. entry url: https://civicdb.org/links/evidence_items/907", "If a patient with Prostate Cancer cancer has tyms underexpression, one recommended therapy is pemetrexed. entry url: https://civicdb.org/links/evidence_items/908", "If a patient with Breast Cancer cancer has top2a expression, one recommended therapy is doxorubicin. entry url: https://civicdb.org/links/evidence_items/909", "If a patient with Ovarian Cancer cancer has top1 expression, one recommended therapy is cyclophosphamide + topotecan + carboplatin. entry url: https://civicdb.org/links/evidence_items/910", "If a patient with Colorectal Cancer cancer has egfr amplification, one recommended therapy is cetuximab. entry url: https://civicdb.org/links/evidence_items/911", "If a patient with Colorectal Cancer cancer has top1 expression, one recommended therapy is irinotecan. entry url: https://civicdb.org/links/evidence_items/912", "If a patient with Cancer cancer has prkaa2 t172 phosphorylation, one recommended therapy is acly sirna. entry url: https://civicdb.org/links/evidence_items/913", "If a patient with Colorectal Cancer cancer has hspa5 expression, one recommended therapy is fluorouracil. entry url: https://civicdb.org/links/evidence_items/914", "If a patient with gastric adeno cancer has eif4ebp1 phosphorylation, one recommended therapy is everolimus. entry url: https://civicdb.org/links/evidence_items/918", "If a patient with Gastrointestinal Stromal Tumor cancer has kit mutation, one recommended therapy is pictilisib + imatinib. entry url: https://civicdb.org/links/evidence_items/919", "If a patient with Breast Cancer cancer has tubb3 expression, one recommended therapy is taxane compound. entry url: https://civicdb.org/links/evidence_items/921", "If a patient with Non-Small Cell Lung Cancer cancer has egfr y1092 phosphorylation, one recommended therapy is erlotinib + gefitinib. entry url: https://civicdb.org/links/evidence_items/923", "If a patient with Sarcoma cancer has igf1r nuclear expression, one recommended therapy is igf1r monoclonal antibody. entry url: https://civicdb.org/links/evidence_items/924", "If a patient with Breast Cancer cancer has foxp3 expression, one recommended therapy is epirubicin. entry url: https://civicdb.org/links/evidence_items/928", "If a patient with gastric adeno cancer has rps6 phosphorylation, one recommended therapy is everolimus. entry url: https://civicdb.org/links/evidence_items/930", "If a patient with Non-Small Cell Lung Cancer cancer has jak1 overexpression, one recommended therapy is enzastaurin. entry url: https://civicdb.org/links/evidence_items/931", "If a patient with nan cancer has brca1 expression, one recommended therapy is vinorelbine. entry url: https://civicdb.org/links/evidence_items/933", "If a patient with Cancer cancer has dusp6 expression, one recommended therapy is trametinib. entry url: https://civicdb.org/links/evidence_items/934", "If a patient with Cancer cancer has kras mutation, one recommended therapy is trametinib. entry url: https://civicdb.org/links/evidence_items/935", "If a patient with Cancer cancer has braf mutation, one recommended therapy is trametinib. entry url: https://civicdb.org/links/evidence_items/936", "If a patient with pancreatic cancer has kras g12d, one recommended therapy is akt inhibitor mk2206. entry url: https://civicdb.org/links/evidence_items/937", "If a patient with pancreatic cancer has pten loss, one recommended therapy is akt inhibitor mk2206. entry url: https://civicdb.org/links/evidence_items/938", "If a patient with nan cancer has hspb1 expression, one recommended therapy is gemcitabine. entry url: https://civicdb.org/links/evidence_items/939", "If a patient with Lung Cancer cancer has nqo1 p187s, one recommended therapy is amrubicin. entry url: https://civicdb.org/links/evidence_items/941", "If a patient with Ovarian Cancer cancer has brca1 underexpression, one recommended therapy is taxane compound + platinum compound. entry url: https://civicdb.org/links/evidence_items/942", "If a patient with Colorectal Cancer cancer has kras mutation, one recommended therapy is epidermal growth factor receptor tyrosine kinase inhibitor + immunomodulatory oligonucleotide. entry url: https://civicdb.org/links/evidence_items/943", "If a patient with Non-Small Cell Lung Cancer cancer has v::alk fusion, one recommended therapy is pemetrexed. entry url: https://civicdb.org/links/evidence_items/945", "If a patient with Colorectal Cancer cancer has kras mutation, one recommended therapy is dasatinib + cetuximab. entry url: https://civicdb.org/links/evidence_items/947", "If a patient with Non-Small Cell Lung Cancer cancer has egfr amplification, one recommended therapy is epidermal growth factor receptor tyrosine kinase inhibitor. entry url: https://civicdb.org/links/evidence_items/948", "If a patient with Non-Small Cell Lung Cancer cancer has egfr overexpression, one recommended therapy is gefitinib. entry url: https://civicdb.org/links/evidence_items/954", "If a patient with Breast Cancer cancer has pten expression, one recommended therapy is trastuzumab. entry url: https://civicdb.org/links/evidence_items/955", "If a patient with Lung Adenocarcinoma cancer has erbb2 kinase domain mutation, one recommended therapy is afatinib. entry url: https://civicdb.org/links/evidence_items/959", "If a patient with Non-Small Cell Lung Cancer cancer has erbb2 y772_a775dup, one recommended therapy is sirolimus + afatinib. entry url: https://civicdb.org/links/evidence_items/960", "If a patient with nan cancer has erbb2 amplification, one recommended therapy is afatinib. entry url: https://civicdb.org/links/evidence_items/961", "If a patient with Pancreatic Adenocarcinoma cancer has erbb2 amplification, one recommended therapy is afatinib. entry url: https://civicdb.org/links/evidence_items/962", "If a patient with Non-Small Cell Lung Cancer cancer has egfr t790m, one recommended therapy is osimertinib. entry url: https://civicdb.org/links/evidence_items/963", "If a patient with Non-Small Cell Lung Cancer cancer has egfr t790m, one recommended therapy is osimertinib. entry url: https://civicdb.org/links/evidence_items/965", "If a patient with Non-Small Cell Lung Cancer cancer has egfr t790m, one recommended therapy is osimertinib. entry url: https://civicdb.org/links/evidence_items/966", "If a patient with Non-Small Cell Lung Cancer cancer has egfr t790m, one recommended therapy is rociletinib + osimertinib. entry url: https://civicdb.org/links/evidence_items/967", "If a patient with Non-Small Cell Lung Cancer cancer has egfr l858r, one recommended therapy is afatinib. entry url: https://civicdb.org/links/evidence_items/968", "If a patient with Non-Small Cell Lung Cancer cancer has egfr exon 19 deletion, one recommended therapy is afatinib. entry url: https://civicdb.org/links/evidence_items/969", "If a patient with Glioblastoma cancer has egfr viii, one recommended therapy is rindopepimut. entry url: https://civicdb.org/links/evidence_items/971", "If a patient with Breast Cancer cancer has erbb2 serum levels, one recommended therapy is lapatinib. entry url: https://civicdb.org/links/evidence_items/972", "If a patient with Colorectal Cancer cancer has lmna::ntrk1 fusion, one recommended therapy is larotrectinib. entry url: https://civicdb.org/links/evidence_items/978", "If a patient with Colorectal Cancer cancer has tpm3::ntrk1 fusion, one recommended therapy is larotrectinib. entry url: https://civicdb.org/links/evidence_items/978", "If a patient with Oligodendroglioma cancer has idh1 r132h, one recommended therapy is agi-5198. entry url: https://civicdb.org/links/evidence_items/979", "If a patient with Lung Adenocarcinoma cancer has egfr exon 19 deletion, one recommended therapy is afatinib. entry url: https://civicdb.org/links/evidence_items/981", "If a patient with Lung Adenocarcinoma cancer has egfr l858r, one recommended therapy is afatinib. entry url: https://civicdb.org/links/evidence_items/982", "If a patient with Lung Adenocarcinoma cancer has egfr exon 19 deletion, one recommended therapy is afatinib. entry url: https://civicdb.org/links/evidence_items/983", "If a patient with Melanoma cancer has hla-dra expression, one recommended therapy is pembrolizumab + atezolizumab + nivolumab. entry url: https://civicdb.org/links/evidence_items/985", "If a patient with Lymphoplasmacytic Lymphoma cancer has myd88 l265p, one recommended therapy is ibrutinib. entry url: https://civicdb.org/links/evidence_items/986", "If a patient with Colorectal Cancer cancer has kras mutation, one recommended therapy is b-raf/vegfr-2 inhibitor raf265 + selumetinib. entry url: https://civicdb.org/links/evidence_items/988", "If a patient with Non-Small Cell Lung Cancer cancer has kras mutation, one recommended therapy is b-raf/vegfr-2 inhibitor raf265 + selumetinib. entry url: https://civicdb.org/links/evidence_items/989", "If a patient with Colorectal Cancer cancer has kras mutation, one recommended therapy is trametinib + afatinib. entry url: https://civicdb.org/links/evidence_items/991", "If a patient with Non-Small Cell Lung Cancer cancer has kras mutation, one recommended therapy is trametinib + afatinib. entry url: https://civicdb.org/links/evidence_items/992", "If a patient with Non-Small Cell Lung Cancer cancer has kras mutation, one recommended therapy is selumetinib + docetaxel. entry url: https://civicdb.org/links/evidence_items/999", "If a patient with Neuroblastoma cancer has nras q61k, one recommended therapy is binimetinib + everolimus. entry url: https://civicdb.org/links/evidence_items/1002", "If a patient with Pancreatic Adenocarcinoma cancer has kras mutation, one recommended therapy is pi3kbeta inhibitor azd8186 + sch772984. entry url: https://civicdb.org/links/evidence_items/1003", "If a patient with Colorectal Cancer cancer has kras mutation, one recommended therapy is teprotumumab + selumetinib. entry url: https://civicdb.org/links/evidence_items/1004", "If a patient with Melanoma cancer has braf v600e, one recommended therapy is dactolisib + selumetinib. entry url: https://civicdb.org/links/evidence_items/1005", "If a patient with Breast Cancer cancer has erbb2 amplification, one recommended therapy is trastuzumab + lapatinib. entry url: https://civicdb.org/links/evidence_items/1006", "If a patient with nan cancer has erbb2 amplification, one recommended therapy is lapatinib + trastuzumab. entry url: https://civicdb.org/links/evidence_items/1007", "If a patient with nan cancer has erbb2 amplification, one recommended therapy is trastuzumab + lapatinib. entry url: https://civicdb.org/links/evidence_items/1009", "If a patient with nan cancer has erbb2 amplification, one recommended therapy is afatinib. entry url: https://civicdb.org/links/evidence_items/1011", "If a patient with nan cancer has erbb2 amplification, one recommended therapy is trastuzumab + afatinib. entry url: https://civicdb.org/links/evidence_items/1013", "If a patient with Prostate Cancer cancer has mre11 frameshift, one recommended therapy is olaparib. entry url: https://civicdb.org/links/evidence_items/1016", "If a patient with nan cancer has egfr viii, one recommended therapy is nimotuzumab. entry url: https://civicdb.org/links/evidence_items/1017", "If a patient with Lung Adenocarcinoma cancer has v::ntrk1 fusion, one recommended therapy is crizotinib + larotrectinib + lestaurtinib. entry url: https://civicdb.org/links/evidence_items/1019", "If a patient with Colorectal Cancer cancer has areg expression, one recommended therapy is panitumumab. entry url: https://civicdb.org/links/evidence_items/1020", "If a patient with Colorectal Cancer cancer has ereg expression, one recommended therapy is panitumumab. entry url: https://civicdb.org/links/evidence_items/1021", "If a patient with gastric adeno cancer has erbb2 amplification, one recommended therapy is trastuzumab. entry url: https://civicdb.org/links/evidence_items/1022", "If a patient with gastric adeno cancer has erbb2 amplification, one recommended therapy is lapatinib. entry url: https://civicdb.org/links/evidence_items/1023", "If a patient with Endometrial Cancer cancer has kit expression, one recommended therapy is imatinib. entry url: https://civicdb.org/links/evidence_items/1024", "If a patient with Endometrial Cancer cancer has kit expression, one recommended therapy is imatinib. entry url: https://civicdb.org/links/evidence_items/1025", "If a patient with Non-Small Cell Lung Cancer cancer has v::ros1 fusion, one recommended therapy is crizotinib. entry url: https://civicdb.org/links/evidence_items/1030", "If a patient with nan cancer has vhl loss, one recommended therapy is temsirolimus. entry url: https://civicdb.org/links/evidence_items/1035", "If a patient with Acute Myeloid Leukemia cancer has flt3 itd, one recommended therapy is sorafenib. entry url: https://civicdb.org/links/evidence_items/1040", "If a patient with Lung Adenocarcinoma cancer has erbb2 kinase domain mutation, one recommended therapy is trastuzumab. entry url: https://civicdb.org/links/evidence_items/1043", "If a patient with nan cancer has erbb2 amplification, one recommended therapy is trastuzumab + irinotecan. entry url: https://civicdb.org/links/evidence_items/1044", "If a patient with Lung Adenocarcinoma cancer has erbb2 y772_a775dup, one recommended therapy is afatinib. entry url: https://civicdb.org/links/evidence_items/1045", "If a patient with lung cancer has erbb2 y772_a775dup, one recommended therapy is afatinib. entry url: https://civicdb.org/links/evidence_items/1047", "If a patient with Lung Adenocarcinoma cancer has erbb2 g778_p780dup, one recommended therapy is dacomitinib. entry url: https://civicdb.org/links/evidence_items/1048", "If a patient with Non-Small Cell Lung Cancer cancer has erbb2 amplification, one recommended therapy is trastuzumab emtansine. entry url: https://civicdb.org/links/evidence_items/1050", "If a patient with Colorectal Cancer cancer has egfr g465r, one recommended therapy is futuximab/modotuximab mixture. entry url: https://civicdb.org/links/evidence_items/1057", "If a patient with Non-Small Cell Lung Cancer cancer has ets2 rs461155, one recommended therapy is cisplatin + paclitaxel. entry url: https://civicdb.org/links/evidence_items/1060", "If a patient with nan cancer has erbb2 amplification, one recommended therapy is docetaxel + trastuzumab + pertuzumab. entry url: https://civicdb.org/links/evidence_items/1077", "If a patient with Colorectal Cancer cancer has egfr s492r, one recommended therapy is panitumumab. entry url: https://civicdb.org/links/evidence_items/1078", "If a patient with Colorectal Cancer cancer has egfr s492r, one recommended therapy is futuximab/modotuximab mixture + panitumumab. entry url: https://civicdb.org/links/evidence_items/1079", "If a patient with Colorectal Cancer cancer has egfr r451c, one recommended therapy is cetuximab + panitumumab + futuximab/modotuximab mixture. entry url: https://civicdb.org/links/evidence_items/1081", "If a patient with Colorectal Cancer cancer has egfr k467t, one recommended therapy is futuximab/modotuximab mixture + panitumumab. entry url: https://civicdb.org/links/evidence_items/1082", "If a patient with nan cancer has egfr p753s, one recommended therapy is cetuximab + sirolimus. entry url: https://civicdb.org/links/evidence_items/1089", "If a patient with nan cancer has pml::rara fusion, one recommended therapy is arsenic trioxide + tretinoin. entry url: https://civicdb.org/links/evidence_items/1091", "If a patient with Non-Small Cell Lung Cancer cancer has met amplification, met splice site (c.3028g>a), one recommended therapy is crizotinib. entry url: https://civicdb.org/links/evidence_items/1095", "If a patient with nan cancer has erbb2 amplification, one recommended therapy is trastuzumab. entry url: https://civicdb.org/links/evidence_items/1097", "If a patient with Medulloblastoma cancer has smo d473h, one recommended therapy is patidegib. entry url: https://civicdb.org/links/evidence_items/1099", "If a patient with Non-Small Cell Lung Cancer cancer has ros1 g2032r, cd74::ros1 fusion, one recommended therapy is cabozantinib. entry url: https://civicdb.org/links/evidence_items/1101", "If a patient with Acute Myeloid Leukemia cancer has cebpa n-terminal frame shift, one recommended therapy is oicr-9429. entry url: https://civicdb.org/links/evidence_items/1103", "If a patient with nan cancer has zmym2::fgfr1 fusion, one recommended therapy is midostaurin. entry url: https://civicdb.org/links/evidence_items/1104", "If a patient with Angiosarcoma cancer has kdr a1065t, one recommended therapy is sunitinib + sorafenib. entry url: https://civicdb.org/links/evidence_items/1106", "If a patient with Angiosarcoma cancer has kdr d717v, one recommended therapy is sorafenib + sunitinib. entry url: https://civicdb.org/links/evidence_items/1107", "If a patient with nan cancer has tsc2 q1178*, one recommended therapy is everolimus. entry url: https://civicdb.org/links/evidence_items/1108", "If a patient with nan cancer has erbb2 amplification, one recommended therapy is neratinib + trastuzumab. entry url: https://civicdb.org/links/evidence_items/1113", "If a patient with Head And Neck Squamous Cell Carcinoma cancer has aldh1a2 underexpression, one recommended therapy is tretinoin. entry url: https://civicdb.org/links/evidence_items/1115", "If a patient with nan cancer has cip2a underexpression, one recommended therapy is gemcitabine. entry url: https://civicdb.org/links/evidence_items/1118", "If a patient with nan cancer has erbb2 amplification, one recommended therapy is trastuzumab. entry url: https://civicdb.org/links/evidence_items/1122", "If a patient with Lung Adenocarcinoma cancer has erbb2 y772_a775dup, one recommended therapy is trastuzumab emtansine. entry url: https://civicdb.org/links/evidence_items/1125", "If a patient with Glioblastoma cancer has egfr viii, one recommended therapy is erlotinib + gefitinib. entry url: https://civicdb.org/links/evidence_items/1128", "If a patient with Glioblastoma cancer has pten expression, one recommended therapy is erlotinib + gefitinib. entry url: https://civicdb.org/links/evidence_items/1129", "If a patient with nan cancer has erbb2 amplification, one recommended therapy is lapatinib + capecitabine. entry url: https://civicdb.org/links/evidence_items/1132", "If a patient with nan cancer has erbb2 amplification, one recommended therapy is trastuzumab + capecitabine. entry url: https://civicdb.org/links/evidence_items/1133", "If a patient with Acute Myeloid Leukemia cancer has kit rs3733542, one recommended therapy is selumetinib. entry url: https://civicdb.org/links/evidence_items/1136", "If a patient with Melanoma cancer has tbk1 overexpression, one recommended therapy is az909 + selumetinib. entry url: https://civicdb.org/links/evidence_items/1138", "If a patient with Cancer cancer has kras mutation, one recommended therapy is g-573 + mek inhibitor gdc-0623. entry url: https://civicdb.org/links/evidence_items/1140", "If a patient with Cancer cancer has braf v600e, one recommended therapy is cobimetinib. entry url: https://civicdb.org/links/evidence_items/1141", "If a patient with Non-Small Cell Lung Cancer cancer has kras g12c, one recommended therapy is selumetinib + docetaxel. entry url: https://civicdb.org/links/evidence_items/1142", "If a patient with Non-Small Cell Lung Cancer cancer has kras g12v, one recommended therapy is selumetinib + docetaxel. entry url: https://civicdb.org/links/evidence_items/1143", "If a patient with Non-Small Cell Lung Cancer cancer has tp53 mutation, one recommended therapy is docetaxel + selumetinib. entry url: https://civicdb.org/links/evidence_items/1145", "If a patient with Non-Small Cell Lung Cancer cancer has tp53 wildtype, one recommended therapy is adjuvant chemotherapy. entry url: https://civicdb.org/links/evidence_items/1149", "If a patient with Non-Small Cell Lung Cancer cancer has havcr2 overexpression, one recommended therapy is pd1 inhibitor + anti-tim-3 monoclonal antibody. entry url: https://civicdb.org/links/evidence_items/1151", "If a patient with Cancer cancer has erbb3 overexpression, one recommended therapy is afatinib + selumetinib. entry url: https://civicdb.org/links/evidence_items/1152", "If a patient with inflammatory breast cancer has mmp2 serum levels, one recommended therapy is bevacizumab. entry url: https://civicdb.org/links/evidence_items/1156", "If a patient with nan cancer has mmp2 serum levels, one recommended therapy is bevacizumab. entry url: https://civicdb.org/links/evidence_items/1158", "If a patient with nan cancer has erbb2 amplification, one recommended therapy is trastuzumab emtansine. entry url: https://civicdb.org/links/evidence_items/1159", "If a patient with nan cancer has erbb2 amplification, one recommended therapy is trastuzumab emtansine. entry url: https://civicdb.org/links/evidence_items/1160", "If a patient with gastric adeno cancer has hsph1 nuclear expression, one recommended therapy is cisplatin + fluorouracil. entry url: https://civicdb.org/links/evidence_items/1163", "If a patient with Colorectal Cancer cancer has hsph1 t17 deletion, one recommended therapy is fluorouracil + oxaliplatin. entry url: https://civicdb.org/links/evidence_items/1164", "If a patient with Non-Small Cell Lung Cancer cancer has cd274 expression, one recommended therapy is avelumab + pembrolizumab + nivolumab + atezolizumab. entry url: https://civicdb.org/links/evidence_items/1167", "If a patient with Sarcoma cancer has tp53 deleterious mutation, one recommended therapy is pazopanib. entry url: https://civicdb.org/links/evidence_items/1170", "If a patient with Non-Small Cell Lung Cancer cancer has cd274 expression, one recommended therapy is atezolizumab. entry url: https://civicdb.org/links/evidence_items/1172", "If a patient with Cancer cancer has kras g12c, one recommended therapy is ars-853 + epidermal growth factor receptor tyrosine kinase inhibitor. entry url: https://civicdb.org/links/evidence_items/1173", "If a patient with nan cancer has erbb2 v842i, one recommended therapy is lapatinib + trastuzumab + neratinib. entry url: https://civicdb.org/links/evidence_items/1174", "If a patient with Non-Small Cell Lung Cancer cancer has v::alk fusion, one recommended therapy is ceritinib. entry url: https://civicdb.org/links/evidence_items/1175", "If a patient with nan cancer has erbb2 l755s, one recommended therapy is trastuzumab + lapatinib + neratinib. entry url: https://civicdb.org/links/evidence_items/1176", "If a patient with nan cancer has erbb2 v777l, one recommended therapy is lapatinib + neratinib + trastuzumab. entry url: https://civicdb.org/links/evidence_items/1177", "If a patient with nan cancer has erbb2 l866m, one recommended therapy is trastuzumab + neratinib + lapatinib. entry url: https://civicdb.org/links/evidence_items/1178", "If a patient with nan cancer has erbb2 s310f/y, one recommended therapy is neratinib + trastuzumab + lapatinib. entry url: https://civicdb.org/links/evidence_items/1179", "If a patient with Cancer cancer has kras mutation, one recommended therapy is azd5438. entry url: https://civicdb.org/links/evidence_items/1183", "If a patient with Lung Adenocarcinoma cancer has met exon 14 skipping mutation, one recommended therapy is crizotinib. entry url: https://civicdb.org/links/evidence_items/1185", "If a patient with Lung Adenocarcinoma cancer has met exon 14 skipping mutation, one recommended therapy is capmatinib. entry url: https://civicdb.org/links/evidence_items/1186", "If a patient with Non-Small Cell Lung Cancer cancer has v::alk fusion, one recommended therapy is crizotinib. entry url: https://civicdb.org/links/evidence_items/1187", "If a patient with Non-Small Cell Lung Cancer cancer has eml4::alk fusion, one recommended therapy is whi-p154. entry url: https://civicdb.org/links/evidence_items/1188", "If a patient with Non-Small Cell Lung Cancer cancer has eml4::alk e20::e20, one recommended therapy is crizotinib. entry url: https://civicdb.org/links/evidence_items/1189", "If a patient with Non-Small Cell Lung Cancer cancer has eml4::alk e2::e20, one recommended therapy is crizotinib. entry url: https://civicdb.org/links/evidence_items/1190", "If a patient with Colorectal Adenocarcinoma cancer has kdr r961w, one recommended therapy is regorafenib. entry url: https://civicdb.org/links/evidence_items/1191", "If a patient with Non-Small Cell Lung Cancer cancer has eml4::alk e6::e20, one recommended therapy is 2,4-pyrimidinediamine. entry url: https://civicdb.org/links/evidence_items/1192", "If a patient with Non-Small Cell Lung Cancer cancer has eml4::alk e6::e20, one recommended therapy is crizotinib. entry url: https://civicdb.org/links/evidence_items/1193", "If a patient with Non-Small Cell Lung Cancer cancer has eml4::alk e6::e20, one recommended therapy is alk inhibitor tae684. entry url: https://civicdb.org/links/evidence_items/1194", "If a patient with Non-Small Cell Lung Cancer cancer has eml4::alk e20::e20, one recommended therapy is crizotinib. entry url: https://civicdb.org/links/evidence_items/1196", "If a patient with Non-Small Cell Lung Cancer cancer has v::alk fusion, one recommended therapy is crizotinib. entry url: https://civicdb.org/links/evidence_items/1198", "If a patient with Non-Small Cell Lung Cancer cancer has v::alk fusion, one recommended therapy is crizotinib. entry url: https://civicdb.org/links/evidence_items/1199", "If a patient with Non-Small Cell Lung Cancer cancer has v::alk fusion, one recommended therapy is crizotinib. entry url: https://civicdb.org/links/evidence_items/1200", "If a patient with Non-Small Cell Lung Cancer cancer has v::alk fusion, one recommended therapy is crizotinib. entry url: https://civicdb.org/links/evidence_items/1201", "If a patient with Non-Small Cell Lung Cancer cancer has v::alk fusion, one recommended therapy is retaspimycin hydrochloride. entry url: https://civicdb.org/links/evidence_items/1202", "If a patient with Non-Small Cell Lung Cancer cancer has eml4::alk fusion, one recommended therapy is crizotinib + retaspimycin hydrochloride. entry url: https://civicdb.org/links/evidence_items/1203", "If a patient with Non-Small Cell Lung Cancer cancer has eml4::alk e20::e20, one recommended therapy is crizotinib + alvespimycin. entry url: https://civicdb.org/links/evidence_items/1204", "If a patient with Non-Small Cell Lung Cancer cancer has eml4::alk fusion, one recommended therapy is crizotinib + alvespimycin. entry url: https://civicdb.org/links/evidence_items/1206", "If a patient with Non-Small Cell Lung Cancer cancer has eml4::alk fusion, one recommended therapy is crizotinib. entry url: https://civicdb.org/links/evidence_items/1207", "If a patient with Uveal Melanoma cancer has gnaq mutation, one recommended therapy is jq1. entry url: https://civicdb.org/links/evidence_items/1210", "If a patient with Uveal Melanoma cancer has gna11 mutation, one recommended therapy is jq1. entry url: https://civicdb.org/links/evidence_items/1211", "If a patient with Glioblastoma cancer has pms2 k706fs*19, one recommended therapy is nivolumab. entry url: https://civicdb.org/links/evidence_items/1214", "If a patient with Non-Small Cell Lung Cancer cancer has kras mutation, one recommended therapy is trametinib. entry url: https://civicdb.org/links/evidence_items/1220", "If a patient with Gastrointestinal Stromal Tumor cancer has kit exon 9 mutation, one recommended therapy is imatinib. entry url: https://civicdb.org/links/evidence_items/1221", "If a patient with Melanoma cancer has kit mutation, one recommended therapy is imatinib. entry url: https://civicdb.org/links/evidence_items/1222", "If a patient with Gastrointestinal Stromal Tumor cancer has kit exon 9 mutation, one recommended therapy is sunitinib. entry url: https://civicdb.org/links/evidence_items/1223", "If a patient with Melanoma cancer has kit exon 11 mutation, one recommended therapy is sunitinib. entry url: https://civicdb.org/links/evidence_items/1224", "If a patient with Melanoma cancer has nras mutation, one recommended therapy is docetaxel + trametinib. entry url: https://civicdb.org/links/evidence_items/1225", "If a patient with Melanoma cancer has nras q61, one recommended therapy is binimetinib. entry url: https://civicdb.org/links/evidence_items/1226", "If a patient with Uveal Melanoma cancer has gna11 mutation, one recommended therapy is trametinib. entry url: https://civicdb.org/links/evidence_items/1228", "If a patient with Uveal Melanoma cancer has gnaq mutation, one recommended therapy is trametinib. entry url: https://civicdb.org/links/evidence_items/1229", "If a patient with Cancer cancer has nras mutation, one recommended therapy is trametinib + metformin. entry url: https://civicdb.org/links/evidence_items/1230", "If a patient with Prostate Cancer cancer has pten deletion, one recommended therapy is everolimus. entry url: https://civicdb.org/links/evidence_items/1231", "If a patient with Uveal Melanoma cancer has gnaq q209, one recommended therapy is refametinib. entry url: https://civicdb.org/links/evidence_items/1233", "If a patient with Uveal Melanoma cancer has bap1 mutation, one recommended therapy is trichostatin a + panobinostat + vorinostat + valproic acid. entry url: https://civicdb.org/links/evidence_items/1234", "If a patient with nan cancer has bap1 mutation, one recommended therapy is mc1568 + mocetinostat + vorinostat. entry url: https://civicdb.org/links/evidence_items/1235", "If a patient with Endometrial Cancer cancer has fgfr2 mutation, one recommended therapy is ponatinib. entry url: https://civicdb.org/links/evidence_items/1236", "If a patient with Non-Small Cell Lung Cancer cancer has alk mutation, one recommended therapy is ceritinib. entry url: https://civicdb.org/links/evidence_items/1237", "If a patient with Anaplastic Large Cell Lymphoma cancer has npm1::alk fusion, one recommended therapy is crizotinib. entry url: https://civicdb.org/links/evidence_items/1239", "If a patient with Anaplastic Large Cell Lymphoma cancer has v::alk fusion, one recommended therapy is crizotinib. entry url: https://civicdb.org/links/evidence_items/1240", "If a patient with Anaplastic Large Cell Lymphoma cancer has npm1::alk fusion, one recommended therapy is crizotinib. entry url: https://civicdb.org/links/evidence_items/1241", "If a patient with Inflammatory Myofibroblastic Tumor cancer has v::alk fusion, one recommended therapy is crizotinib. entry url: https://civicdb.org/links/evidence_items/1243", "If a patient with Inflammatory Myofibroblastic Tumor cancer has ranbp2::alk fusion, one recommended therapy is crizotinib. entry url: https://civicdb.org/links/evidence_items/1244", "If a patient with Cancer cancer has eml4::alk e6::e20, one recommended therapy is crizotinib. entry url: https://civicdb.org/links/evidence_items/1245", "If a patient with nan cancer has fgfr1 n546k, one recommended therapy is ponatinib. entry url: https://civicdb.org/links/evidence_items/1246", "If a patient with nan cancer has fgfr1 amplification, one recommended therapy is ponatinib. entry url: https://civicdb.org/links/evidence_items/1247", "If a patient with Lung Adenocarcinoma cancer has cd72::ros1 fusion, one recommended therapy is ceritinib. entry url: https://civicdb.org/links/evidence_items/1248", "If a patient with Non-Small Cell Lung Cancer cancer has ros1 g2032r, cd74::ros1 fusion, one recommended therapy is foretinib + cabozantinib. entry url: https://civicdb.org/links/evidence_items/1249", "If a patient with Non-Small Cell Lung Cancer cancer has ros1 g2032r, v::ros1 fusion, one recommended therapy is lorlatinib. entry url: https://civicdb.org/links/evidence_items/1251", "If a patient with Non-Small Cell Lung Cancer cancer has ros1 l2026m, cd74::ros1 fusion, one recommended therapy is lorlatinib. entry url: https://civicdb.org/links/evidence_items/1253", "If a patient with Non-Small Cell Lung Cancer cancer has ros1 g2032r, cd74::ros1 fusion, one recommended therapy is foretinib. entry url: https://civicdb.org/links/evidence_items/1255", "If a patient with Non-Small Cell Lung Cancer cancer has ros1 l2026m, cd74::ros1 fusion, one recommended therapy is foretinib. entry url: https://civicdb.org/links/evidence_items/1258", "If a patient with Non-Small Cell Lung Cancer cancer has ros1 g2101a, cd74::ros1 fusion, one recommended therapy is foretinib. entry url: https://civicdb.org/links/evidence_items/1260", "If a patient with diffuse large b-cell lymphoma cancer has cltc::alk fusion, one recommended therapy is alk inhibitor tae684. entry url: https://civicdb.org/links/evidence_items/1261", "If a patient with diffuse large b-cell lymphoma cancer has v::alk fusion, one recommended therapy is crizotinib. entry url: https://civicdb.org/links/evidence_items/1264", "If a patient with diffuse large b-cell lymphoma cancer has cltc::alk fusion, one recommended therapy is crizotinib. entry url: https://civicdb.org/links/evidence_items/1265", "If a patient with Cancer cancer has braf del 485-490, one recommended therapy is pan-raf inhibitor ly3009120. entry url: https://civicdb.org/links/evidence_items/1267", "If a patient with Neuroblastoma cancer has alk r1275q, one recommended therapy is crizotinib. entry url: https://civicdb.org/links/evidence_items/1269", "If a patient with Neuroblastoma cancer has alk r1275q, one recommended therapy is crizotinib. entry url: https://civicdb.org/links/evidence_items/1270", "If a patient with Non-Small Cell Lung Cancer cancer has v::alk fusion, one recommended therapy is alectinib. entry url: https://civicdb.org/links/evidence_items/1272", "If a patient with Non-Small Cell Lung Cancer cancer has v::alk fusion, one recommended therapy is alectinib. entry url: https://civicdb.org/links/evidence_items/1273", "If a patient with Non-Small Cell Lung Cancer cancer has v::alk fusion, one recommended therapy is alectinib. entry url: https://civicdb.org/links/evidence_items/1279", "If a patient with Non-Small Cell Lung Cancer cancer has v::alk fusion, one recommended therapy is alectinib. entry url: https://civicdb.org/links/evidence_items/1282", "If a patient with Non-Small Cell Lung Cancer cancer has alk i1171, one recommended therapy is ceritinib. entry url: https://civicdb.org/links/evidence_items/1284", "If a patient with Non-Small Cell Lung Cancer cancer has alk i1171, one recommended therapy is alk inhibitor tae684. entry url: https://civicdb.org/links/evidence_items/1285", "If a patient with Non-Small Cell Lung Cancer cancer has eml4::alk fusion, alk v1180l, one recommended therapy is ceritinib. entry url: https://civicdb.org/links/evidence_items/1289", "If a patient with Non-Small Cell Lung Cancer cancer has eml4::alk fusion, alk v1180l, one recommended therapy is alk inhibitor tae684. entry url: https://civicdb.org/links/evidence_items/1290", "If a patient with Non-Small Cell Lung Cancer cancer has eml4::alk fusion, alk v1180l, one recommended therapy is brigatinib. entry url: https://civicdb.org/links/evidence_items/1291", "If a patient with Acute Myeloid Leukemia cancer has flt3 tkd mutation, one recommended therapy is midostaurin. entry url: https://civicdb.org/links/evidence_items/1295", "If a patient with nan cancer has pik3ca mutation, one recommended therapy is everolimus. entry url: https://civicdb.org/links/evidence_items/1296", "If a patient with nan cancer has pten loss, one recommended therapy is everolimus. entry url: https://civicdb.org/links/evidence_items/1297", "If a patient with Colorectal Adenocarcinoma cancer has v::ros1 fusion, one recommended therapy is crizotinib. entry url: https://civicdb.org/links/evidence_items/1301", "If a patient with Pancreatic Cancer cancer has palb2 biallelic inactivation, one recommended therapy is mitomycin. entry url: https://civicdb.org/links/evidence_items/1305", "If a patient with Pancreatic Cancer cancer has fancc loss-of-function, one recommended therapy is melphalan + chlorambucil + cisplatin + mitomycin + gemcitabine. entry url: https://civicdb.org/links/evidence_items/1307", "If a patient with Pancreatic Cancer cancer has brca2 loss-of-function, one recommended therapy is mitomycin. entry url: https://civicdb.org/links/evidence_items/1308", "If a patient with Gastrointestinal Stromal Tumor cancer has pdgfra i843del, one recommended therapy is imatinib. entry url: https://civicdb.org/links/evidence_items/1309", "If a patient with nan cancer has ebf1::pdgfrb fusion, one recommended therapy is imatinib. entry url: https://civicdb.org/links/evidence_items/1310", "If a patient with nan cancer has mtor s2215y, one recommended therapy is sirolimus. entry url: https://civicdb.org/links/evidence_items/1319", "If a patient with nan cancer has mtor c1483y, one recommended therapy is sirolimus. entry url: https://civicdb.org/links/evidence_items/1320", "If a patient with nan cancer has mtor e1799k, one recommended therapy is sirolimus. entry url: https://civicdb.org/links/evidence_items/1321", "If a patient with Endometrial Cancer cancer has fgfr2 n550k, one recommended therapy is pd173074. entry url: https://civicdb.org/links/evidence_items/1322", "If a patient with Colorectal Cancer cancer has ppp1r15a rs557806, one recommended therapy is bevacizumab + folfiri regimen. entry url: https://civicdb.org/links/evidence_items/1325", "If a patient with Colorectal Cancer cancer has kras exon 2 mutation, one recommended therapy is selumetinib + irinotecan. entry url: https://civicdb.org/links/evidence_items/1326", "If a patient with Neuroblastoma cancer has alk f1174l, one recommended therapy is azd3463. entry url: https://civicdb.org/links/evidence_items/1327", "If a patient with Neuroblastoma cancer has alk f1174l, one recommended therapy is lorlatinib. entry url: https://civicdb.org/links/evidence_items/1329", "If a patient with Neuroblastoma cancer has alk f1245c, one recommended therapy is lorlatinib. entry url: https://civicdb.org/links/evidence_items/1330", "If a patient with Neuroblastoma cancer has alk r1275q, one recommended therapy is lorlatinib. entry url: https://civicdb.org/links/evidence_items/1331", "If a patient with Non-Small Cell Lung Cancer cancer has eml4::alk fusion, one recommended therapy is lorlatinib. entry url: https://civicdb.org/links/evidence_items/1332", "If a patient with Colorectal Adenocarcinoma cancer has v::alk fusion, one recommended therapy is crizotinib. entry url: https://civicdb.org/links/evidence_items/1334", "If a patient with Breast Cancer cancer has v::alk fusion, one recommended therapy is crizotinib. entry url: https://civicdb.org/links/evidence_items/1335", "If a patient with Neuroblastoma cancer has alk exon 4-11 deletion, one recommended therapy is brigatinib. entry url: https://civicdb.org/links/evidence_items/1336", "If a patient with Non-Small Cell Lung Cancer cancer has eml4::alk fusion, alk f1245c, one recommended therapy is ceritinib. entry url: https://civicdb.org/links/evidence_items/1338", "If a patient with Non-Small Cell Lung Cancer cancer has eml4::alk e6::e20, one recommended therapy is ceritinib. entry url: https://civicdb.org/links/evidence_items/1340", "If a patient with Non-Small Cell Lung Cancer cancer has eml4::alk fusion, alk l1196m, one recommended therapy is ceritinib. entry url: https://civicdb.org/links/evidence_items/1341", "If a patient with Non-Small Cell Lung Cancer cancer has alk g1269a, v::alk fusion, one recommended therapy is ceritinib. entry url: https://civicdb.org/links/evidence_items/1342", "If a patient with Cancer cancer has eml4::alk fusion, alk s1206y, one recommended therapy is ceritinib. entry url: https://civicdb.org/links/evidence_items/1343", "If a patient with Non-Small Cell Lung Cancer cancer has alk i1171, one recommended therapy is ceritinib. entry url: https://civicdb.org/links/evidence_items/1344", "If a patient with Non-Small Cell Lung Cancer cancer has eml4::alk fusion, alk t1151dup, one recommended therapy is tanespimycin. entry url: https://civicdb.org/links/evidence_items/1349", "If a patient with Non-Small Cell Lung Cancer cancer has eml4::alk fusion, alk g1202r, one recommended therapy is tanespimycin. entry url: https://civicdb.org/links/evidence_items/1352", "If a patient with Cancer cancer has alk g1269a, v::alk fusion, one recommended therapy is brigatinib. entry url: https://civicdb.org/links/evidence_items/1353", "If a patient with Cancer cancer has alk g1269a, v::alk fusion, one recommended therapy is ceritinib. entry url: https://civicdb.org/links/evidence_items/1355", "If a patient with Cancer cancer has npm1::alk fusion, one recommended therapy is crizotinib. entry url: https://civicdb.org/links/evidence_items/1356", "If a patient with head and neck cancer has pik3ca mutation, one recommended therapy is dactolisib. entry url: https://civicdb.org/links/evidence_items/1360", "If a patient with head and neck cancer has pik3ca h1047r, one recommended therapy is dactolisib. entry url: https://civicdb.org/links/evidence_items/1361", "If a patient with head and neck cancer has pik3ca h1047r, one recommended therapy is dactolisib. entry url: https://civicdb.org/links/evidence_items/1362", "If a patient with head and neck cancer has pik3ca h1047r, one recommended therapy is dactolisib + cetuximab. entry url: https://civicdb.org/links/evidence_items/1363", "If a patient with medullary thyroid cancer has ret m918t, one recommended therapy is sorafenib. entry url: https://civicdb.org/links/evidence_items/1365", "If a patient with Liposarcoma cancer has cdk4 amplification, one recommended therapy is palbociclib. entry url: https://civicdb.org/links/evidence_items/1366", "If a patient with Non-Small Cell Lung Cancer cancer has alk i1171, one recommended therapy is ceritinib. entry url: https://civicdb.org/links/evidence_items/1368", "If a patient with Cancer cancer has brca1 mutation, one recommended therapy is olaparib. entry url: https://civicdb.org/links/evidence_items/1370", "If a patient with Cancer cancer has brca2 mutation, one recommended therapy is olaparib. entry url: https://civicdb.org/links/evidence_items/1371", "If a patient with Melanoma cancer has cdkn2a loss, one recommended therapy is alvocidib. entry url: https://civicdb.org/links/evidence_items/1372", "If a patient with Renal Cell Carcinoma cancer has cdkn2a loss, one recommended therapy is palbociclib. entry url: https://civicdb.org/links/evidence_items/1373", "If a patient with Renal Cell Carcinoma cancer has cdkn2b loss, one recommended therapy is palbociclib. entry url: https://civicdb.org/links/evidence_items/1374", "If a patient with Melanoma cancer has cdkn2a loss, one recommended therapy is palbociclib. entry url: https://civicdb.org/links/evidence_items/1375", "If a patient with Melanoma cancer has cdk4 r24c, one recommended therapy is palbociclib. entry url: https://civicdb.org/links/evidence_items/1376", "If a patient with Ovarian Cancer cancer has cdkn2a loss, one recommended therapy is palbociclib. entry url: https://civicdb.org/links/evidence_items/1377", "If a patient with nan cancer has erbb2 amplification, one recommended therapy is pictilisib. entry url: https://civicdb.org/links/evidence_items/1380", "If a patient with nan cancer has erbb2 amplification, one recommended therapy is a66. entry url: https://civicdb.org/links/evidence_items/1381", "If a patient with Chronic Myelogenous Leukemia cancer has bcr::abl1 fusion, abl1 t315i, one recommended therapy is ponatinib. entry url: https://civicdb.org/links/evidence_items/1390", "If a patient with Lung Adenocarcinoma cancer has egfr s768i, one recommended therapy is erlotinib. entry url: https://civicdb.org/links/evidence_items/1394", "If a patient with Lung Adenocarcinoma cancer has egfr s768i, one recommended therapy is gefitinib. entry url: https://civicdb.org/links/evidence_items/1395", "If a patient with Lung Adenocarcinoma cancer has egfr t790m, egfr exon 19 deletion, one recommended therapy is osimertinib. entry url: https://civicdb.org/links/evidence_items/1397", "If a patient with Melanoma cancer has braf v600e, one recommended therapy is vemurafenib. entry url: https://civicdb.org/links/evidence_items/1398", "If a patient with Melanoma cancer has braf v600k, one recommended therapy is vemurafenib. entry url: https://civicdb.org/links/evidence_items/1399", "If a patient with Melanoma cancer has braf v600k, one recommended therapy is vemurafenib. entry url: https://civicdb.org/links/evidence_items/1400", "If a patient with head and neck cancer has pik3ca h1047r, one recommended therapy is alpelisib. entry url: https://civicdb.org/links/evidence_items/1401", "If a patient with Cancer cancer has pik3ca mutation, one recommended therapy is alpelisib. entry url: https://civicdb.org/links/evidence_items/1402", "If a patient with nan cancer has pik3ca amplification, one recommended therapy is alpelisib. entry url: https://civicdb.org/links/evidence_items/1403", "If a patient with Melanoma cancer has braf v600, one recommended therapy is dabrafenib. entry url: https://civicdb.org/links/evidence_items/1407", "If a patient with Colorectal Cancer cancer has braf v600e, one recommended therapy is vemurafenib + gefitinib + cetuximab. entry url: https://civicdb.org/links/evidence_items/1408", "If a patient with Melanoma cancer has braf v600e, one recommended therapy is vemurafenib. entry url: https://civicdb.org/links/evidence_items/1409", "If a patient with Melanoma cancer has braf v600e, one recommended therapy is vemurafenib. entry url: https://civicdb.org/links/evidence_items/1410", "If a patient with Melanoma cancer has braf v600, one recommended therapy is trametinib + dabrafenib. entry url: https://civicdb.org/links/evidence_items/1411", "If a patient with papillary thyroid cancer has braf v600e, one recommended therapy is vemurafenib. entry url: https://civicdb.org/links/evidence_items/1414", "If a patient with Colorectal Cancer cancer has braf v600, one recommended therapy is dabrafenib + trametinib. entry url: https://civicdb.org/links/evidence_items/1415", "If a patient with Breast Cancer cancer has sf3b1 k700e, one recommended therapy is spliceostatin a. entry url: https://civicdb.org/links/evidence_items/1417", "If a patient with Breast Cancer cancer has sf3b1 k666n, one recommended therapy is spliceostatin a. entry url: https://civicdb.org/links/evidence_items/1418", "If a patient with Non-Small Cell Lung Cancer cancer has v::alk fusion, one recommended therapy is crizotinib. entry url: https://civicdb.org/links/evidence_items/1419", "If a patient with Melanoma cancer has braf v600e, one recommended therapy is vemurafenib + cobimetinib. entry url: https://civicdb.org/links/evidence_items/1421", "If a patient with Melanoma cancer has braf v600, one recommended therapy is vemurafenib + cobimetinib. entry url: https://civicdb.org/links/evidence_items/1422", "If a patient with nan cancer has kit m541l, one recommended therapy is imatinib. entry url: https://civicdb.org/links/evidence_items/1423", "If a patient with Gastrointestinal Stromal Tumor cancer has kit exon 9 mutation, one recommended therapy is sunitinib. entry url: https://civicdb.org/links/evidence_items/1424", "If a patient with Colorectal Cancer cancer has braf v600e, one recommended therapy is dactolisib + gdc-0879. entry url: https://civicdb.org/links/evidence_items/1428", "If a patient with Melanoma cancer has nras mutation, one recommended therapy is omipalisib + trametinib. entry url: https://civicdb.org/links/evidence_items/1429", "If a patient with Gastrointestinal Neuroendocrine Tumor cancer has braf v600e, one recommended therapy is trametinib + vemurafenib + dabrafenib. entry url: https://civicdb.org/links/evidence_items/1430", "If a patient with nan cancer has erbb2 amplification, one recommended therapy is trastuzumab emtansine. entry url: https://civicdb.org/links/evidence_items/1432", "If a patient with nan cancer has erbb2 amplification, one recommended therapy is pertuzumab + trastuzumab + docetaxel. entry url: https://civicdb.org/links/evidence_items/1437", "If a patient with nan cancer has mtor e2014k, mtor e2419k, one recommended therapy is pazopanib + everolimus. entry url: https://civicdb.org/links/evidence_items/1438", "If a patient with nan cancer has erbb2 amplification, one recommended therapy is trastuzumab + lapatinib. entry url: https://civicdb.org/links/evidence_items/1439", "If a patient with Lung Adenocarcinoma cancer has rictor amplification, one recommended therapy is sapanisertib + onatasertib. entry url: https://civicdb.org/links/evidence_items/1440", "If a patient with nan cancer has fip1l1::pdgfra fusion, one recommended therapy is imatinib. entry url: https://civicdb.org/links/evidence_items/1441", "If a patient with nan cancer has v::ros1 fusion, one recommended therapy is crizotinib. entry url: https://civicdb.org/links/evidence_items/1443", "If a patient with Inflammatory Myofibroblastic Tumor cancer has tfg::ros1 fusion, one recommended therapy is crizotinib. entry url: https://civicdb.org/links/evidence_items/1444", "If a patient with nan cancer has fip1l1::pdgfra fusion, one recommended therapy is imatinib. entry url: https://civicdb.org/links/evidence_items/1445", "If a patient with Lung Adenocarcinoma cancer has pik3ca h1047r, one recommended therapy is dactolisib. entry url: https://civicdb.org/links/evidence_items/1447", "If a patient with nan cancer has erbb2 amplification, one recommended therapy is trastuzumab + pilaralisib. entry url: https://civicdb.org/links/evidence_items/1448", "If a patient with Melanoma cancer has braf d594a, one recommended therapy is mitogen-activated protein kinase kinase inhibitor + sorafenib. entry url: https://civicdb.org/links/evidence_items/1454", "If a patient with nan cancer has pten loss, one recommended therapy is trastuzumab + pi3k/bet inhibitor ly294002. entry url: https://civicdb.org/links/evidence_items/1455", "If a patient with Melanoma cancer has braf d594v, one recommended therapy is sorafenib + trametinib. entry url: https://civicdb.org/links/evidence_items/1456", "If a patient with Melanoma cancer has braf k483m, one recommended therapy is mitogen-activated protein kinase kinase inhibitor + sorafenib. entry url: https://civicdb.org/links/evidence_items/1457", "If a patient with Melanoma cancer has braf l597r, one recommended therapy is trametinib + vemurafenib. entry url: https://civicdb.org/links/evidence_items/1458", "If a patient with Melanoma cancer has braf l597s, one recommended therapy is trametinib + vemurafenib. entry url: https://civicdb.org/links/evidence_items/1459", "If a patient with Melanoma cancer has braf l597s, one recommended therapy is mek inhibitor rec-4881. entry url: https://civicdb.org/links/evidence_items/1460", "If a patient with Melanoma cancer has braf l597q, one recommended therapy is trametinib + vemurafenib. entry url: https://civicdb.org/links/evidence_items/1461", "If a patient with Melanoma cancer has braf k601e, one recommended therapy is trametinib + vemurafenib. entry url: https://civicdb.org/links/evidence_items/1462", "If a patient with Melanoma cancer has braf l597v, one recommended therapy is trametinib. entry url: https://civicdb.org/links/evidence_items/1463", "If a patient with Head And Neck Squamous Cell Carcinoma cancer has pik3ca amplification, one recommended therapy is taselisib. entry url: https://civicdb.org/links/evidence_items/1464", "If a patient with Head And Neck Squamous Cell Carcinoma cancer has pik3ca h1047r, one recommended therapy is taselisib. entry url: https://civicdb.org/links/evidence_items/1465", "If a patient with Melanoma cancer has nf1 mutation, one recommended therapy is mirdametinib + sirolimus. entry url: https://civicdb.org/links/evidence_items/1469", "If a patient with Melanoma cancer has nf1 mutation, one recommended therapy is vtx-11e + az628. entry url: https://civicdb.org/links/evidence_items/1471", "If a patient with Melanoma cancer has nras mutation, one recommended therapy is binimetinib. entry url: https://civicdb.org/links/evidence_items/1472", "If a patient with Melanoma cancer has nras q61, one recommended therapy is selumetinib. entry url: https://civicdb.org/links/evidence_items/1473", "If a patient with Melanoma cancer has nras q61k, one recommended therapy is selumetinib. entry url: https://civicdb.org/links/evidence_items/1475", "If a patient with Melanoma cancer has nras mutation, one recommended therapy is amuvatinib. entry url: https://civicdb.org/links/evidence_items/1476", "If a patient with chronic lymphocytic leukemia cancer has tp53 mutation, one recommended therapy is alemtuzumab. entry url: https://civicdb.org/links/evidence_items/1481", "If a patient with Essential Thrombocythemia cancer has calr exon 9 frameshift, one recommended therapy is peginterferon alfa-2a. entry url: https://civicdb.org/links/evidence_items/1482", "If a patient with Head And Neck Squamous Cell Carcinoma cancer has pik3ca mutation, one recommended therapy is radiation therapy + taselisib. entry url: https://civicdb.org/links/evidence_items/1490", "If a patient with Cancer cancer has pten mutation, one recommended therapy is ipatasertib. entry url: https://civicdb.org/links/evidence_items/1491", "If a patient with Melanoma cancer has ezh2 y646, one recommended therapy is gsk126. entry url: https://civicdb.org/links/evidence_items/1494", "If a patient with Melanoma cancer has ccnd1 amplification, one recommended therapy is sorafenib + carboplatin + paclitaxel. entry url: https://civicdb.org/links/evidence_items/1495", "If a patient with Melanoma cancer has raf1 amplification, one recommended therapy is carboplatin + sorafenib + paclitaxel. entry url: https://civicdb.org/links/evidence_items/1496", "If a patient with Melanoma cancer has kras amplification, one recommended therapy is carboplatin + docetaxel + sorafenib. entry url: https://civicdb.org/links/evidence_items/1497", "If a patient with nan cancer has v::pdgfrb fusion, one recommended therapy is imatinib. entry url: https://civicdb.org/links/evidence_items/1498", "If a patient with gastric adeno cancer has erbb2 amplification, one recommended therapy is trastuzumab. entry url: https://civicdb.org/links/evidence_items/1499", "If a patient with nan cancer has pten loss, one recommended therapy is capivasertib + docetaxel. entry url: https://civicdb.org/links/evidence_items/1500", "If a patient with nan cancer has pik3ca mutation, one recommended therapy is capivasertib. entry url: https://civicdb.org/links/evidence_items/1501", "If a patient with Cancer cancer has pten loss, one recommended therapy is capivasertib. entry url: https://civicdb.org/links/evidence_items/1502", "If a patient with Cancer cancer has pik3ca mutation, one recommended therapy is capivasertib. entry url: https://civicdb.org/links/evidence_items/1503", "If a patient with nan cancer has pik3ca mutation, one recommended therapy is capivasertib. entry url: https://civicdb.org/links/evidence_items/1504", "If a patient with nan cancer has pik3ca h1047r, one recommended therapy is trastuzumab + capivasertib. entry url: https://civicdb.org/links/evidence_items/1505", "If a patient with nan cancer has pik3ca h1047r, one recommended therapy is lapatinib + capivasertib. entry url: https://civicdb.org/links/evidence_items/1506", "If a patient with Melanoma cancer has nras mutation, one recommended therapy is binimetinib. entry url: https://civicdb.org/links/evidence_items/1509", "If a patient with Cancer cancer has cd274 expression, one recommended therapy is nivolumab. entry url: https://civicdb.org/links/evidence_items/1517", "If a patient with papillary adeno cancer has ret overexpression, one recommended therapy is sunitinib. entry url: https://civicdb.org/links/evidence_items/1518", "If a patient with nan cancer has pml::rara fusion, one recommended therapy is tretinoin. entry url: https://civicdb.org/links/evidence_items/1519", "If a patient with nan cancer has ctla4::cd28 fusion, one recommended therapy is ipilimumab. entry url: https://civicdb.org/links/evidence_items/1520", "If a patient with Prostate Cancer cancer has pten mutation, one recommended therapy is enzalutamide + alpelisib + pi3kbeta inhibitor azd8186. entry url: https://civicdb.org/links/evidence_items/1522", "If a patient with Head And Neck Squamous Cell Carcinoma cancer has notch1 loss-of-function, one recommended therapy is porcupine inhibitor wnt974. entry url: https://civicdb.org/links/evidence_items/1525", "If a patient with nan cancer has cdk6 overexpression, one recommended therapy is fulvestrant + palbociclib. entry url: https://civicdb.org/links/evidence_items/1527", "If a patient with nan cancer has flt3 overexpression, one recommended therapy is sunitinib. entry url: https://civicdb.org/links/evidence_items/1528", "If a patient with nan cancer has brca1 mutation, one recommended therapy is platinum compound. entry url: https://civicdb.org/links/evidence_items/1529", "If a patient with nan cancer has brca2 mutation, one recommended therapy is platinum compound. entry url: https://civicdb.org/links/evidence_items/1530", "If a patient with nan cancer has brca1 mutation, one recommended therapy is platinum compound. entry url: https://civicdb.org/links/evidence_items/1531", "If a patient with nan cancer has brca2 mutation, one recommended therapy is platinum compound. entry url: https://civicdb.org/links/evidence_items/1532", "If a patient with Melanoma cancer has pten v317fs, one recommended therapy is mek inhibitor ci-1040 + akt inhibitor mk2206. entry url: https://civicdb.org/links/evidence_items/1534", "If a patient with Breast Cancer cancer has esr1 overexpression, one recommended therapy is palbociclib + letrozole. entry url: https://civicdb.org/links/evidence_items/1541", "If a patient with Head And Neck Squamous Cell Carcinoma cancer has pik3ca e542k, one recommended therapy is apitolisib. entry url: https://civicdb.org/links/evidence_items/1549", "If a patient with Cancer cancer has pik3ca e545k, one recommended therapy is apitolisib. entry url: https://civicdb.org/links/evidence_items/1550", "If a patient with Acute Myeloid Leukemia cancer has flt3 itd, one recommended therapy is sorafenib. entry url: https://civicdb.org/links/evidence_items/1555", "If a patient with nan cancer has erbb2 amplification, one recommended therapy is trastuzumab + palbociclib. entry url: https://civicdb.org/links/evidence_items/1561", "If a patient with Breast Cancer cancer has ccnd1 amplification, one recommended therapy is palbociclib. entry url: https://civicdb.org/links/evidence_items/1562", "If a patient with Mantle Cell Lymphoma cancer has ccnd1 overexpression, one recommended therapy is palbociclib. entry url: https://civicdb.org/links/evidence_items/1563", "If a patient with Glioblastoma cancer has met amplification, one recommended therapy is crizotinib. entry url: https://civicdb.org/links/evidence_items/1565", "If a patient with Non-Small Cell Lung Cancer cancer has met amplification, one recommended therapy is crizotinib. entry url: https://civicdb.org/links/evidence_items/1566", "If a patient with Melanoma cancer has ppfibp2::braf fusion, one recommended therapy is trametinib. entry url: https://civicdb.org/links/evidence_items/1570", "If a patient with Melanoma cancer has kiaa1549::braf fusion, one recommended therapy is trametinib. entry url: https://civicdb.org/links/evidence_items/1571", "If a patient with Colorectal Cancer cancer has egfr expression, one recommended therapy is cetuximab. entry url: https://civicdb.org/links/evidence_items/1572", "If a patient with Non-Small Cell Lung Cancer cancer has braf v600, one recommended therapy is vemurafenib. entry url: https://civicdb.org/links/evidence_items/1574", "If a patient with nan cancer has braf v600, one recommended therapy is vemurafenib. entry url: https://civicdb.org/links/evidence_items/1575", "If a patient with Non-Small Cell Lung Cancer cancer has v::alk fusion, one recommended therapy is crizotinib. entry url: https://civicdb.org/links/evidence_items/1577", "If a patient with Hairy Cell Leukemia cancer has braf v600e, one recommended therapy is vemurafenib. entry url: https://civicdb.org/links/evidence_items/1579", "If a patient with Uveal Melanoma cancer has met overexpression, one recommended therapy is crizotinib. entry url: https://civicdb.org/links/evidence_items/1583", "If a patient with Acute Myeloid Leukemia cancer has dnmt3a mutation, one recommended therapy is decitabine. entry url: https://civicdb.org/links/evidence_items/1587", "If a patient with Colorectal Cancer cancer has met amplification, one recommended therapy is vemurafenib + crizotinib. entry url: https://civicdb.org/links/evidence_items/1588", "If a patient with Colorectal Cancer cancer has braf v600e, one recommended therapy is vemurafenib + panitumumab. entry url: https://civicdb.org/links/evidence_items/1589", "If a patient with papillary thyroid cancer has braf v600e, one recommended therapy is vemurafenib. entry url: https://civicdb.org/links/evidence_items/1591", "If a patient with Non-Small Cell Lung Cancer cancer has egfr t790m, one recommended therapy is osimertinib. entry url: https://civicdb.org/links/evidence_items/1592", "If a patient with Sarcoma cancer has rad23b expression, one recommended therapy is vorinostat. entry url: https://civicdb.org/links/evidence_items/1597", "If a patient with Breast Cancer cancer has pik3ca mutation, one recommended therapy is ribociclib + phosphatidylinositide 3-kinase inhibitor. entry url: https://civicdb.org/links/evidence_items/1600", "If a patient with Non-Small Cell Lung Cancer cancer has ccdc6::ret fusion, one recommended therapy is nintedanib. entry url: https://civicdb.org/links/evidence_items/1601", "If a patient with nan cancer has fgfr3 s249c, one recommended therapy is pazopanib. entry url: https://civicdb.org/links/evidence_items/1603", "If a patient with Breast Cancer cancer has fgfr1 amplification, one recommended therapy is dovitinib. entry url: https://civicdb.org/links/evidence_items/1604", "If a patient with Breast Cancer cancer has fgfr2 amplification, one recommended therapy is dovitinib. entry url: https://civicdb.org/links/evidence_items/1605", "If a patient with Breast Cancer cancer has fgf3 amplification, one recommended therapy is dovitinib. entry url: https://civicdb.org/links/evidence_items/1606", "If a patient with Breast Cancer cancer has pik3ca mutation, one recommended therapy is phosphatidylinositide 3-kinase inhibitor + palbociclib. entry url: https://civicdb.org/links/evidence_items/1607", "If a patient with nan cancer has vhl r200w (c.598c>t), one recommended therapy is ruxolitinib. entry url: https://civicdb.org/links/evidence_items/1608", "If a patient with Breast Cancer cancer has pik3ca mutation, one recommended therapy is everolimus + mtor kinase inhibitor pp242. entry url: https://civicdb.org/links/evidence_items/1610", "If a patient with Breast Cancer cancer has pik3r1 mutation, one recommended therapy is mtor kinase inhibitor pp242. entry url: https://civicdb.org/links/evidence_items/1612", "If a patient with Breast Cancer cancer has erbb2 amplification, one recommended therapy is mtor kinase inhibitor pp242. entry url: https://civicdb.org/links/evidence_items/1613", "If a patient with Endometrial Cancer cancer has pten loss, one recommended therapy is temsirolimus. entry url: https://civicdb.org/links/evidence_items/1614", "If a patient with Endometrial Cancer cancer has pik3ca mutation, one recommended therapy is pictilisib. entry url: https://civicdb.org/links/evidence_items/1616", "If a patient with Pancreatic Cancer cancer has stk11 d194e, one recommended therapy is everolimus. entry url: https://civicdb.org/links/evidence_items/1617", "If a patient with nan cancer has stk11 loss, one recommended therapy is sirolimus. entry url: https://civicdb.org/links/evidence_items/1618", "If a patient with nan cancer has stk11 loss, one recommended therapy is sirolimus. entry url: https://civicdb.org/links/evidence_items/1619", "If a patient with Lung Adenocarcinoma cancer has akt2 amplification, one recommended therapy is vandetanib + everolimus. entry url: https://civicdb.org/links/evidence_items/1621", "If a patient with Lung Adenocarcinoma cancer has kif5b::ret fusion, one recommended therapy is vandetanib + everolimus. entry url: https://civicdb.org/links/evidence_items/1622", "If a patient with nan cancer has pik3ca h1047r, one recommended therapy is everolimus + fulvestrant. entry url: https://civicdb.org/links/evidence_items/1623", "If a patient with Thyroid Cancer cancer has pik3ca h1047r, one recommended therapy is temsirolimus + perifosine. entry url: https://civicdb.org/links/evidence_items/1625", "If a patient with Thyroid Cancer cancer has pik3ca e542k, one recommended therapy is perifosine + temsirolimus. entry url: https://civicdb.org/links/evidence_items/1626", "If a patient with Thyroid Cancer cancer has pten r130*, one recommended therapy is perifosine + temsirolimus. entry url: https://civicdb.org/links/evidence_items/1627", "If a patient with Renal Cell Carcinoma cancer has fbxw7 loss-of-function, one recommended therapy is everolimus. entry url: https://civicdb.org/links/evidence_items/1628", "If a patient with Cancer cancer has fbxw7 mutation, one recommended therapy is mtor inhibitor. entry url: https://civicdb.org/links/evidence_items/1631", "If a patient with Cancer cancer has fbxw7 loss-of-function, one recommended therapy is sirolimus. entry url: https://civicdb.org/links/evidence_items/1632", "If a patient with Colorectal Adenocarcinoma cancer has jun overexpression, one recommended therapy is irbesartan. entry url: https://civicdb.org/links/evidence_items/1633", "If a patient with Colon Adenocarcinoma cancer has fos overexpression, one recommended therapy is irbesartan. entry url: https://civicdb.org/links/evidence_items/1634", "If a patient with Lymphoplasmacytic Lymphoma cancer has myd88 l265p, one recommended therapy is irak-1/4 inhibitor + img-2005-5. entry url: https://civicdb.org/links/evidence_items/1641", "If a patient with Hepatocellular Carcinoma cancer has kras mutation, one recommended therapy is refametinib + sorafenib. entry url: https://civicdb.org/links/evidence_items/1642", "If a patient with nan cancer has atrx underexpression, one recommended therapy is pcv regimen + temozolomide. entry url: https://civicdb.org/links/evidence_items/1647", "If a patient with Lung Adenocarcinoma cancer has met exon 14 skipping mutation, one recommended therapy is crizotinib. entry url: https://civicdb.org/links/evidence_items/1651", "If a patient with nan cancer has aurka expression, one recommended therapy is fluorouracil + radiation therapy + cisplatin. entry url: https://civicdb.org/links/evidence_items/1653", "If a patient with nan cancer has map2k1 q56_v60del, one recommended therapy is selumetinib. entry url: https://civicdb.org/links/evidence_items/1661", "If a patient with nan cancer has braf::cul1 fusion, one recommended therapy is mitogen-activated protein kinase kinase inhibitor. entry url: https://civicdb.org/links/evidence_items/1662", "If a patient with Melanoma cancer has zkscan1::braf fusion, one recommended therapy is trametinib. entry url: https://civicdb.org/links/evidence_items/1663", "If a patient with spindle cell sarcoma cancer has kiaa1549::braf fusion, one recommended therapy is sorafenib + bevacizumab + temsirolimus. entry url: https://civicdb.org/links/evidence_items/1664", "If a patient with Non-Small Cell Lung Cancer cancer has egfr l858r, one recommended therapy is gefitinib. entry url: https://civicdb.org/links/evidence_items/1665", "If a patient with Non-Small Cell Lung Cancer cancer has egfr exon 19 deletion, one recommended therapy is gefitinib. entry url: https://civicdb.org/links/evidence_items/1666", "If a patient with Ovarian Cancer cancer has brca1 mutation, one recommended therapy is olaparib + cediranib. entry url: https://civicdb.org/links/evidence_items/1677", "If a patient with Ovarian Cancer cancer has brca2 mutation, one recommended therapy is cediranib + olaparib. entry url: https://civicdb.org/links/evidence_items/1678", "If a patient with nan cancer has brca1 mutation, one recommended therapy is carboplatin + cisplatin. entry url: https://civicdb.org/links/evidence_items/1684", "If a patient with nan cancer has brca2 mutation, one recommended therapy is carboplatin + cisplatin. entry url: https://civicdb.org/links/evidence_items/1685", "If a patient with Colorectal Cancer cancer has erbb2 amplification, one recommended therapy is trastuzumab + lapatinib. entry url: https://civicdb.org/links/evidence_items/1689", "If a patient with Lung Adenocarcinoma cancer has sdc4::ros1 fusion, one recommended therapy is crizotinib. entry url: https://civicdb.org/links/evidence_items/1690", "If a patient with Lung Adenocarcinoma cancer has v::alk fusion, one recommended therapy is crizotinib. entry url: https://civicdb.org/links/evidence_items/1691", "If a patient with Lung Adenocarcinoma cancer has met amplification, one recommended therapy is crizotinib. entry url: https://civicdb.org/links/evidence_items/1692", "If a patient with nan cancer has erbb2 amplification, one recommended therapy is trastuzumab. entry url: https://civicdb.org/links/evidence_items/1693", "If a patient with nan cancer has erbb2 mutation, one recommended therapy is platinum compound. entry url: https://civicdb.org/links/evidence_items/1694", "If a patient with nan cancer has braf v600e, one recommended therapy is vemurafenib. entry url: https://civicdb.org/links/evidence_items/1698", "If a patient with nan cancer has braf v600e, one recommended therapy is vemurafenib. entry url: https://civicdb.org/links/evidence_items/1699", "If a patient with nan cancer has mycl expression, one recommended therapy is i-bet151 + jq1. entry url: https://civicdb.org/links/evidence_items/1706", "If a patient with Glioblastoma cancer has hgf expression, one recommended therapy is met tyrosine kinase inhibitor sgx523. entry url: https://civicdb.org/links/evidence_items/1707", "If a patient with Colorectal Cancer cancer has egfr expression, one recommended therapy is panitumumab. entry url: https://civicdb.org/links/evidence_items/1708", "If a patient with Colorectal Cancer cancer has egfr expression, one recommended therapy is cetuximab. entry url: https://civicdb.org/links/evidence_items/1709", "If a patient with Non-Small Cell Lung Cancer cancer has met amplification, one recommended therapy is crizotinib. entry url: https://civicdb.org/links/evidence_items/1713", "If a patient with Cancer cancer has met amplification, one recommended therapy is crizotinib. entry url: https://civicdb.org/links/evidence_items/1714", "If a patient with Cholangiocarcinoma cancer has errfi1 e384*, one recommended therapy is erlotinib. entry url: https://civicdb.org/links/evidence_items/1724", "If a patient with Systemic Mastocytosis cancer has kit d816v, one recommended therapy is midostaurin. entry url: https://civicdb.org/links/evidence_items/1725", "If a patient with Non-Small Cell Lung Cancer cancer has egfr mutation, one recommended therapy is afatinib. entry url: https://civicdb.org/links/evidence_items/1728", "If a patient with Breast Cancer cancer has sgk1 overexpression, one recommended therapy is sgk1-inh + alpelisib. entry url: https://civicdb.org/links/evidence_items/1731", "If a patient with Non-Small Cell Lung Cancer cancer has cd274 expression, one recommended therapy is pembrolizumab. entry url: https://civicdb.org/links/evidence_items/1733", "If a patient with Ovarian Cancer cancer has ccne1 overexpression, one recommended therapy is cdk inhibitor sns-032. entry url: https://civicdb.org/links/evidence_items/1734", "If a patient with nan cancer has ccne1 amplification, one recommended therapy is dinaciclib + akt inhibitor mk2206. entry url: https://civicdb.org/links/evidence_items/1735", "If a patient with Non-Small Cell Lung Cancer cancer has egfr g719s, one recommended therapy is gefitinib + erlotinib. entry url: https://civicdb.org/links/evidence_items/1736", "If a patient with Non-Small Cell Lung Cancer cancer has braf g596c, one recommended therapy is dabrafenib + trametinib. entry url: https://civicdb.org/links/evidence_items/1738", "If a patient with Synovial Sarcoma cancer has smarcb1 underexpression, one recommended therapy is tazemetostat. entry url: https://civicdb.org/links/evidence_items/1739", "If a patient with Rhabdoid Cancer cancer has smarcb1 deletion, one recommended therapy is tazemetostat. entry url: https://civicdb.org/links/evidence_items/1740", "If a patient with nan cancer has nf2 loss, one recommended therapy is selumetinib. entry url: https://civicdb.org/links/evidence_items/1742", "If a patient with Malignant Peripheral Nerve Sheath Tumor cancer has nf1 loss, one recommended therapy is jq1 compound. entry url: https://civicdb.org/links/evidence_items/1743", "If a patient with nan cancer has erbb3 v104m, one recommended therapy is afatinib. entry url: https://civicdb.org/links/evidence_items/1746", "If a patient with nan cancer has erbb3 r103g, one recommended therapy is afatinib. entry url: https://civicdb.org/links/evidence_items/1747", "If a patient with nan cancer has erbb3 g284r, one recommended therapy is afatinib. entry url: https://civicdb.org/links/evidence_items/1748", "If a patient with Melanoma cancer has braf v600e, one recommended therapy is vemurafenib. entry url: https://civicdb.org/links/evidence_items/1749", "If a patient with Melanoma cancer has braf v600, one recommended therapy is trametinib. entry url: https://civicdb.org/links/evidence_items/1750", "If a patient with nan cancer has mthfr a222v, one recommended therapy is fluorouracil. entry url: https://civicdb.org/links/evidence_items/1757", "If a patient with nan cancer has erbb2 amplification, one recommended therapy is trastuzumab emtansine. entry url: https://civicdb.org/links/evidence_items/1764", "If a patient with nan cancer has cdkn2a loss, one recommended therapy is letrozole + palbociclib. entry url: https://civicdb.org/links/evidence_items/1765", "If a patient with nan cancer has fgfr1 amplification, one recommended therapy is ponatinib. entry url: https://civicdb.org/links/evidence_items/1767", "If a patient with Non-Small Cell Lung Cancer cancer has pdgfra amplification, one recommended therapy is sunitinib. entry url: https://civicdb.org/links/evidence_items/1771", "If a patient with Ovarian Cancer cancer has brca1 mutation, one recommended therapy is olaparib. entry url: https://civicdb.org/links/evidence_items/1772", "If a patient with Ovarian Cancer cancer has brca2 mutation, one recommended therapy is olaparib. entry url: https://civicdb.org/links/evidence_items/1773", "If a patient with nan cancer has fip1l1::pdgfra fusion, one recommended therapy is imatinib. entry url: https://civicdb.org/links/evidence_items/1774", "If a patient with nan cancer has fip1l1::pdgfra fusion, one recommended therapy is ponatinib. entry url: https://civicdb.org/links/evidence_items/1777", "If a patient with nan cancer has fip1l1::pdgfra fusion, pdgfra t674i, one recommended therapy is ponatinib. entry url: https://civicdb.org/links/evidence_items/1779", "If a patient with Lung Adenocarcinoma cancer has egfr g719, one recommended therapy is erlotinib. entry url: https://civicdb.org/links/evidence_items/1780", "If a patient with nut midline cancer has brd4::nutm1 fusion, one recommended therapy is jq1. entry url: https://civicdb.org/links/evidence_items/1781", "If a patient with Lung Adenocarcinoma cancer has egfr k757r, one recommended therapy is erlotinib. entry url: https://civicdb.org/links/evidence_items/1786", "If a patient with Lung Adenocarcinoma cancer has egfr e746g, one recommended therapy is erlotinib. entry url: https://civicdb.org/links/evidence_items/1787", "If a patient with Lung Adenocarcinoma cancer has egfr v769_d770insasv, one recommended therapy is erlotinib. entry url: https://civicdb.org/links/evidence_items/1799", "If a patient with nan cancer has tnks2::pdgfra fusion, one recommended therapy is imatinib. entry url: https://civicdb.org/links/evidence_items/1838", "If a patient with Non-Small Cell Lung Cancer cancer has erbb3 v855a, one recommended therapy is afatinib + pertuzumab. entry url: https://civicdb.org/links/evidence_items/1845", "If a patient with Cholangiocarcinoma cancer has fgfr2::bicc1 fusion, one recommended therapy is infigratinib + pd173074. entry url: https://civicdb.org/links/evidence_items/1851", "If a patient with Cholangiocarcinoma cancer has fgfr2::ahcyl1 fusion, one recommended therapy is infigratinib + pd173074. entry url: https://civicdb.org/links/evidence_items/1853", "If a patient with nan cancer has ptprd v253i, one recommended therapy is cixutumumab + teprotumumab. entry url: https://civicdb.org/links/evidence_items/1856", "If a patient with Glioblastoma cancer has pole mutation, one recommended therapy is pembrolizumab. entry url: https://civicdb.org/links/evidence_items/1861", "If a patient with Endometrial Cancer cancer has pole mutation, one recommended therapy is pembrolizumab. entry url: https://civicdb.org/links/evidence_items/1862", "If a patient with Non-Small Cell Lung Cancer cancer has met d1228v, one recommended therapy is cabozantinib. entry url: https://civicdb.org/links/evidence_items/1864", "If a patient with nan cancer has rb1 mutation, one recommended therapy is chemotherapy. entry url: https://civicdb.org/links/evidence_items/1866", "If a patient with Non-Small Cell Lung Cancer cancer has egfr t790m, one recommended therapy is osimertinib. entry url: https://civicdb.org/links/evidence_items/1867", "If a patient with Non-Small Cell Lung Cancer cancer has sqstm1::ntrk1 fusion, one recommended therapy is entrectinib. entry url: https://civicdb.org/links/evidence_items/1868", "If a patient with mammary analogue secretory cancer has etv6::ntrk3 fusion, one recommended therapy is entrectinib. entry url: https://civicdb.org/links/evidence_items/1869", "If a patient with nan cancer has msh2 loss, one recommended therapy is durvalumab + anti-pd-1 monoclonal antibody medi0680. entry url: https://civicdb.org/links/evidence_items/1877", "If a patient with nan cancer has msh6 loss, one recommended therapy is anti-pd-1 monoclonal antibody medi0680 + durvalumab. entry url: https://civicdb.org/links/evidence_items/1878", "If a patient with Ewing Sarcoma cancer has cdkn2a loss, one recommended therapy is palbociclib + linsitinib. entry url: https://civicdb.org/links/evidence_items/1879", "If a patient with Ewing Sarcoma cancer has cdkn2b loss, one recommended therapy is palbociclib + linsitinib. entry url: https://civicdb.org/links/evidence_items/1880", "If a patient with Dermatofibrosarcoma Protuberans cancer has cdkn2a loss, one recommended therapy is palbociclib. entry url: https://civicdb.org/links/evidence_items/1881", "If a patient with Lung Adenocarcinoma cancer has erbb2 y772_a775dup, one recommended therapy is afatinib. entry url: https://civicdb.org/links/evidence_items/1888", "If a patient with Lung Adenocarcinoma cancer has erbb2 g776l, one recommended therapy is afatinib. entry url: https://civicdb.org/links/evidence_items/1889", "If a patient with Lung Adenocarcinoma cancer has erbb2 g778_p780dup, one recommended therapy is afatinib. entry url: https://civicdb.org/links/evidence_items/1890", "If a patient with Non-Small Cell Lung Cancer cancer has erbb2 g778_p780dup, one recommended therapy is dacomitinib. entry url: https://civicdb.org/links/evidence_items/1892", "If a patient with Non-Small Cell Lung Cancer cancer has erbb2 m774delinswlv, one recommended therapy is dacomitinib. entry url: https://civicdb.org/links/evidence_items/1894", "If a patient with Angiosarcoma cancer has ptprb loss-of-function, one recommended therapy is sunitinib + vatalanib. entry url: https://civicdb.org/links/evidence_items/1895", "If a patient with Ovarian Cancer cancer has brca1 mutation, one recommended therapy is rucaparib. entry url: https://civicdb.org/links/evidence_items/1897", "If a patient with Colorectal Cancer cancer has kras g12d, one recommended therapy is therapeutic tumor infiltrating lymphocytes. entry url: https://civicdb.org/links/evidence_items/1898", "If a patient with Hepatocellular Carcinoma cancer has jak1 s703i, one recommended therapy is ruxolitinib. entry url: https://civicdb.org/links/evidence_items/1900", "If a patient with Colorectal Cancer cancer has braf v600e, one recommended therapy is cetuximab + irinotecan + vemurafenib. entry url: https://civicdb.org/links/evidence_items/1902", "If a patient with Mantle Cell Lymphoma cancer has atm mutation, one recommended therapy is olaparib. entry url: https://civicdb.org/links/evidence_items/1907", "If a patient with Lung Squamous Cell Carcinoma cancer has fgfr1 amplification, one recommended therapy is infigratinib. entry url: https://civicdb.org/links/evidence_items/1908", "If a patient with nan cancer has fgfr3 mutation, one recommended therapy is infigratinib. entry url: https://civicdb.org/links/evidence_items/1910", "If a patient with Cholangiocarcinoma cancer has fgfr2 mutation, one recommended therapy is infigratinib. entry url: https://civicdb.org/links/evidence_items/1912", "If a patient with Cholangiocarcinoma cancer has fgfr2::v fusion, one recommended therapy is infigratinib. entry url: https://civicdb.org/links/evidence_items/1913", "If a patient with Cholangiocarcinoma cancer has fgfr2::? fusion, one recommended therapy is infigratinib. entry url: https://civicdb.org/links/evidence_items/1913", "If a patient with nan cancer has fgfr2::bicc1 fusion, one recommended therapy is erdafitinib. entry url: https://civicdb.org/links/evidence_items/1917", "If a patient with Cancer cancer has fgfr2::v fusion, one recommended therapy is erdafitinib. entry url: https://civicdb.org/links/evidence_items/1918", "If a patient with Cancer cancer has fgfr3::tacc3 fusion, one recommended therapy is erdafitinib. entry url: https://civicdb.org/links/evidence_items/1919", "If a patient with Endometrial Cancer cancer has fgfr2::bicc1 fusion, one recommended therapy is erdafitinib. entry url: https://civicdb.org/links/evidence_items/1920", "If a patient with nan cancer has akt3 overexpression, one recommended therapy is pan-akt kinase inhibitor gsk690693. entry url: https://civicdb.org/links/evidence_items/1923", "If a patient with Breast Cancer cancer has brca1 loss-of-function, one recommended therapy is pidnarulex + quarfloxin. entry url: https://civicdb.org/links/evidence_items/1924", "If a patient with Breast Cancer cancer has brca2 loss-of-function, one recommended therapy is quarfloxin + pidnarulex. entry url: https://civicdb.org/links/evidence_items/1925", "If a patient with Melanoma cancer has alk alternative transcript (ati), one recommended therapy is crizotinib. entry url: https://civicdb.org/links/evidence_items/1936", "If a patient with Non-Small Cell Lung Cancer cancer has egfr mutation, one recommended therapy is gefitinib. entry url: https://civicdb.org/links/evidence_items/1937", "If a patient with Uveal Melanoma cancer has gna11 mutation, one recommended therapy is sotrastaurin acetate + mirdametinib. entry url: https://civicdb.org/links/evidence_items/1952", "If a patient with Uveal Melanoma cancer has gnaq mutation, one recommended therapy is sotrastaurin acetate + mirdametinib. entry url: https://civicdb.org/links/evidence_items/1953", "If a patient with nan cancer has nf1 mutation, one recommended therapy is selumetinib. entry url: https://civicdb.org/links/evidence_items/1958", "If a patient with Prostate Cancer cancer has atm mutation, one recommended therapy is olaparib. entry url: https://civicdb.org/links/evidence_items/1960", "If a patient with Prostate Cancer cancer has palb2 biallelic inactivation, one recommended therapy is olaparib. entry url: https://civicdb.org/links/evidence_items/1963", "If a patient with Melanoma cancer has pdgfra p577s, one recommended therapy is crenolanib + imatinib. entry url: https://civicdb.org/links/evidence_items/1974", "If a patient with Melanoma cancer has pdgfra r841k, one recommended therapy is crenolanib + imatinib. entry url: https://civicdb.org/links/evidence_items/1975", "If a patient with Melanoma cancer has pdgfra h845y, one recommended therapy is imatinib + crenolanib. entry url: https://civicdb.org/links/evidence_items/1976", "If a patient with Melanoma cancer has pdgfra g853d, one recommended therapy is crenolanib + imatinib. entry url: https://civicdb.org/links/evidence_items/1977", "If a patient with Colorectal Cancer cancer has met amplification, one recommended therapy is cetuximab + crizotinib. entry url: https://civicdb.org/links/evidence_items/1979", "If a patient with Breast Cancer cancer has mtap underexpression, one recommended therapy is pyrimidine antagonist. entry url: https://civicdb.org/links/evidence_items/1980", "If a patient with Chordoma cancer has egfr expression, one recommended therapy is lapatinib. entry url: https://civicdb.org/links/evidence_items/1984", "If a patient with Cancer cancer has erbb2 t862a, one recommended therapy is lapatinib. entry url: https://civicdb.org/links/evidence_items/1986", "If a patient with Cancer cancer has erbb2 v773a, one recommended therapy is lapatinib. entry url: https://civicdb.org/links/evidence_items/1987", "If a patient with Cancer cancer has erbb2 n857s, one recommended therapy is lapatinib. entry url: https://civicdb.org/links/evidence_items/1988", "If a patient with Cancer cancer has erbb2 h878y, one recommended therapy is lapatinib. entry url: https://civicdb.org/links/evidence_items/1989", "If a patient with nan cancer has fgfr2 amplification, one recommended therapy is fexagratinib. entry url: https://civicdb.org/links/evidence_items/1990", "If a patient with Breast Cancer cancer has fgfr1 amplification, one recommended therapy is fexagratinib. entry url: https://civicdb.org/links/evidence_items/1991", "If a patient with Head And Neck Squamous Cell Carcinoma cancer has erbb2 overexpression, one recommended therapy is lapatinib. entry url: https://civicdb.org/links/evidence_items/1992", "If a patient with Colorectal Cancer cancer has kras g12v, one recommended therapy is dactolisib + selumetinib. entry url: https://civicdb.org/links/evidence_items/2001", "If a patient with nan cancer has idh1 r132, one recommended therapy is sunitinib + bevacizumab. entry url: https://civicdb.org/links/evidence_items/2020", "If a patient with nan cancer has pik3ca e542k, one recommended therapy is pictilisib. entry url: https://civicdb.org/links/evidence_items/2022", "If a patient with Breast Cancer cancer has pik3ca e542k, one recommended therapy is pictilisib. entry url: https://civicdb.org/links/evidence_items/2026", "If a patient with Breast Cancer cancer has pik3ca e545k, one recommended therapy is pictilisib. entry url: https://civicdb.org/links/evidence_items/2034", "If a patient with Non-Small Cell Lung Cancer cancer has pik3ca e545k, one recommended therapy is pi103. entry url: https://civicdb.org/links/evidence_items/2040", "If a patient with nan cancer has pten loss, one recommended therapy is pictilisib. entry url: https://civicdb.org/links/evidence_items/2045", "If a patient with Non-Small Cell Lung Cancer cancer has egfr mutation, one recommended therapy is erlotinib + gefitinib. entry url: https://civicdb.org/links/evidence_items/2053", "If a patient with nan cancer has pik3ca e542k, one recommended therapy is pi-103. entry url: https://civicdb.org/links/evidence_items/2058", "If a patient with nan cancer has pik3ca e545k, one recommended therapy is pictilisib. entry url: https://civicdb.org/links/evidence_items/2062", "If a patient with Breast Cancer cancer has erbb2 amplification, one recommended therapy is pictilisib. entry url: https://civicdb.org/links/evidence_items/2071", "If a patient with nan cancer has pik3ca c420r, one recommended therapy is pictilisib. entry url: https://civicdb.org/links/evidence_items/2078", "If a patient with nan cancer has pik3ca k111n, one recommended therapy is pictilisib. entry url: https://civicdb.org/links/evidence_items/2085", "If a patient with Breast Cancer cancer has pik3ca h1047l, one recommended therapy is pictilisib. entry url: https://civicdb.org/links/evidence_items/2089", "If a patient with nan cancer has pik3ca h1047r, one recommended therapy is pictilisib. entry url: https://civicdb.org/links/evidence_items/2096", "If a patient with Breast Cancer cancer has pik3ca h1047r, one recommended therapy is pictilisib. entry url: https://civicdb.org/links/evidence_items/2102", "If a patient with Melanoma cancer has braf v600e, one recommended therapy is trametinib. entry url: https://civicdb.org/links/evidence_items/2135", "If a patient with Non-Small Cell Lung Cancer cancer has egfr mutation, one recommended therapy is gefitinib. entry url: https://civicdb.org/links/evidence_items/2148", "If a patient with Non-Small Cell Lung Cancer cancer has egfr mutation, one recommended therapy is afatinib. entry url: https://civicdb.org/links/evidence_items/2153", "If a patient with Non-Small Cell Lung Cancer cancer has egfr l858r, one recommended therapy is gefitinib. entry url: https://civicdb.org/links/evidence_items/2156", "If a patient with Non-Small Cell Lung Cancer cancer has egfr exon 19 deletion, one recommended therapy is gefitinib. entry url: https://civicdb.org/links/evidence_items/2156", "If a patient with Lung Adenocarcinoma cancer has egfr t790m, one recommended therapy is osimertinib. entry url: https://civicdb.org/links/evidence_items/2157", "If a patient with Non-Small Cell Lung Cancer cancer has egfr t790m, one recommended therapy is dacomitinib. entry url: https://civicdb.org/links/evidence_items/2161", "If a patient with Non-Small Cell Lung Cancer cancer has egfr t790m, one recommended therapy is neratinib. entry url: https://civicdb.org/links/evidence_items/2162", "If a patient with Non-Small Cell Lung Cancer cancer has egfr t790m, one recommended therapy is afatinib. entry url: https://civicdb.org/links/evidence_items/2163", "If a patient with Non-Small Cell Lung Cancer cancer has egfr t790m, one recommended therapy is afatinib. entry url: https://civicdb.org/links/evidence_items/2164", "If a patient with Non-Small Cell Lung Cancer cancer has egfr t790m, one recommended therapy is canertinib. entry url: https://civicdb.org/links/evidence_items/2165", "If a patient with Colorectal Cancer cancer has kras g13d, one recommended therapy is selumetinib + dactolisib. entry url: https://civicdb.org/links/evidence_items/2183", "If a patient with Colorectal Cancer cancer has nras q61k, one recommended therapy is dactolisib + selumetinib. entry url: https://civicdb.org/links/evidence_items/2192", "If a patient with Colorectal Cancer cancer has kras a146t, one recommended therapy is selumetinib + dactolisib. entry url: https://civicdb.org/links/evidence_items/2206", "If a patient with Colorectal Cancer cancer has kras a146v, one recommended therapy is selumetinib + dactolisib. entry url: https://civicdb.org/links/evidence_items/2209", "If a patient with Colorectal Cancer cancer has kras g12c, one recommended therapy is selumetinib + dactolisib. entry url: https://civicdb.org/links/evidence_items/2212", "If a patient with Colorectal Cancer cancer has kras g12d, one recommended therapy is selumetinib + dactolisib. entry url: https://civicdb.org/links/evidence_items/2218", "If a patient with nan cancer has tp53 y220c, one recommended therapy is mitomycin + etoposide + cisplatin. entry url: https://civicdb.org/links/evidence_items/2306", "If a patient with nan cancer has tp53 r175h, one recommended therapy is eap protocol. entry url: https://civicdb.org/links/evidence_items/2310", "If a patient with nan cancer has idh1 r132c, one recommended therapy is temozolomide. entry url: https://civicdb.org/links/evidence_items/2327", "If a patient with nan cancer has idh1 r132c, one recommended therapy is agi-5198. entry url: https://civicdb.org/links/evidence_items/2329", "If a patient with Acute Myeloid Leukemia cancer has idh1 r132c, one recommended therapy is ivosidenib. entry url: https://civicdb.org/links/evidence_items/2331", "If a patient with Acute Myeloid Leukemia cancer has idh1 r132c, one recommended therapy is bptes. entry url: https://civicdb.org/links/evidence_items/2332", "If a patient with Gastrointestinal Stromal Tumor cancer has kit t417_d419delinsy, one recommended therapy is imatinib. entry url: https://civicdb.org/links/evidence_items/2417", "If a patient with Gastrointestinal Stromal Tumor cancer has kit k484_g487del, one recommended therapy is imatinib. entry url: https://civicdb.org/links/evidence_items/2465", "If a patient with Gastrointestinal Stromal Tumor cancer has kit exon 9 mutation, one recommended therapy is imatinib. entry url: https://civicdb.org/links/evidence_items/2466", "If a patient with Gastrointestinal Stromal Tumor cancer has kit exon 11 mutation, one recommended therapy is imatinib. entry url: https://civicdb.org/links/evidence_items/2471", "If a patient with Gastrointestinal Stromal Tumor cancer has pdgfra v561d, one recommended therapy is imatinib. entry url: https://civicdb.org/links/evidence_items/2474", "If a patient with Gastrointestinal Stromal Tumor cancer has kit exon 13 mutation, one recommended therapy is imatinib. entry url: https://civicdb.org/links/evidence_items/2475", "If a patient with Gastrointestinal Stromal Tumor cancer has kit expression, one recommended therapy is imatinib. entry url: https://civicdb.org/links/evidence_items/2480", "If a patient with Gastrointestinal Stromal Tumor cancer has pdgfra mutation, one recommended therapy is imatinib. entry url: https://civicdb.org/links/evidence_items/2487", "If a patient with Melanoma cancer has braf v600k, one recommended therapy is dabrafenib. entry url: https://civicdb.org/links/evidence_items/2505", "If a patient with Melanoma cancer has braf v600k, one recommended therapy is trametinib. entry url: https://civicdb.org/links/evidence_items/2506", "If a patient with Non-Small Cell Lung Cancer cancer has egfr g719a, one recommended therapy is gefitinib. entry url: https://civicdb.org/links/evidence_items/2508", "If a patient with nan cancer has egfr e746_a750del, one recommended therapy is erlotinib. entry url: https://civicdb.org/links/evidence_items/2513", "If a patient with Lung Adenocarcinoma cancer has egfr exon 19 deletion, one recommended therapy is gefitinib. entry url: https://civicdb.org/links/evidence_items/2519", "If a patient with Non-Small Cell Lung Cancer cancer has egfr mutation, one recommended therapy is gefitinib. entry url: https://civicdb.org/links/evidence_items/2559", "If a patient with Non-Small Cell Lung Cancer cancer has egfr l858r, one recommended therapy is gefitinib. entry url: https://civicdb.org/links/evidence_items/2621", "If a patient with Lung Adenocarcinoma cancer has egfr l858r, one recommended therapy is gefitinib. entry url: https://civicdb.org/links/evidence_items/2624", "If a patient with Non-Small Cell Lung Cancer cancer has egfr e746_a750del, one recommended therapy is gefitinib. entry url: https://civicdb.org/links/evidence_items/2625", "If a patient with Non-Small Cell Lung Cancer cancer has egfr l858r, one recommended therapy is lapatinib. entry url: https://civicdb.org/links/evidence_items/2626", "If a patient with Non-Small Cell Lung Cancer cancer has egfr l858r, one recommended therapy is dacomitinib. entry url: https://civicdb.org/links/evidence_items/2627", "If a patient with Non-Small Cell Lung Cancer cancer has egfr l858r, one recommended therapy is neratinib. entry url: https://civicdb.org/links/evidence_items/2628", "If a patient with Non-Small Cell Lung Cancer cancer has egfr l858r, one recommended therapy is afatinib. entry url: https://civicdb.org/links/evidence_items/2629", "If a patient with Non-Small Cell Lung Cancer cancer has egfr l858r, one recommended therapy is canertinib. entry url: https://civicdb.org/links/evidence_items/2631", "If a patient with Non-Small Cell Lung Cancer cancer has egfr l858r, one recommended therapy is erlotinib. entry url: https://civicdb.org/links/evidence_items/2632", "If a patient with Lung Adenocarcinoma cancer has egfr l858r, one recommended therapy is gefitinib. entry url: https://civicdb.org/links/evidence_items/2634", "If a patient with Cancer cancer has bcr::abl1 fusion, abl1 m244v, one recommended therapy is imatinib. entry url: https://civicdb.org/links/evidence_items/2638", "If a patient with Chronic Myelogenous Leukemia cancer has bcr::abl1 fusion, abl1 q252h, one recommended therapy is imatinib. entry url: https://civicdb.org/links/evidence_items/2650", "If a patient with Chronic Myelogenous Leukemia cancer has bcr::abl1 fusion, abl1 d276g, one recommended therapy is nilotinib. entry url: https://civicdb.org/links/evidence_items/2666", "If a patient with Chronic Myelogenous Leukemia cancer has bcr::abl1 fusion, abl1 m351t, one recommended therapy is imatinib. entry url: https://civicdb.org/links/evidence_items/2682", "If a patient with Chronic Myelogenous Leukemia cancer has bcr::abl1 fusion, abl1 m351t, one recommended therapy is imatinib. entry url: https://civicdb.org/links/evidence_items/2684", "If a patient with Chronic Myelogenous Leukemia cancer has bcr::abl1 fusion, abl1 m351t, one recommended therapy is nilotinib. entry url: https://civicdb.org/links/evidence_items/2685", "If a patient with nan cancer has tp53 overexpression, one recommended therapy is cisplatin + etoposide + mitomycin. entry url: https://civicdb.org/links/evidence_items/2799", "If a patient with nan cancer has tp53 r282l, one recommended therapy is eap protocol. entry url: https://civicdb.org/links/evidence_items/2818", "If a patient with nan cancer has tp53 r213p, one recommended therapy is eap protocol. entry url: https://civicdb.org/links/evidence_items/2819", "If a patient with nan cancer has tp53 mutation, one recommended therapy is cisplatin + etoposide + doxorubicin. entry url: https://civicdb.org/links/evidence_items/2820", "If a patient with Chronic Myelogenous Leukemia cancer has bcr::abl1 fusion, abl1 f486s, one recommended therapy is nilotinib. entry url: https://civicdb.org/links/evidence_items/2829", "If a patient with Chronic Myelogenous Leukemia cancer has bcr::abl1 fusion, abl1 v299l, one recommended therapy is nilotinib. entry url: https://civicdb.org/links/evidence_items/2862", "If a patient with Chronic Myelogenous Leukemia cancer has bcr::abl1 fusion, abl1 g398r, one recommended therapy is nilotinib. entry url: https://civicdb.org/links/evidence_items/2864", "If a patient with Ovarian Cancer cancer has brca2 mutation, one recommended therapy is rucaparib. entry url: https://civicdb.org/links/evidence_items/2868", "If a patient with Ovarian Cancer cancer has brca1 q1467*, one recommended therapy is rucaparib. entry url: https://civicdb.org/links/evidence_items/2878", "If a patient with Ovarian Cancer cancer has brca2 m1r, one recommended therapy is rucaparib. entry url: https://civicdb.org/links/evidence_items/2879", "If a patient with Ovarian Cancer cancer has brca2 m1i, one recommended therapy is rucaparib. entry url: https://civicdb.org/links/evidence_items/2880", "If a patient with Ovarian Cancer cancer has brca2 v159m, one recommended therapy is rucaparib. entry url: https://civicdb.org/links/evidence_items/2881", "If a patient with Ovarian Cancer cancer has brca2 v211l, one recommended therapy is rucaparib. entry url: https://civicdb.org/links/evidence_items/2882", "If a patient with Ovarian Cancer cancer has brca2 v211i, one recommended therapy is rucaparib. entry url: https://civicdb.org/links/evidence_items/2883", "If a patient with Ovarian Cancer cancer has brca2 r2336p, one recommended therapy is rucaparib. entry url: https://civicdb.org/links/evidence_items/2884", "If a patient with Melanoma cancer has kit d820y, one recommended therapy is sunitinib. entry url: https://civicdb.org/links/evidence_items/2888", "If a patient with mucosal melanoma cancer has kit k642e, one recommended therapy is imatinib. entry url: https://civicdb.org/links/evidence_items/2889", "If a patient with Glioblastoma cancer has mgmt underexpression, one recommended therapy is temozolomide. entry url: https://civicdb.org/links/evidence_items/2899", "If a patient with nan cancer has mgmt underexpression, one recommended therapy is temozolomide. entry url: https://civicdb.org/links/evidence_items/2901", "If a patient with Oligodendroglioma cancer has mgmt underexpression, one recommended therapy is temozolomide. entry url: https://civicdb.org/links/evidence_items/2902", "If a patient with Glioblastoma cancer has mgmt underexpression, one recommended therapy is temozolomide. entry url: https://civicdb.org/links/evidence_items/2903", "If a patient with nan cancer has mgmt underexpression, one recommended therapy is temozolomide. entry url: https://civicdb.org/links/evidence_items/2904", "If a patient with Non-Small Cell Lung Cancer cancer has rrm1 underexpression, one recommended therapy is cisplatin + gemcitabine. entry url: https://civicdb.org/links/evidence_items/2905", "If a patient with Non-Small Cell Lung Cancer cancer has nras q61k, one recommended therapy is selumetinib + trametinib. entry url: https://civicdb.org/links/evidence_items/2907", "If a patient with Sarcoma cancer has fgfr1 expression, one recommended therapy is fgf/vegf receptor tyrosine kinase inhibitor + pd173074 + infigratinib + fexagratinib. entry url: https://civicdb.org/links/evidence_items/2915", "If a patient with Melanoma cancer has nras mutation, one recommended therapy is binimetinib + ribociclib. entry url: https://civicdb.org/links/evidence_items/2931", "If a patient with nan cancer has idh1 mutation, one recommended therapy is olaparib. entry url: https://civicdb.org/links/evidence_items/2933", "If a patient with Lung Adenocarcinoma cancer has map2k1 k57n, one recommended therapy is selumetinib. entry url: https://civicdb.org/links/evidence_items/2936", "If a patient with Melanoma cancer has nras mutation, one recommended therapy is binimetinib. entry url: https://civicdb.org/links/evidence_items/2937", "If a patient with Lung Cancer cancer has egfr mutation, one recommended therapy is gefitinib. entry url: https://civicdb.org/links/evidence_items/2939", "If a patient with nan cancer has ctag1b overexpression, one recommended therapy is letetresgene autoleucel. entry url: https://civicdb.org/links/evidence_items/2940", "If a patient with nan cancer has ctag2 overexpression, one recommended therapy is letetresgene autoleucel. entry url: https://civicdb.org/links/evidence_items/2941", "If a patient with Solid Tumor cancer has v::ntrk1 fusion, one recommended therapy is entrectinib. entry url: https://civicdb.org/links/evidence_items/2948", "If a patient with Cancer cancer has v::ntrk3 fusion, one recommended therapy is entrectinib. entry url: https://civicdb.org/links/evidence_items/2949", "If a patient with Non-Small Cell Lung Cancer cancer has sqstm1::ntrk1 fusion, one recommended therapy is entrectinib. entry url: https://civicdb.org/links/evidence_items/2950", "If a patient with Non-Small Cell Lung Cancer cancer has v::ros1 fusion, one recommended therapy is entrectinib. entry url: https://civicdb.org/links/evidence_items/2951", "If a patient with Cancer cancer has v::alk fusion, one recommended therapy is entrectinib. entry url: https://civicdb.org/links/evidence_items/2952", "If a patient with Cancer cancer has v::ntrk1 fusion, one recommended therapy is larotrectinib. entry url: https://civicdb.org/links/evidence_items/2953", "If a patient with Sarcoma cancer has lmna::ntrk1 fusion, one recommended therapy is larotrectinib. entry url: https://civicdb.org/links/evidence_items/2955", "If a patient with Colorectal Adenocarcinoma cancer has lmna::ntrk1 fusion, one recommended therapy is entrectinib. entry url: https://civicdb.org/links/evidence_items/2960", "If a patient with Cancer cancer has tp53 wildtype, one recommended therapy is rebemadlin. entry url: https://civicdb.org/links/evidence_items/2963", "If a patient with Cancer cancer has tp53 wildtype, one recommended therapy is mdm2 inhibitor amgmds3. entry url: https://civicdb.org/links/evidence_items/2964", "If a patient with Leukemia cancer has tp53 wildtype, one recommended therapy is rg7112. entry url: https://civicdb.org/links/evidence_items/2965", "If a patient with nan cancer has arid1a loss, one recommended therapy is dasatinib. entry url: https://civicdb.org/links/evidence_items/2982", "If a patient with nan cancer has arid1a loss, one recommended therapy is gsk126. entry url: https://civicdb.org/links/evidence_items/2983", "If a patient with cervix cancer has pik3ca e545k, one recommended therapy is cisplatin + pictilisib. entry url: https://civicdb.org/links/evidence_items/2984", "If a patient with Neuroblastoma cancer has alk f1245v, one recommended therapy is entrectinib. entry url: https://civicdb.org/links/evidence_items/2987", "If a patient with Melanoma cancer has mertk overexpression, one recommended therapy is unc1062. entry url: https://civicdb.org/links/evidence_items/2991", "If a patient with Non-Small Cell Lung Cancer cancer has egfr l858r, one recommended therapy is erlotinib. entry url: https://civicdb.org/links/evidence_items/2994", "If a patient with Non-Small Cell Lung Cancer cancer has egfr exon 19 deletion, one recommended therapy is erlotinib. entry url: https://civicdb.org/links/evidence_items/2995", "If a patient with Non-Small Cell Lung Cancer cancer has egfr exon 19 deletion, one recommended therapy is afatinib. entry url: https://civicdb.org/links/evidence_items/2996", "If a patient with Non-Small Cell Lung Cancer cancer has egfr l858r, one recommended therapy is afatinib. entry url: https://civicdb.org/links/evidence_items/2997", "If a patient with nan cancer has myc overexpression, one recommended therapy is olaparib + prexasertib + cisplatin. entry url: https://civicdb.org/links/evidence_items/3003", "If a patient with Acute Myeloid Leukemia cancer has flt3 d835v, one recommended therapy is sunitinib + cytarabine. entry url: https://civicdb.org/links/evidence_items/3009", "If a patient with Acute Myeloid Leukemia cancer has flt3 d835v, one recommended therapy is sunitinib + daunorubicin. entry url: https://civicdb.org/links/evidence_items/3010", "If a patient with Non-Small Cell Lung Cancer cancer has egfr mutation, one recommended therapy is gefitinib. entry url: https://civicdb.org/links/evidence_items/3016", "If a patient with Non-Small Cell Lung Cancer cancer has braf v600e, one recommended therapy is dabrafenib + trametinib. entry url: https://civicdb.org/links/evidence_items/3017", "If a patient with Non-Small Cell Lung Cancer cancer has fgfr1 amplification, one recommended therapy is dovitinib. entry url: https://civicdb.org/links/evidence_items/3027", "If a patient with Gastrointestinal Stromal Tumor cancer has kit v559d, one recommended therapy is imatinib. entry url: https://civicdb.org/links/evidence_items/3028", "If a patient with Cancer cancer has kit v559d, one recommended therapy is tandutinib + dasatinib + sunitinib + imatinib + pd-180970. entry url: https://civicdb.org/links/evidence_items/3029", "If a patient with Acute Myeloid Leukemia cancer has flt3 d835v, one recommended therapy is as602868 + tyrphostin ag 1296. entry url: https://civicdb.org/links/evidence_items/3034", "If a patient with Cancer cancer has akt1 e17k, one recommended therapy is capivasertib. entry url: https://civicdb.org/links/evidence_items/3039", "If a patient with Cancer cancer has pik3ca mutation, one recommended therapy is capivasertib. entry url: https://civicdb.org/links/evidence_items/3040", "If a patient with follicular thyroid cancer has gnas r201h, one recommended therapy is radioactive iodine. entry url: https://civicdb.org/links/evidence_items/3045", "If a patient with Uveal Melanoma cancer has gna11 mutation, one recommended therapy is cabozantinib. entry url: https://civicdb.org/links/evidence_items/3049", "If a patient with Non-Small Cell Lung Cancer cancer has kras mutation, one recommended therapy is teprotumumab + erlotinib. entry url: https://civicdb.org/links/evidence_items/3713", "If a patient with Melanoma cancer has braf v600e, one recommended therapy is vemurafenib. entry url: https://civicdb.org/links/evidence_items/3750", "If a patient with Melanoma cancer has braf v600e, one recommended therapy is vemurafenib. entry url: https://civicdb.org/links/evidence_items/3755", "If a patient with Melanoma cancer has braf v600e, one recommended therapy is vemurafenib. entry url: https://civicdb.org/links/evidence_items/3757", "If a patient with Melanoma cancer has braf v600e, one recommended therapy is trametinib + dabrafenib. entry url: https://civicdb.org/links/evidence_items/3758", "If a patient with nan cancer has braf v600e, one recommended therapy is vemurafenib. entry url: https://civicdb.org/links/evidence_items/3777", "If a patient with nan cancer has braf v600e, one recommended therapy is vemurafenib. entry url: https://civicdb.org/links/evidence_items/3787", "If a patient with Lung Adenocarcinoma cancer has egfr l858r, one recommended therapy is erlotinib. entry url: https://civicdb.org/links/evidence_items/3791", "If a patient with Lung Adenocarcinoma cancer has egfr exon 19 deletion, one recommended therapy is erlotinib. entry url: https://civicdb.org/links/evidence_items/3791", "If a patient with Non-Small Cell Lung Cancer cancer has egfr mutation, one recommended therapy is erlotinib. entry url: https://civicdb.org/links/evidence_items/3794", "If a patient with Non-Small Cell Lung Cancer cancer has egfr l861q, one recommended therapy is gefitinib. entry url: https://civicdb.org/links/evidence_items/3802", "If a patient with Cancer cancer has egfr l858r, one recommended therapy is erlotinib + multikinase inhibitor aee788 + gefitinib. entry url: https://civicdb.org/links/evidence_items/3811", "If a patient with Lung Cancer cancer has egfr mutation, one recommended therapy is erlotinib. entry url: https://civicdb.org/links/evidence_items/3864", "If a patient with Acute Myeloid Leukemia cancer has flt3 d835v, one recommended therapy is sunitinib. entry url: https://civicdb.org/links/evidence_items/4022", "If a patient with Gastrointestinal Stromal Tumor cancer has kit v560_l576del, one recommended therapy is regorafenib. entry url: https://civicdb.org/links/evidence_items/4061", "If a patient with Gastrointestinal Stromal Tumor cancer has kit w557_k558del, one recommended therapy is ponatinib + imatinib. entry url: https://civicdb.org/links/evidence_items/4084", "If a patient with Gastrointestinal Stromal Tumor cancer has kit w557_k558del, one recommended therapy is regorafenib + sunitinib. entry url: https://civicdb.org/links/evidence_items/4087", "If a patient with Gastrointestinal Stromal Tumor cancer has kit p551_e554delpmye, one recommended therapy is ponatinib. entry url: https://civicdb.org/links/evidence_items/4125", "If a patient with Gastrointestinal Stromal Tumor cancer has kit v560d, one recommended therapy is imatinib + sunitinib + ponatinib + regorafenib. entry url: https://civicdb.org/links/evidence_items/4127", "If a patient with Cancer cancer has kit l576p, one recommended therapy is dasatinib + imatinib. entry url: https://civicdb.org/links/evidence_items/4141", "If a patient with Gastrointestinal Stromal Tumor cancer has kit wildtype, one recommended therapy is regorafenib. entry url: https://civicdb.org/links/evidence_items/4144", "If a patient with Melanoma cancer has kit k642e, one recommended therapy is dasatinib. entry url: https://civicdb.org/links/evidence_items/4147", "If a patient with Melanoma cancer has braf v600k, one recommended therapy is vemurafenib. entry url: https://civicdb.org/links/evidence_items/4180", "If a patient with Melanoma cancer has braf v600k, one recommended therapy is trametinib + dabrafenib. entry url: https://civicdb.org/links/evidence_items/4181", "If a patient with nan cancer has egfr r108k, one recommended therapy is erlotinib. entry url: https://civicdb.org/links/evidence_items/4186", "If a patient with nan cancer has egfr t263p, one recommended therapy is erlotinib. entry url: https://civicdb.org/links/evidence_items/4187", "If a patient with nan cancer has egfr a289v, one recommended therapy is erlotinib. entry url: https://civicdb.org/links/evidence_items/4188", "If a patient with Non-Small Cell Lung Cancer cancer has egfr g719, one recommended therapy is gefitinib + erlotinib. entry url: https://civicdb.org/links/evidence_items/4189", "If a patient with Non-Small Cell Lung Cancer cancer has egfr g719s, one recommended therapy is erlotinib. entry url: https://civicdb.org/links/evidence_items/4190", "If a patient with Non-Small Cell Lung Cancer cancer has egfr v742a, one recommended therapy is erlotinib. entry url: https://civicdb.org/links/evidence_items/4197", "If a patient with Non-Small Cell Lung Cancer cancer has egfr e746_a750del, one recommended therapy is gefitinib. entry url: https://civicdb.org/links/evidence_items/4198", "If a patient with Non-Small Cell Lung Cancer cancer has egfr mutation, one recommended therapy is erlotinib. entry url: https://civicdb.org/links/evidence_items/4201", "If a patient with Lung Adenocarcinoma cancer has egfr e746_t751>i, one recommended therapy is gefitinib. entry url: https://civicdb.org/links/evidence_items/4209", "If a patient with Non-Small Cell Lung Cancer cancer has egfr g719d, one recommended therapy is erlotinib + gefitinib. entry url: https://civicdb.org/links/evidence_items/4210", "If a patient with Non-Small Cell Lung Cancer cancer has egfr v774a, one recommended therapy is gefitinib. entry url: https://civicdb.org/links/evidence_items/4226", "If a patient with Non-Small Cell Lung Cancer cancer has egfr v834i, one recommended therapy is gefitinib. entry url: https://civicdb.org/links/evidence_items/4248", "If a patient with Non-Small Cell Lung Cancer cancer has egfr l838p, one recommended therapy is gefitinib. entry url: https://civicdb.org/links/evidence_items/4252", "If a patient with Cancer cancer has egfr l858r, one recommended therapy is erlotinib. entry url: https://civicdb.org/links/evidence_items/4265", "If a patient with Non-Small Cell Lung Cancer cancer has egfr l747_p753delinss, one recommended therapy is erlotinib. entry url: https://civicdb.org/links/evidence_items/4266", "If a patient with Cancer cancer has egfr r831h, one recommended therapy is erlotinib. entry url: https://civicdb.org/links/evidence_items/4279", "If a patient with Non-Small Cell Lung Cancer cancer has egfr l858r, one recommended therapy is erlotinib. entry url: https://civicdb.org/links/evidence_items/4284", "If a patient with Cancer cancer has egfr l858r, one recommended therapy is erlotinib. entry url: https://civicdb.org/links/evidence_items/4285", "If a patient with Non-Small Cell Lung Cancer cancer has egfr l858r, one recommended therapy is erlotinib. entry url: https://civicdb.org/links/evidence_items/4286", "If a patient with Non-Small Cell Lung Cancer cancer has egfr l858r, one recommended therapy is erlotinib. entry url: https://civicdb.org/links/evidence_items/4287", "If a patient with Lung Adenocarcinoma cancer has egfr l858r, one recommended therapy is erlotinib. entry url: https://civicdb.org/links/evidence_items/4290", "If a patient with Lung Adenocarcinoma cancer has egfr l858r, one recommended therapy is erlotinib. entry url: https://civicdb.org/links/evidence_items/4291", "If a patient with nan cancer has egfr l858r, one recommended therapy is erlotinib. entry url: https://civicdb.org/links/evidence_items/4293", "If a patient with Non-Small Cell Lung Cancer cancer has egfr l858r, one recommended therapy is osimertinib. entry url: https://civicdb.org/links/evidence_items/4294", "If a patient with nan cancer has egfr l858r, one recommended therapy is erlotinib. entry url: https://civicdb.org/links/evidence_items/4295", "If a patient with Non-Small Cell Lung Cancer cancer has egfr l861, one recommended therapy is erlotinib + gefitinib. entry url: https://civicdb.org/links/evidence_items/4298", "If a patient with nan cancer has egfr l861q, one recommended therapy is erlotinib. entry url: https://civicdb.org/links/evidence_items/4299", "If a patient with Cancer cancer has egfr e868g, one recommended therapy is erlotinib. entry url: https://civicdb.org/links/evidence_items/4301", "If a patient with Chronic Myelogenous Leukemia cancer has bcr::abl1 fusion, abl1 t315i, one recommended therapy is axitinib. entry url: https://civicdb.org/links/evidence_items/4369", "If a patient with Chronic Myelogenous Leukemia cancer has bcr::abl1 fusion, abl1 t315i, one recommended therapy is axitinib. entry url: https://civicdb.org/links/evidence_items/4371", "If a patient with nan cancer has bcr::abl1 fusion, one recommended therapy is dasatinib. entry url: https://civicdb.org/links/evidence_items/4436", "If a patient with Gastrointestinal Stromal Tumor cancer has kit v559d, one recommended therapy is imatinib + regorafenib + ponatinib. entry url: https://civicdb.org/links/evidence_items/4459", "If a patient with Non-Small Cell Lung Cancer cancer has egfr r776c, one recommended therapy is erlotinib. entry url: https://civicdb.org/links/evidence_items/4468", "If a patient with Colorectal Cancer cancer has arid1a q456*, one recommended therapy is dasatinib. entry url: https://civicdb.org/links/evidence_items/4487", "If a patient with Melanoma cancer has braf v600d, one recommended therapy is vemurafenib. entry url: https://civicdb.org/links/evidence_items/4488", "If a patient with Melanoma cancer has braf v600d, one recommended therapy is vemurafenib. entry url: https://civicdb.org/links/evidence_items/4489", "If a patient with Non-Small Cell Lung Cancer cancer has egfr a864t, one recommended therapy is erlotinib. entry url: https://civicdb.org/links/evidence_items/4495", "If a patient with Non-Small Cell Lung Cancer cancer has egfr a763_y764insfqea, one recommended therapy is erlotinib. entry url: https://civicdb.org/links/evidence_items/4497", "If a patient with nan cancer has egfr viii, one recommended therapy is erlotinib. entry url: https://civicdb.org/links/evidence_items/4500", "If a patient with Chronic Myelogenous Leukemia cancer has bcr::abl1 fusion, abl1 v299l, one recommended therapy is axitinib. entry url: https://civicdb.org/links/evidence_items/4537", "If a patient with Chronic Myelogenous Leukemia cancer has bcr::abl1 fusion, abl1 d421g, one recommended therapy is bosutinib. entry url: https://civicdb.org/links/evidence_items/4559", "If a patient with Chronic Myelogenous Leukemia cancer has bcr::abl1 fusion, abl1 g398r, one recommended therapy is dasatinib. entry url: https://civicdb.org/links/evidence_items/4561", "If a patient with Gastrointestinal Stromal Tumor cancer has kit k550_w557del, one recommended therapy is imatinib + regorafenib + ponatinib + sunitinib. entry url: https://civicdb.org/links/evidence_items/4583", "If a patient with Gastrointestinal Stromal Tumor cancer has kit d820y, one recommended therapy is regorafenib. entry url: https://civicdb.org/links/evidence_items/4589", "If a patient with Gastrointestinal Stromal Tumor cancer has kit k558delinsnp, one recommended therapy is regorafenib + ponatinib + imatinib + sunitinib. entry url: https://civicdb.org/links/evidence_items/4594", "If a patient with Gastrointestinal Stromal Tumor cancer has kit n822k, one recommended therapy is regorafenib. entry url: https://civicdb.org/links/evidence_items/4595", "If a patient with Gastrointestinal Stromal Tumor cancer has kit exon 11 mutation, one recommended therapy is regorafenib. entry url: https://civicdb.org/links/evidence_items/4599", "If a patient with nan cancer has brca1 w1815x, one recommended therapy is olaparib. entry url: https://civicdb.org/links/evidence_items/4623", "If a patient with Gastrointestinal Stromal Tumor cancer has kit exon 9 mutation, one recommended therapy is regorafenib. entry url: https://civicdb.org/links/evidence_items/4628", "If a patient with Gastrointestinal Stromal Tumor cancer has kit exon 11 mutation, one recommended therapy is regorafenib. entry url: https://civicdb.org/links/evidence_items/4629", "If a patient with Cancer cancer has egfr w731l, one recommended therapy is erlotinib. entry url: https://civicdb.org/links/evidence_items/4655", "If a patient with Cancer cancer has egfr e734q, one recommended therapy is erlotinib. entry url: https://civicdb.org/links/evidence_items/4656", "If a patient with Cancer cancer has egfr t785a, one recommended therapy is erlotinib. entry url: https://civicdb.org/links/evidence_items/4657", "If a patient with Cancer cancer has egfr c797y, one recommended therapy is erlotinib. entry url: https://civicdb.org/links/evidence_items/4658", "If a patient with Cancer cancer has egfr y801h, one recommended therapy is erlotinib. entry url: https://civicdb.org/links/evidence_items/4659", "If a patient with Lung Adenocarcinoma cancer has egfr l747_s752delinsq, one recommended therapy is erlotinib. entry url: https://civicdb.org/links/evidence_items/4667", "If a patient with Non-Small Cell Lung Cancer cancer has egfr l861r, one recommended therapy is gefitinib. entry url: https://civicdb.org/links/evidence_items/4669", "If a patient with Chronic Myelogenous Leukemia cancer has bcr::abl1 fusion, abl1 d363g, one recommended therapy is dasatinib. entry url: https://civicdb.org/links/evidence_items/4692", "If a patient with Chronic Myelogenous Leukemia cancer has bcr::abl1 fusion, one recommended therapy is dasatinib. entry url: https://civicdb.org/links/evidence_items/4706", "If a patient with Non-Small Cell Lung Cancer cancer has egfr rare exon 18-21 mutation, one recommended therapy is erlotinib + gefitinib. entry url: https://civicdb.org/links/evidence_items/4755", "If a patient with Non-Small Cell Lung Cancer cancer has egfr l858r, one recommended therapy is gefitinib + erlotinib. entry url: https://civicdb.org/links/evidence_items/4759", "If a patient with Non-Small Cell Lung Cancer cancer has egfr exon 19 deletion, one recommended therapy is gefitinib + erlotinib. entry url: https://civicdb.org/links/evidence_items/4759", "If a patient with Lung Adenocarcinoma cancer has egfr exon 19 deletion, one recommended therapy is erlotinib. entry url: https://civicdb.org/links/evidence_items/4766", "If a patient with Lung Adenocarcinoma cancer has pold1 c284y, one recommended therapy is pembrolizumab. entry url: https://civicdb.org/links/evidence_items/4776", "If a patient with Non-Small Cell Lung Cancer cancer has pold1 e374k, one recommended therapy is pembrolizumab. entry url: https://civicdb.org/links/evidence_items/4777", "If a patient with Lung Adenocarcinoma cancer has met exon 14 skipping mutation, one recommended therapy is crizotinib. entry url: https://civicdb.org/links/evidence_items/4786", "If a patient with Non-Small Cell Lung Cancer cancer has abl1 r351w, one recommended therapy is dasatinib. entry url: https://civicdb.org/links/evidence_items/4787", "If a patient with Non-Small Cell Lung Cancer cancer has abl1 g340l, one recommended therapy is imatinib mesylate + dasatinib. entry url: https://civicdb.org/links/evidence_items/4788", "If a patient with Cancer cancer has kit s628n, one recommended therapy is dasatinib + imatinib. entry url: https://civicdb.org/links/evidence_items/4791", "If a patient with nan cancer has arid1a p1175fs*5, one recommended therapy is dasatinib. entry url: https://civicdb.org/links/evidence_items/4826", "If a patient with Acute Myeloid Leukemia cancer has idh2 mutation, one recommended therapy is enasidenib. entry url: https://civicdb.org/links/evidence_items/4833", "If a patient with Non-Small Cell Lung Cancer cancer has v::alk fusion, one recommended therapy is brigatinib. entry url: https://civicdb.org/links/evidence_items/4835", "If a patient with Breast Cancer cancer has brca1 loss-of-function, one recommended therapy is talazoparib. entry url: https://civicdb.org/links/evidence_items/4838", "If a patient with Breast Cancer cancer has brca2 loss-of-function, one recommended therapy is talazoparib. entry url: https://civicdb.org/links/evidence_items/4839", "If a patient with nan cancer has erbb2 overexpression, one recommended therapy is trastuzumab emtansine. entry url: https://civicdb.org/links/evidence_items/4840", "If a patient with Liposarcoma cancer has cdk4 amplification, one recommended therapy is palbociclib. entry url: https://civicdb.org/links/evidence_items/4841", "If a patient with Non-Small Cell Lung Cancer cancer has kras mutation, one recommended therapy is abemaciclib. entry url: https://civicdb.org/links/evidence_items/4842", "If a patient with Lung Adenocarcinoma cancer has v::ret fusion, one recommended therapy is cabozantinib. entry url: https://civicdb.org/links/evidence_items/4847", "If a patient with Non-Small Cell Lung Cancer cancer has v::ret fusion, one recommended therapy is vandetanib. entry url: https://civicdb.org/links/evidence_items/4848", "If a patient with Non-Small Cell Lung Cancer cancer has v::ret fusion, one recommended therapy is vandetanib. entry url: https://civicdb.org/links/evidence_items/4849", "If a patient with Non-Small Cell Lung Cancer cancer has v::ret fusion, one recommended therapy is alectinib. entry url: https://civicdb.org/links/evidence_items/4850", "If a patient with Non-Small Cell Lung Cancer cancer has cd274 expression, one recommended therapy is avelumab + atezolizumab + pembrolizumab + nivolumab + durvalumab. entry url: https://civicdb.org/links/evidence_items/4857", "If a patient with Non-Small Cell Lung Cancer cancer has v::alk fusion, one recommended therapy is alectinib + crizotinib. entry url: https://civicdb.org/links/evidence_items/4858", "If a patient with Non-Small Cell Lung Cancer cancer has egfr exon 19 deletion, one recommended therapy is dacomitinib + erlotinib. entry url: https://civicdb.org/links/evidence_items/4859", "If a patient with Non-Small Cell Lung Cancer cancer has egfr l858r, one recommended therapy is dacomitinib. entry url: https://civicdb.org/links/evidence_items/4860", "If a patient with adrenal cancer has fgfr3::tacc3 fusion, fgfr2::ccdc6 fusion, one recommended therapy is erdafitinib. entry url: https://civicdb.org/links/evidence_items/4861", "If a patient with Non-Small Cell Lung Cancer cancer has kras mutation, one recommended therapy is docetaxel + trametinib + pemetrexed. entry url: https://civicdb.org/links/evidence_items/4862", "If a patient with Non-Small Cell Lung Cancer cancer has kras mutation, one recommended therapy is atezolizumab + nivolumab. entry url: https://civicdb.org/links/evidence_items/4863", "If a patient with Non-Small Cell Lung Cancer cancer has kras mutation, one recommended therapy is immune checkpoint inhibitor. entry url: https://civicdb.org/links/evidence_items/4864", "If a patient with Colorectal Cancer cancer has kras mutation, one recommended therapy is palbociclib + binimetinib. entry url: https://civicdb.org/links/evidence_items/4869", "If a patient with Sarcoma cancer has cdk4 expression, one recommended therapy is palbociclib. entry url: https://civicdb.org/links/evidence_items/4872", "If a patient with nan cancer has chek1 overexpression, one recommended therapy is olaparib + cisplatin + prexasertib. entry url: https://civicdb.org/links/evidence_items/4874", "If a patient with Ovarian Cancer cancer has brca2 loss-of-function, one recommended therapy is talazoparib. entry url: https://civicdb.org/links/evidence_items/4875", "If a patient with Ovarian Cancer cancer has brca1 loss-of-function, one recommended therapy is talazoparib. entry url: https://civicdb.org/links/evidence_items/4876", "If a patient with Non-Small Cell Lung Cancer cancer has egfr expression, one recommended therapy is gefitinib. entry url: https://civicdb.org/links/evidence_items/4877", "If a patient with Melanoma cancer has braf l597q, one recommended therapy is trametinib. entry url: https://civicdb.org/links/evidence_items/4905", "If a patient with Non-Small Cell Lung Cancer cancer has egfr gain-of-function, one recommended therapy is gefitinib. entry url: https://civicdb.org/links/evidence_items/4931", "If a patient with Uveal Melanoma cancer has gnaq mutation, one recommended therapy is cabozantinib. entry url: https://civicdb.org/links/evidence_items/5068", "If a patient with Acute Myeloid Leukemia cancer has idh2 mutation, one recommended therapy is enasidenib. entry url: https://civicdb.org/links/evidence_items/5069", "If a patient with nan cancer has atm underexpression, one recommended therapy is paclitaxel + olaparib. entry url: https://civicdb.org/links/evidence_items/5215", "If a patient with Acute Myeloid Leukemia cancer has flt3 mutation, one recommended therapy is midostaurin. entry url: https://civicdb.org/links/evidence_items/5261", "If a patient with Renal Cell Carcinoma cancer has vhl mutation, one recommended therapy is everolimus. entry url: https://civicdb.org/links/evidence_items/5323", "If a patient with Breast Cancer cancer has erbb2 mutation, one recommended therapy is neratinib. entry url: https://civicdb.org/links/evidence_items/5338", "If a patient with Cancer cancer has kit v560d, one recommended therapy is imatinib mesylate. entry url: https://civicdb.org/links/evidence_items/5348", "If a patient with nan cancer has myc overexpression, one recommended therapy is jq-1. entry url: https://civicdb.org/links/evidence_items/5505", "If a patient with Pancreatic Cancer cancer has rrm1 underexpression, one recommended therapy is gemcitabine. entry url: https://civicdb.org/links/evidence_items/5506", "If a patient with Pancreatic Cancer cancer has rrm1 underexpression, one recommended therapy is gemcitabine. entry url: https://civicdb.org/links/evidence_items/5508", "If a patient with Non-Small Cell Lung Cancer cancer has rrm1 underexpression, one recommended therapy is gemcitabine. entry url: https://civicdb.org/links/evidence_items/5530", "If a patient with Non-Small Cell Lung Cancer cancer has rrm1 underexpression, one recommended therapy is gemcitabine + vinorelbine + paclitaxel. entry url: https://civicdb.org/links/evidence_items/5599", "If a patient with Non-Small Cell Lung Cancer cancer has cd274 expression, one recommended therapy is pembrolizumab. entry url: https://civicdb.org/links/evidence_items/5811", "If a patient with nan cancer has brca1 loss-of-function, one recommended therapy is olaparib. entry url: https://civicdb.org/links/evidence_items/5815", "If a patient with nan cancer has brca2 loss-of-function, one recommended therapy is olaparib. entry url: https://civicdb.org/links/evidence_items/5816", "If a patient with nan cancer has rad50 l1237f, one recommended therapy is checkpoint kinase inhibitor azd7762 + irinotecan. entry url: https://civicdb.org/links/evidence_items/5829", "If a patient with nan cancer has brca1 mutation, one recommended therapy is olaparib. entry url: https://civicdb.org/links/evidence_items/5830", "If a patient with Breast Cancer cancer has brca2 mutation, one recommended therapy is olaparib. entry url: https://civicdb.org/links/evidence_items/5831", "If a patient with Cholangiocarcinoma cancer has atp1b1::nrg1 fusion, one recommended therapy is afatinib. entry url: https://civicdb.org/links/evidence_items/5858", "If a patient with Lung Adenocarcinoma cancer has sdc4::nrg1 fusion, one recommended therapy is afatinib. entry url: https://civicdb.org/links/evidence_items/5859", "If a patient with Cholangiocarcinoma cancer has braf v600e, one recommended therapy is trametinib + dabrafenib. entry url: https://civicdb.org/links/evidence_items/5902", "If a patient with Intrahepatic Cholangiocarcinoma cancer has braf v600e, one recommended therapy is dabrafenib + trametinib. entry url: https://civicdb.org/links/evidence_items/5903", "If a patient with Intrahepatic Cholangiocarcinoma cancer has braf v600e, one recommended therapy is trametinib + dabrafenib. entry url: https://civicdb.org/links/evidence_items/5904", "If a patient with Cholangiocarcinoma cancer has braf v600, one recommended therapy is vemurafenib. entry url: https://civicdb.org/links/evidence_items/5905", "If a patient with Cholangiocarcinoma cancer has braf v600e, one recommended therapy is irinotecan + vemurafenib + panitumumab. entry url: https://civicdb.org/links/evidence_items/5906", "If a patient with Cholangiocarcinoma cancer has fgfr2::v fusion, one recommended therapy is infigratinib. entry url: https://civicdb.org/links/evidence_items/5908", "If a patient with Cholangiocarcinoma cancer has fgfr2::? fusion, one recommended therapy is infigratinib. entry url: https://civicdb.org/links/evidence_items/5908", "If a patient with Lung Adenocarcinoma cancer has egfr::rad51 fusion, one recommended therapy is erlotinib. entry url: https://civicdb.org/links/evidence_items/5909", "If a patient with Cholangiocarcinoma cancer has fgfr2 mutation, one recommended therapy is infigratinib. entry url: https://civicdb.org/links/evidence_items/5912", "If a patient with Pancreatic Cancer cancer has brca2 mutation, one recommended therapy is olaparib. entry url: https://civicdb.org/links/evidence_items/5913", "If a patient with Pancreatic Cancer cancer has brca1 mutation, one recommended therapy is olaparib. entry url: https://civicdb.org/links/evidence_items/5914", "If a patient with Pancreatic Cancer cancer has brca1 mutation, one recommended therapy is oxaliplatin + cisplatin. entry url: https://civicdb.org/links/evidence_items/5915", "If a patient with Pancreatic Cancer cancer has brca2 mutation, one recommended therapy is platinum compound. entry url: https://civicdb.org/links/evidence_items/5916", "If a patient with Cancer cancer has egfr l858r, one recommended therapy is erlotinib. entry url: https://civicdb.org/links/evidence_items/5922", "If a patient with Peritoneal Mesothelioma cancer has egfr mutation, one recommended therapy is cytoreductive surgery + hyperthermic intraperitoneal chemotherapy. entry url: https://civicdb.org/links/evidence_items/5923", "If a patient with Non-Small Cell Lung Cancer cancer has egfr amplification, one recommended therapy is gefitinib + erlotinib. entry url: https://civicdb.org/links/evidence_items/5924", "If a patient with Non-Small Cell Lung Cancer cancer has egfr amplification, one recommended therapy is erlotinib + gefitinib. entry url: https://civicdb.org/links/evidence_items/5925", "If a patient with nan cancer has bap1 alternative transcript (ati), one recommended therapy is olaparib + apitolisib. entry url: https://civicdb.org/links/evidence_items/5929", "If a patient with Pancreatic Cancer cancer has brca1 mutation, one recommended therapy is cisplatin + veliparib + gemcitabine. entry url: https://civicdb.org/links/evidence_items/5932", "If a patient with Pancreatic Cancer cancer has brca2 mutation, one recommended therapy is veliparib + gemcitabine + cisplatin. entry url: https://civicdb.org/links/evidence_items/5933", "If a patient with Pancreatic Cancer cancer has brca2 mutation, one recommended therapy is iniparib. entry url: https://civicdb.org/links/evidence_items/5936", "If a patient with Colon Adenocarcinoma cancer has strn::alk fusion, one recommended therapy is ceritinib. entry url: https://civicdb.org/links/evidence_items/5952", "If a patient with Colorectal Cancer cancer has bard1 loss-of-function, one recommended therapy is olaparib. entry url: https://civicdb.org/links/evidence_items/5953", "If a patient with anaplastic thyroid cancer has v::alk fusion, one recommended therapy is crizotinib. entry url: https://civicdb.org/links/evidence_items/5954", "If a patient with Non-Small Cell Lung Cancer cancer has braf v600e, one recommended therapy is vemurafenib. entry url: https://civicdb.org/links/evidence_items/5958", "If a patient with Ovarian Cancer cancer has braf v600e, one recommended therapy is vemurafenib. entry url: https://civicdb.org/links/evidence_items/5959", "If a patient with Colorectal Cancer cancer has braf v600e, one recommended therapy is vemurafenib. entry url: https://civicdb.org/links/evidence_items/5960", "If a patient with anaplastic thyroid cancer has braf v600e, one recommended therapy is vemurafenib + pertuzumab. entry url: https://civicdb.org/links/evidence_items/5961", "If a patient with nan cancer has braf v600e, one recommended therapy is vemurafenib. entry url: https://civicdb.org/links/evidence_items/5962", "If a patient with Pancreatic Cancer cancer has cux1::braf fusion, one recommended therapy is vemurafenib. entry url: https://civicdb.org/links/evidence_items/5977", "If a patient with Cancer cancer has ptch1 mutation, one recommended therapy is vismodegib. entry url: https://civicdb.org/links/evidence_items/5978", "If a patient with Non-Small Cell Lung Cancer cancer has erbb2 mutation, one recommended therapy is trastuzumab + pertuzumab. entry url: https://civicdb.org/links/evidence_items/5980", "If a patient with Colorectal Cancer cancer has erbb2 amplification, one recommended therapy is pertuzumab + trastuzumab. entry url: https://civicdb.org/links/evidence_items/5981", "If a patient with nan cancer has erbb2 amplification, one recommended therapy is pertuzumab + trastuzumab. entry url: https://civicdb.org/links/evidence_items/5982", "If a patient with Biliary Tract Cancer cancer has erbb2 amplification, one recommended therapy is pertuzumab + trastuzumab. entry url: https://civicdb.org/links/evidence_items/5983", "If a patient with nan cancer has erbb2 amplification, one recommended therapy is pertuzumab + trastuzumab. entry url: https://civicdb.org/links/evidence_items/5984", "If a patient with Pancreatic Cancer cancer has erbb2 amplification, one recommended therapy is trastuzumab + pertuzumab. entry url: https://civicdb.org/links/evidence_items/5985", "If a patient with Sarcoma cancer has ass1 loss, one recommended therapy is pegargiminase + chloroquine. entry url: https://civicdb.org/links/evidence_items/5988", "If a patient with Non-Small Cell Lung Cancer cancer has rasa1 loss-of-function, one recommended therapy is trametinib. entry url: https://civicdb.org/links/evidence_items/5994", "If a patient with Breast Cancer cancer has tlk2 amplification, one recommended therapy is go6983 + gf109203x. entry url: https://civicdb.org/links/evidence_items/6000", "If a patient with Melanoma cancer has braf d594g, one recommended therapy is sorafenib. entry url: https://civicdb.org/links/evidence_items/6001", "If a patient with Melanoma cancer has braf g469e, one recommended therapy is sorafenib. entry url: https://civicdb.org/links/evidence_items/6003", "If a patient with Pancreatic Adenocarcinoma cancer has egfr l747_p753delinss, one recommended therapy is erlotinib. entry url: https://civicdb.org/links/evidence_items/6005", "If a patient with Neuroblastoma cancer has mycn amplification, one recommended therapy is jq1 + panobinostat. entry url: https://civicdb.org/links/evidence_items/6019", "If a patient with nan cancer has v::alk fusion, one recommended therapy is crizotinib. entry url: https://civicdb.org/links/evidence_items/6042", "If a patient with nan cancer has v::alk fusion, one recommended therapy is crizotinib. entry url: https://civicdb.org/links/evidence_items/6043", "If a patient with Melanoma cancer has braf v600, one recommended therapy is vemurafenib + cobimetinib. entry url: https://civicdb.org/links/evidence_items/6044", "If a patient with anaplastic thyroid cancer has braf v600e, one recommended therapy is vemurafenib. entry url: https://civicdb.org/links/evidence_items/6045", "If a patient with Colorectal Cancer cancer has braf v600, one recommended therapy is cetuximab + encorafenib. entry url: https://civicdb.org/links/evidence_items/6046", "If a patient with Colorectal Cancer cancer has braf v600, one recommended therapy is alpelisib + encorafenib + cetuximab. entry url: https://civicdb.org/links/evidence_items/6047", "If a patient with Sarcoma cancer has strn::ntrk2 fusion, one recommended therapy is larotrectinib. entry url: https://civicdb.org/links/evidence_items/6098", "If a patient with nan cancer has etv6::ntrk3 fusion, one recommended therapy is larotrectinib. entry url: https://civicdb.org/links/evidence_items/6099", "If a patient with Sarcoma cancer has lmna::ntrk1 fusion, one recommended therapy is larotrectinib. entry url: https://civicdb.org/links/evidence_items/6100", "If a patient with Sarcoma cancer has tpm3::ntrk1 fusion, one recommended therapy is larotrectinib. entry url: https://civicdb.org/links/evidence_items/6101", "If a patient with Sarcoma cancer has pde4dip::ntrk1 fusion, one recommended therapy is larotrectinib. entry url: https://civicdb.org/links/evidence_items/6102", "If a patient with nan cancer has sqstm1::ntrk1 fusion, one recommended therapy is larotrectinib. entry url: https://civicdb.org/links/evidence_items/6103", "If a patient with Colorectal Cancer cancer has braf v600e, one recommended therapy is trametinib + dabrafenib + panitumumab. entry url: https://civicdb.org/links/evidence_items/6123", "If a patient with Salivary Gland Cancer cancer has erbb2 overexpression, one recommended therapy is paclitaxel + trastuzumab. entry url: https://civicdb.org/links/evidence_items/6170", "If a patient with Salivary Gland Cancer cancer has erbb2 overexpression, one recommended therapy is trastuzumab + capecitabine + zoledronic acid. entry url: https://civicdb.org/links/evidence_items/6171", "If a patient with Melanoma cancer has braf v600e, one recommended therapy is trametinib + dabrafenib. entry url: https://civicdb.org/links/evidence_items/6178", "If a patient with Melanoma cancer has braf v600k, one recommended therapy is trametinib + dabrafenib. entry url: https://civicdb.org/links/evidence_items/6179", "If a patient with Melanoma cancer has braf v600, one recommended therapy is trametinib + dabrafenib. entry url: https://civicdb.org/links/evidence_items/6180", "If a patient with Lung Adenocarcinoma cancer has egfr l858r, one recommended therapy is gefitinib. entry url: https://civicdb.org/links/evidence_items/6183", "If a patient with Lung Adenocarcinoma cancer has egfr exon 19 deletion, one recommended therapy is gefitinib. entry url: https://civicdb.org/links/evidence_items/6184", "If a patient with Lung Adenocarcinoma cancer has egfr rare mutation, one recommended therapy is gefitinib. entry url: https://civicdb.org/links/evidence_items/6186", "If a patient with Pancreatic Adenocarcinoma cancer has v::nrg1 fusion, one recommended therapy is afatinib. entry url: https://civicdb.org/links/evidence_items/6273", "If a patient with Ovarian Cancer cancer has brca1 mutation, one recommended therapy is rucaparib. entry url: https://civicdb.org/links/evidence_items/6341", "If a patient with Ovarian Cancer cancer has brca2 mutation, one recommended therapy is rucaparib. entry url: https://civicdb.org/links/evidence_items/6343", "If a patient with Colorectal Cancer cancer has pik3ca mutation, one recommended therapy is aspirin. entry url: https://civicdb.org/links/evidence_items/6375", "If a patient with Non-Small Cell Lung Cancer cancer has abl1 r351w, one recommended therapy is imatinib. entry url: https://civicdb.org/links/evidence_items/6376", "If a patient with Gastrointestinal Stromal Tumor cancer has kit exon 11 mutation, one recommended therapy is regorafenib. entry url: https://civicdb.org/links/evidence_items/6377", "If a patient with Chronic Neutrophilic Leukemia cancer has csf3r t618i, one recommended therapy is ruxolitinib. entry url: https://civicdb.org/links/evidence_items/6380", "If a patient with Chronic Neutrophilic Leukemia cancer has csf3r t618i, one recommended therapy is ruxolitinib. entry url: https://civicdb.org/links/evidence_items/6381", "If a patient with Melanoma cancer has trim63::ntrk1 fusion, one recommended therapy is larotrectinib. entry url: https://civicdb.org/links/evidence_items/6392", "If a patient with Melanoma cancer has ddr2::ntrk1 fusion, one recommended therapy is larotrectinib. entry url: https://civicdb.org/links/evidence_items/6393", "If a patient with Melanoma cancer has gon4l::ntrk1 fusion, one recommended therapy is larotrectinib. entry url: https://civicdb.org/links/evidence_items/6394", "If a patient with Acute Myeloid Leukemia cancer has etv6::ntrk2 fusion, one recommended therapy is larotrectinib. entry url: https://civicdb.org/links/evidence_items/6396", "If a patient with nan cancer has fgfr3::tacc3 fusion, one recommended therapy is infigratinib. entry url: https://civicdb.org/links/evidence_items/6409", "If a patient with Intrahepatic Cholangiocarcinoma cancer has idh1 r132, one recommended therapy is dasatinib. entry url: https://civicdb.org/links/evidence_items/6439", "If a patient with nan cancer has etv6::ntrk3 fusion, one recommended therapy is larotrectinib. entry url: https://civicdb.org/links/evidence_items/6473", "If a patient with nan cancer has etv6::ntrk3 fusion, one recommended therapy is larotrectinib. entry url: https://civicdb.org/links/evidence_items/6475", "If a patient with Solid Tumor cancer has v::ntrk1 fusion, one recommended therapy is larotrectinib. entry url: https://civicdb.org/links/evidence_items/6567", "If a patient with Solid Tumor cancer has v::ntrk3 fusion, one recommended therapy is larotrectinib. entry url: https://civicdb.org/links/evidence_items/6568", "If a patient with Sarcoma cancer has v::ntrk1 fusion, one recommended therapy is larotrectinib. entry url: https://civicdb.org/links/evidence_items/6569", "If a patient with B-lymphoblastic Leukemia/lymphoma cancer has etv6::ntrk3 fusion, one recommended therapy is larotrectinib. entry url: https://civicdb.org/links/evidence_items/6930", "If a patient with Melanoma cancer has braf v600, one recommended therapy is trametinib + dabrafenib. entry url: https://civicdb.org/links/evidence_items/6937", "If a patient with Melanoma cancer has braf v600e, one recommended therapy is dabrafenib + trametinib. entry url: https://civicdb.org/links/evidence_items/6938", "If a patient with Melanoma cancer has braf v600k, one recommended therapy is dabrafenib + trametinib. entry url: https://civicdb.org/links/evidence_items/6939", "If a patient with Melanoma cancer has braf v600e, one recommended therapy is dabrafenib + trametinib. entry url: https://civicdb.org/links/evidence_items/6940", "If a patient with Melanoma cancer has braf v600e, ezh2 y646f, one recommended therapy is jqez5. entry url: https://civicdb.org/links/evidence_items/6952", "If a patient with Melanoma cancer has braf v600k, one recommended therapy is dabrafenib + trametinib. entry url: https://civicdb.org/links/evidence_items/6965", "If a patient with Melanoma cancer has braf v600, one recommended therapy is cobimetinib + vemurafenib. entry url: https://civicdb.org/links/evidence_items/6966", "If a patient with B-lymphoblastic Leukemia/lymphoma cancer has etv6::abl1 fusion, one recommended therapy is dasatinib. entry url: https://civicdb.org/links/evidence_items/6969", "If a patient with anaplastic thyroid cancer has braf v600e, one recommended therapy is dabrafenib + trametinib. entry url: https://civicdb.org/links/evidence_items/6975", "If a patient with nan cancer has ebf1::pdgfrb fusion, one recommended therapy is imatinib. entry url: https://civicdb.org/links/evidence_items/6976", "If a patient with nan cancer has aggf1::pdgfrb fusion, pdgfrb c843g, one recommended therapy is chz868. entry url: https://civicdb.org/links/evidence_items/6999", "If a patient with nan cancer has golga5::jak2 fusion, one recommended therapy is ruxolitinib. entry url: https://civicdb.org/links/evidence_items/7007", "If a patient with Alveolar Rhabdomyosarcoma cancer has pax3::foxo1 fusion, one recommended therapy is bet inhibitor. entry url: https://civicdb.org/links/evidence_items/7011", "If a patient with Malignant Peripheral Nerve Sheath Tumor cancer has parp1 overexpression, one recommended therapy is olaparib. entry url: https://civicdb.org/links/evidence_items/7016", "If a patient with nut midline cancer has brd4::nutm1 fusion, one recommended therapy is birabresib. entry url: https://civicdb.org/links/evidence_items/7018", "If a patient with nan cancer has jak2 f694l, one recommended therapy is ruxolitinib. entry url: https://civicdb.org/links/evidence_items/7021", "If a patient with Non-Small Cell Lung Cancer cancer has egfr mutation, one recommended therapy is erlotinib. entry url: https://civicdb.org/links/evidence_items/7024", "If a patient with nan cancer has ebf1::pdgfrb fusion, one recommended therapy is imatinib. entry url: https://civicdb.org/links/evidence_items/7028", "If a patient with Non-Small Cell Lung Cancer cancer has v::ret fusion, one recommended therapy is selpercatinib. entry url: https://civicdb.org/links/evidence_items/7066", "If a patient with medullary thyroid cancer has ret v804m, one recommended therapy is selpercatinib. entry url: https://civicdb.org/links/evidence_items/7068", "If a patient with papillary thyroid cancer has v::ret fusion, one recommended therapy is selpercatinib. entry url: https://civicdb.org/links/evidence_items/7069", "If a patient with medullary thyroid cancer has ret mutation, one recommended therapy is selpercatinib. entry url: https://civicdb.org/links/evidence_items/7070", "If a patient with nan cancer has ebf1::pdgfrb fusion, one recommended therapy is imatinib + dasatinib. entry url: https://civicdb.org/links/evidence_items/7128", "If a patient with Non-Small Cell Lung Cancer cancer has smarca4 loss, one recommended therapy is palbociclib + abemaciclib. entry url: https://civicdb.org/links/evidence_items/7155", "If a patient with Head And Neck Squamous Cell Carcinoma cancer has pik3ca mutation, one recommended therapy is sulindac + aspirin + celecoxib. entry url: https://civicdb.org/links/evidence_items/7185", "If a patient with nan cancer has kit m541l, one recommended therapy is imatinib. entry url: https://civicdb.org/links/evidence_items/7195", "If a patient with nan cancer has kiaa1549::braf fusion, one recommended therapy is everolimus + trametinib. entry url: https://civicdb.org/links/evidence_items/7199", "If a patient with nan cancer has nup214::abl1 fusion, one recommended therapy is vincristine + dasatinib + dexamethasone. entry url: https://civicdb.org/links/evidence_items/7208", "If a patient with Breast Cancer cancer has fgfr1 amplification, one recommended therapy is pazopanib. entry url: https://civicdb.org/links/evidence_items/7246", "If a patient with nan cancer has rcsd1::abl1 fusion, one recommended therapy is imatinib. entry url: https://civicdb.org/links/evidence_items/7248", "If a patient with nan cancer has rcsd1::abl1 fusion, one recommended therapy is dasatinib. entry url: https://civicdb.org/links/evidence_items/7249", "If a patient with nan cancer has rcsd1::abl2 fusion, one recommended therapy is dasatinib. entry url: https://civicdb.org/links/evidence_items/7251", "If a patient with nan cancer has ssbp2::jak2 fusion, one recommended therapy is ruxolitinib. entry url: https://civicdb.org/links/evidence_items/7257", "If a patient with Colorectal Cancer cancer has braf v600e, one recommended therapy is cetuximab + binimetinib + encorafenib. entry url: https://civicdb.org/links/evidence_items/7260", "If a patient with nan cancer has fgfr2 mutation, one recommended therapy is erdafitinib. entry url: https://civicdb.org/links/evidence_items/7261", "If a patient with nan cancer has fgfr2::v fusion, one recommended therapy is erdafitinib. entry url: https://civicdb.org/links/evidence_items/7261", "If a patient with nan cancer has fgfr2::? fusion, one recommended therapy is erdafitinib. entry url: https://civicdb.org/links/evidence_items/7261", "If a patient with Biliary Tract Cancer cancer has braf v600e, one recommended therapy is dabrafenib + trametinib. entry url: https://civicdb.org/links/evidence_items/7264", "If a patient with Non-Small Cell Lung Cancer cancer has met exon 14 skipping mutation, one recommended therapy is tepotinib. entry url: https://civicdb.org/links/evidence_items/7272", "If a patient with Ovarian Cancer cancer has brca1 mutation, one recommended therapy is olaparib. entry url: https://civicdb.org/links/evidence_items/7274", "If a patient with Ovarian Cancer cancer has brca1 mutation, one recommended therapy is olaparib. entry url: https://civicdb.org/links/evidence_items/7275", "If a patient with Ovarian Cancer cancer has brca2 mutation, one recommended therapy is olaparib. entry url: https://civicdb.org/links/evidence_items/7276", "If a patient with Acute Myeloid Leukemia cancer has idh1 mutation, one recommended therapy is ivosidenib. entry url: https://civicdb.org/links/evidence_items/7278", "If a patient with Non-Small Cell Lung Cancer cancer has v::ros1 fusion, one recommended therapy is crizotinib. entry url: https://civicdb.org/links/evidence_items/7282", "If a patient with Acute Myeloid Leukemia cancer has flt3 mutation, one recommended therapy is gilteritinib. entry url: https://civicdb.org/links/evidence_items/7283", "If a patient with Non-Small Cell Lung Cancer cancer has v::alk fusion, one recommended therapy is alectinib. entry url: https://civicdb.org/links/evidence_items/7284", "If a patient with Non-Small Cell Lung Cancer cancer has v::alk fusion, one recommended therapy is ceritinib. entry url: https://civicdb.org/links/evidence_items/7285", "If a patient with Non-Small Cell Lung Cancer cancer has v::alk fusion, one recommended therapy is lorlatinib. entry url: https://civicdb.org/links/evidence_items/7286", "If a patient with Melanoma cancer has braf v600, one recommended therapy is binimetinib + encorafenib. entry url: https://civicdb.org/links/evidence_items/7287", "If a patient with B-lymphoblastic Leukemia/lymphoma cancer has foxp1::abl1 fusion, one recommended therapy is dasatinib. entry url: https://civicdb.org/links/evidence_items/7292", "If a patient with Colorectal Cancer cancer has erbb2 amplification, one recommended therapy is pertuzumab + trastuzumab. entry url: https://civicdb.org/links/evidence_items/7302", "If a patient with spindle cell sarcoma cancer has kiaa1549::braf fusion, one recommended therapy is sorafenib + bevacizumab + temsirolimus. entry url: https://civicdb.org/links/evidence_items/7312", "If a patient with Breast Cancer cancer has pik3ca mutation, one recommended therapy is fulvestrant + alpelisib. entry url: https://civicdb.org/links/evidence_items/7313", "If a patient with Lung Adenocarcinoma cancer has egfr::rad51 fusion, one recommended therapy is icotinib. entry url: https://civicdb.org/links/evidence_items/7314", "If a patient with Breast Cancer cancer has pik3ca e542k, one recommended therapy is alpelisib + fulvestrant. entry url: https://civicdb.org/links/evidence_items/7315", "If a patient with Breast Cancer cancer has pik3ca q546e, one recommended therapy is alpelisib + fulvestrant. entry url: https://civicdb.org/links/evidence_items/7316", "If a patient with Breast Cancer cancer has pik3ca q546r, one recommended therapy is alpelisib + fulvestrant. entry url: https://civicdb.org/links/evidence_items/7316", "If a patient with Breast Cancer cancer has pik3ca h1047r, one recommended therapy is fulvestrant + alpelisib. entry url: https://civicdb.org/links/evidence_items/7318", "If a patient with Breast Cancer cancer has pik3ca h1047y, one recommended therapy is fulvestrant + alpelisib. entry url: https://civicdb.org/links/evidence_items/7318", "If a patient with Breast Cancer cancer has pik3ca h1047l, one recommended therapy is fulvestrant + alpelisib. entry url: https://civicdb.org/links/evidence_items/7318", "If a patient with Intrahepatic Cholangiocarcinoma cancer has fgfr2::v fusion, one recommended therapy is derazantinib. entry url: https://civicdb.org/links/evidence_items/7329", "If a patient with Intrahepatic Cholangiocarcinoma cancer has fgfr2::? fusion, one recommended therapy is derazantinib. entry url: https://civicdb.org/links/evidence_items/7329", "If a patient with Breast Cancer cancer has ccne1 underexpression, one recommended therapy is fulvestrant + palbociclib. entry url: https://civicdb.org/links/evidence_items/7331", "If a patient with Colorectal Cancer cancer has braf v600, one recommended therapy is cetuximab + vemurafenib + irinotecan. entry url: https://civicdb.org/links/evidence_items/7355", "If a patient with Anaplastic Large Cell Lymphoma cancer has v::alk fusion, one recommended therapy is crizotinib. entry url: https://civicdb.org/links/evidence_items/7361", "If a patient with Inflammatory Myofibroblastic Tumor cancer has v::alk fusion, one recommended therapy is crizotinib. entry url: https://civicdb.org/links/evidence_items/7362", "If a patient with Non-Small Cell Lung Cancer cancer has egfr l858r, one recommended therapy is dacomitinib. entry url: https://civicdb.org/links/evidence_items/7363", "If a patient with Non-Small Cell Lung Cancer cancer has egfr exon 19 deletion, one recommended therapy is dacomitinib. entry url: https://civicdb.org/links/evidence_items/7363", "If a patient with B-lymphoblastic Leukemia/lymphoma cancer has ikzf1 deletion, one recommended therapy is daunorubicin + imatinib + methotrexate + fludarabine + cytarabine. entry url: https://civicdb.org/links/evidence_items/7366", "If a patient with Acute Myeloid Leukemia cancer has flt3 itd, one recommended therapy is ponatinib. entry url: https://civicdb.org/links/evidence_items/7369", "If a patient with Acute Myeloid Leukemia cancer has fip1l1::pdgfra fusion, one recommended therapy is sorafenib + sunitinib. entry url: https://civicdb.org/links/evidence_items/7378", "If a patient with Acute Myeloid Leukemia cancer has kit n822k, one recommended therapy is ponatinib. entry url: https://civicdb.org/links/evidence_items/7379", "If a patient with Acute Myeloid Leukemia cancer has fgfr1op2::fgfr1 fusion, one recommended therapy is ponatinib. entry url: https://civicdb.org/links/evidence_items/7380", "If a patient with Leukemia cancer has flt3 itd, one recommended therapy is sunitinib + sorafenib. entry url: https://civicdb.org/links/evidence_items/7382", "If a patient with Pancreatic Adenocarcinoma cancer has brca1 loss-of-function, one recommended therapy is olaparib. entry url: https://civicdb.org/links/evidence_items/7384", "If a patient with Pancreatic Adenocarcinoma cancer has brca2 loss-of-function, one recommended therapy is olaparib. entry url: https://civicdb.org/links/evidence_items/7385", "If a patient with Gastrointestinal Stromal Tumor cancer has kit a502_y503insay, one recommended therapy is sunitinib. entry url: https://civicdb.org/links/evidence_items/7392", "If a patient with Gastrointestinal Stromal Tumor cancer has kit v560_l576del, one recommended therapy is imatinib + ponatinib. entry url: https://civicdb.org/links/evidence_items/7393", "If a patient with Gastrointestinal Stromal Tumor cancer has kit v560g, one recommended therapy is imatinib + regorafenib + ponatinib. entry url: https://civicdb.org/links/evidence_items/7395", "If a patient with Gastrointestinal Stromal Tumor cancer has kit k642e, one recommended therapy is ponatinib + sunitinib. entry url: https://civicdb.org/links/evidence_items/7397", "If a patient with nan cancer has etv6::ntrk3 fusion, one recommended therapy is larotrectinib. entry url: https://civicdb.org/links/evidence_items/7418", "If a patient with spindle cell sarcoma cancer has tpm3::ntrk1 fusion, one recommended therapy is larotrectinib. entry url: https://civicdb.org/links/evidence_items/7419", "If a patient with Sarcoma cancer has pde4dip::ntrk1 fusion, one recommended therapy is larotrectinib. entry url: https://civicdb.org/links/evidence_items/7420", "If a patient with nan cancer has fgfr3 mutation, one recommended therapy is erdafitinib. entry url: https://civicdb.org/links/evidence_items/7422", "If a patient with Lung Squamous Cell Carcinoma cancer has nfe2l2 mutation, one recommended therapy is sapanisertib. entry url: https://civicdb.org/links/evidence_items/7446", "If a patient with Cholangiocarcinoma cancer has idh1 mutation, one recommended therapy is ivosidenib. entry url: https://civicdb.org/links/evidence_items/7447", "If a patient with Breast Cancer cancer has pik3ca e545k, one recommended therapy is fulvestrant + alpelisib. entry url: https://civicdb.org/links/evidence_items/7468", "If a patient with Breast Cancer cancer has pik3ca e545a, one recommended therapy is fulvestrant + alpelisib. entry url: https://civicdb.org/links/evidence_items/7468", "If a patient with Breast Cancer cancer has pik3ca e545g, one recommended therapy is fulvestrant + alpelisib. entry url: https://civicdb.org/links/evidence_items/7468", "If a patient with Breast Cancer cancer has pik3ca e545d, one recommended therapy is fulvestrant + alpelisib. entry url: https://civicdb.org/links/evidence_items/7468", "If a patient with Colorectal Cancer cancer has ccdc6::ret fusion, one recommended therapy is agerafenib. entry url: https://civicdb.org/links/evidence_items/7480", "If a patient with Colorectal Cancer cancer has cad::alk fusion, one recommended therapy is entrectinib. entry url: https://civicdb.org/links/evidence_items/7481", "If a patient with Glioblastoma cancer has gopc::ros1 e7::e35, one recommended therapy is lorlatinib. entry url: https://civicdb.org/links/evidence_items/7483", "If a patient with nan cancer has nf1 mutation, one recommended therapy is selumetinib. entry url: https://civicdb.org/links/evidence_items/7487", "If a patient with Breast Cancer cancer has fgfr1 amplification, one recommended therapy is lucitanib. entry url: https://civicdb.org/links/evidence_items/7488", "If a patient with nan cancer has atp1b1::nrg1 fusion, one recommended therapy is afatinib. entry url: https://civicdb.org/links/evidence_items/7492", "If a patient with nan cancer has app::nrg1 fusion, one recommended therapy is afatinib. entry url: https://civicdb.org/links/evidence_items/7493", "If a patient with Solid Tumor cancer has etv6::ntrk3 fusion, one recommended therapy is larotrectinib. entry url: https://civicdb.org/links/evidence_items/7496", "If a patient with head and neck cancer has met r1004g, one recommended therapy is crizotinib. entry url: https://civicdb.org/links/evidence_items/7498", "If a patient with Lung Adenocarcinoma cancer has ros1 g2032r, slc4a4::ros1 fusion, one recommended therapy is ds-6501b. entry url: https://civicdb.org/links/evidence_items/7538", "If a patient with Solid Tumor cancer has tp53 mutation, one recommended therapy is vorinostat + pazopanib. entry url: https://civicdb.org/links/evidence_items/7540", "If a patient with Colorectal Cancer cancer has braf g466v, one recommended therapy is irinotecan + panitumumab. entry url: https://civicdb.org/links/evidence_items/7552", "If a patient with urinary bladder cancer has fgfr3 mutation, one recommended therapy is cisplatin + gemcitabine. entry url: https://civicdb.org/links/evidence_items/7566", "If a patient with Solid Tumor cancer has kras g12c, one recommended therapy is adagrasib. entry url: https://civicdb.org/links/evidence_items/7572", "If a patient with Langerhans Cell Sarcoma cancer has braf v600e, one recommended therapy is vemurafenib. entry url: https://civicdb.org/links/evidence_items/7583", "If a patient with Glioma cancer has h3-3a k28m, one recommended therapy is dordaviprone. entry url: https://civicdb.org/links/evidence_items/7601", "If a patient with Non-Small Cell Lung Cancer cancer has egfr exon 20 insertion, one recommended therapy is osimertinib. entry url: https://civicdb.org/links/evidence_items/7610", "If a patient with Colorectal Cancer cancer has braf v600e, one recommended therapy is cetuximab + encorafenib + binimetinib. entry url: https://civicdb.org/links/evidence_items/7612", "If a patient with Melanoma cancer has braf v600d, one recommended therapy is braf inhibitor. entry url: https://civicdb.org/links/evidence_items/7616", "If a patient with Melanoma cancer has braf v600d, one recommended therapy is mitogen-activated protein kinase kinase inhibitor + braf inhibitor. entry url: https://civicdb.org/links/evidence_items/7629", "If a patient with Melanoma cancer has braf v600_k601>e, one recommended therapy is mitogen-activated protein kinase kinase inhibitor + braf inhibitor. entry url: https://civicdb.org/links/evidence_items/7630", "If a patient with Melanoma cancer has braf g469, one recommended therapy is braf inhibitor + mitogen-activated protein kinase kinase inhibitor. entry url: https://civicdb.org/links/evidence_items/7634", "If a patient with Hepatocellular Carcinoma cancer has fgf19 overexpression, one recommended therapy is fisogatinib. entry url: https://civicdb.org/links/evidence_items/7636", "If a patient with Cholangiocarcinoma cancer has erbb2 amplification, one recommended therapy is trastuzumab + pertuzumab. entry url: https://civicdb.org/links/evidence_items/7638", "If a patient with Non-Small Cell Lung Cancer cancer has met exon 14 skipping mutation, one recommended therapy is crizotinib. entry url: https://civicdb.org/links/evidence_items/7642", "If a patient with Non-Small Cell Lung Cancer cancer has met exon 14 skipping mutation, one recommended therapy is crizotinib. entry url: https://civicdb.org/links/evidence_items/7643", "If a patient with nan cancer has erbb2 amplification, one recommended therapy is trastuzumab deruxtecan. entry url: https://civicdb.org/links/evidence_items/7647", "If a patient with medullary thyroid cancer has ret m918t, one recommended therapy is cabozantinib. entry url: https://civicdb.org/links/evidence_items/7710", "If a patient with Glioblastoma cancer has brca2 k3326*, one recommended therapy is temozolomide + olaparib. entry url: https://civicdb.org/links/evidence_items/7724", "If a patient with Acute Myeloid Leukemia cancer has flt3 mutation, one recommended therapy is gilteritinib. entry url: https://civicdb.org/links/evidence_items/7728", "If a patient with Pancreatic Cancer cancer has braf n486_p490del, one recommended therapy is trametinib. entry url: https://civicdb.org/links/evidence_items/7730", "If a patient with nan cancer has nrf1::braf fusion, one recommended therapy is trametinib. entry url: https://civicdb.org/links/evidence_items/7763", "If a patient with Chronic Myelogenous Leukemia cancer has bcr::abl1 fusion, abl1 t315v, one recommended therapy is axitinib. entry url: https://civicdb.org/links/evidence_items/7766", "If a patient with Chronic Myelogenous Leukemia cancer has bcr::abl1 fusion, abl1 v299l, one recommended therapy is axitinib. entry url: https://civicdb.org/links/evidence_items/7767", "If a patient with Chronic Myelogenous Leukemia cancer has bcr::abl1 fusion, abl1 t315a, one recommended therapy is axitinib. entry url: https://civicdb.org/links/evidence_items/7768", "If a patient with Chronic Myelogenous Leukemia cancer has bcr::abl1 fusion, abl1 e279k, one recommended therapy is axitinib. entry url: https://civicdb.org/links/evidence_items/7772", "If a patient with Chronic Myelogenous Leukemia cancer has bcr::abl1 fusion, abl1 e255k, abl1 v299l, one recommended therapy is ponatinib + dasatinib. entry url: https://civicdb.org/links/evidence_items/7781", "If a patient with B-lymphoblastic Leukemia/lymphoma cancer has rcsd1::abl1 fusion, one recommended therapy is imatinib. entry url: https://civicdb.org/links/evidence_items/7783", "If a patient with Head And Neck Squamous Cell Carcinoma cancer has dpyd exon 11-19 deletion, one recommended therapy is fluorouracil + leucovorin. entry url: https://civicdb.org/links/evidence_items/7787", "If a patient with Non-Small Cell Lung Cancer cancer has met::atxn7l1 fusion, one recommended therapy is crizotinib. entry url: https://civicdb.org/links/evidence_items/7793", "If a patient with histiocytic and dendritic cell cancer has met exon 14 skipping mutation, one recommended therapy is crizotinib. entry url: https://civicdb.org/links/evidence_items/7796", "If a patient with Cancer cancer has met exon 14 skipping mutation, one recommended therapy is capmatinib. entry url: https://civicdb.org/links/evidence_items/7797", "If a patient with nan cancer has cdk4 expression, one recommended therapy is dexamethasone + ribociclib. entry url: https://civicdb.org/links/evidence_items/7798", "If a patient with nan cancer has cdk6 overexpression, one recommended therapy is palbociclib. entry url: https://civicdb.org/links/evidence_items/7800", "If a patient with nan cancer has cdk6 expression, one recommended therapy is dexamethasone + ribociclib. entry url: https://civicdb.org/links/evidence_items/7801", "If a patient with Colorectal Cancer cancer has erbb2 amplification, one recommended therapy is afatinib. entry url: https://civicdb.org/links/evidence_items/7807", "If a patient with nan cancer has fgfr1 amplification, one recommended therapy is pazopanib. entry url: https://civicdb.org/links/evidence_items/7811", "If a patient with Head And Neck Squamous Cell Carcinoma cancer has fgfr2 p253r, one recommended therapy is pazopanib. entry url: https://civicdb.org/links/evidence_items/7833", "If a patient with Chronic Myelogenous Leukemia cancer has bcr::abl1 fusion, one recommended therapy is nilotinib + dasatinib + bafetinib. entry url: https://civicdb.org/links/evidence_items/7838", "If a patient with Sarcoma cancer has jak1 overexpression, one recommended therapy is ruxolitinib. entry url: https://civicdb.org/links/evidence_items/7852", "If a patient with B-lymphoblastic Leukemia/lymphoma cancer has prps1 n144s, one recommended therapy is cytarabine. entry url: https://civicdb.org/links/evidence_items/7910", "If a patient with B-lymphoblastic Leukemia/lymphoma cancer has prps1 l191f, one recommended therapy is cytarabine. entry url: https://civicdb.org/links/evidence_items/7911", "If a patient with B-lymphoblastic Leukemia/lymphoma cancer has prps1 a190t, one recommended therapy is lometrexol + mercaptopurine. entry url: https://civicdb.org/links/evidence_items/7913", "If a patient with Non-Small Cell Lung Cancer cancer has v::ros1 fusion, one recommended therapy is crizotinib. entry url: https://civicdb.org/links/evidence_items/7933", "If a patient with Rhabdomyosarcoma cancer has pdgfra overexpression, one recommended therapy is sunitinib. entry url: https://civicdb.org/links/evidence_items/7988", "If a patient with nan cancer has bcr::pdgfra fusion, one recommended therapy is imatinib. entry url: https://civicdb.org/links/evidence_items/7990", "If a patient with Dermatofibrosarcoma Protuberans cancer has col1a1::pdgfb fusion, one recommended therapy is sunitinib. entry url: https://civicdb.org/links/evidence_items/7991", "If a patient with Dermatofibrosarcoma Protuberans cancer has pdgfrb overexpression, one recommended therapy is sunitinib. entry url: https://civicdb.org/links/evidence_items/7992", "If a patient with B-lymphoblastic Leukemia/lymphoma cancer has etv6::ntrk3 fusion, one recommended therapy is larotrectinib. entry url: https://civicdb.org/links/evidence_items/7993", "If a patient with Acute Myeloid Leukemia cancer has etv6::ntrk3 fusion, one recommended therapy is entrectinib. entry url: https://civicdb.org/links/evidence_items/7994", "If a patient with Breast Cancer cancer has pik3ca h1047l, one recommended therapy is pi-103. entry url: https://civicdb.org/links/evidence_items/8009", "If a patient with nan cancer has pik3ca k111n, one recommended therapy is pi-103. entry url: https://civicdb.org/links/evidence_items/8011", "If a patient with nan cancer has pten loss, one recommended therapy is pi-103. entry url: https://civicdb.org/links/evidence_items/8012", "If a patient with nan cancer has pik3ca e542k, one recommended therapy is pi3ka/di. entry url: https://civicdb.org/links/evidence_items/8013", "If a patient with Breast Cancer cancer has pik3ca e542k, one recommended therapy is pi3ka/di. entry url: https://civicdb.org/links/evidence_items/8016", "If a patient with nan cancer has pik3ca e545k, one recommended therapy is pi3ka/di. entry url: https://civicdb.org/links/evidence_items/8017", "If a patient with Breast Cancer cancer has pik3ca e545k, one recommended therapy is pi3ka/di. entry url: https://civicdb.org/links/evidence_items/8018", "If a patient with Breast Cancer cancer has pik3ca h1047l, one recommended therapy is pi3ka/di. entry url: https://civicdb.org/links/evidence_items/8019", "If a patient with nan cancer has pik3ca k111n, one recommended therapy is pi3ka/di. entry url: https://civicdb.org/links/evidence_items/8020", "If a patient with papillary thyroid cancer has tpm3::ntrk1 fusion, one recommended therapy is larotrectinib. entry url: https://civicdb.org/links/evidence_items/8042", "If a patient with Cancer cancer has flt3 d835y, one recommended therapy is gilteritinib. entry url: https://civicdb.org/links/evidence_items/8106", "If a patient with Acute Myeloid Leukemia cancer has flt3 d835y, one recommended therapy is gilteritinib. entry url: https://civicdb.org/links/evidence_items/8108", "If a patient with nan cancer has fgfr2::v fusion, one recommended therapy is pemigatinib. entry url: https://civicdb.org/links/evidence_items/8173", "If a patient with nan cancer has fgfr2::? fusion, one recommended therapy is pemigatinib. entry url: https://civicdb.org/links/evidence_items/8173", "If a patient with nan cancer has ebf1::pdgfrb fusion, one recommended therapy is imatinib + chemotherapy. entry url: https://civicdb.org/links/evidence_items/8260", "If a patient with nan cancer has pik3ca amplification, one recommended therapy is dactolisib + lapatinib. entry url: https://civicdb.org/links/evidence_items/8271", "If a patient with Acute Myeloid Leukemia cancer has flt3 y842c, one recommended therapy is lestaurtinib. entry url: https://civicdb.org/links/evidence_items/8339", "If a patient with Acute Myeloid Leukemia cancer has flt3 y842c, one recommended therapy is midostaurin. entry url: https://civicdb.org/links/evidence_items/8340", "If a patient with Acute Myeloid Leukemia cancer has flt3 d835i, one recommended therapy is gilteritinib. entry url: https://civicdb.org/links/evidence_items/8351", "If a patient with Colorectal Cancer cancer has pik3ca h1047r, one recommended therapy is vemurafenib + akt inhibitor mk2206. entry url: https://civicdb.org/links/evidence_items/8364", "If a patient with Melanoma cancer has golga4::raf1 fusion, one recommended therapy is trametinib + cobimetinib. entry url: https://civicdb.org/links/evidence_items/8374", "If a patient with nan cancer has palb2 mutation, one recommended therapy is olaparib. entry url: https://civicdb.org/links/evidence_items/8504", "If a patient with nan cancer has atm mutation, one recommended therapy is olaparib. entry url: https://civicdb.org/links/evidence_items/8505", "If a patient with Colorectal Cancer cancer has braf v600e, one recommended therapy is vemurafenib + irinotecan + cetuximab. entry url: https://civicdb.org/links/evidence_items/8506", "If a patient with Colorectal Cancer cancer has braf v600e, one recommended therapy is vemurafenib + erlotinib. entry url: https://civicdb.org/links/evidence_items/8507", "If a patient with Acute Myeloid Leukemia cancer has flt3 d835h, one recommended therapy is gilteritinib. entry url: https://civicdb.org/links/evidence_items/8517", "If a patient with Acute Myeloid Leukemia cancer has flt3 d835v, one recommended therapy is gilteritinib. entry url: https://civicdb.org/links/evidence_items/8518", "If a patient with Non-Small Cell Lung Cancer cancer has v::alk fusion, one recommended therapy is alectinib. entry url: https://civicdb.org/links/evidence_items/8657", "If a patient with nan cancer has kras mutation, one recommended therapy is binimetinib. entry url: https://civicdb.org/links/evidence_items/8773", "If a patient with nan cancer has brca2 mutation, one recommended therapy is olaparib. entry url: https://civicdb.org/links/evidence_items/8842", "If a patient with Non-Small Cell Lung Cancer cancer has met exon 14 skipping mutation, one recommended therapy is capmatinib. entry url: https://civicdb.org/links/evidence_items/8847", "If a patient with Non-Small Cell Lung Cancer cancer has v::ret fusion, one recommended therapy is selpercatinib. entry url: https://civicdb.org/links/evidence_items/8850", "If a patient with medullary thyroid cancer has ret mutation, one recommended therapy is selpercatinib. entry url: https://civicdb.org/links/evidence_items/8851", "If a patient with Thyroid Cancer cancer has v::ret fusion, one recommended therapy is selpercatinib. entry url: https://civicdb.org/links/evidence_items/8852", "If a patient with Acute Myeloid Leukemia cancer has idh1 mutation, one recommended therapy is venetoclax. entry url: https://civicdb.org/links/evidence_items/8856", "If a patient with Acute Myeloid Leukemia cancer has idh2 mutation, one recommended therapy is venetoclax. entry url: https://civicdb.org/links/evidence_items/8857", "If a patient with nan cancer has sqstm1::ntrk1 fusion, one recommended therapy is larotrectinib. entry url: https://civicdb.org/links/evidence_items/8865", "If a patient with nan cancer has lmna::ntrk1 fusion, one recommended therapy is crizotinib. entry url: https://civicdb.org/links/evidence_items/8878", "If a patient with Colorectal Cancer cancer has lmna::ntrk1 fusion, one recommended therapy is entrectinib. entry url: https://civicdb.org/links/evidence_items/8900", "If a patient with spindle cell sarcoma cancer has lmna::ntrk1 fusion, one recommended therapy is trk inhibitor. entry url: https://civicdb.org/links/evidence_items/8902", "If a patient with B-lymphoblastic Leukemia/lymphoma cancer has etv6::ntrk3 fusion, one recommended therapy is larotrectinib + etoposide + methotrexate. entry url: https://civicdb.org/links/evidence_items/8917", "If a patient with Acute Myeloid Leukemia cancer has flt3 itd, one recommended therapy is gilteritinib. entry url: https://civicdb.org/links/evidence_items/8923", "If a patient with Acute Myeloid Leukemia cancer has flt3 itd, one recommended therapy is gilteritinib. entry url: https://civicdb.org/links/evidence_items/8924", "If a patient with B-lymphoblastic Leukemia/lymphoma cancer has etv6::ntrk3 fusion, one recommended therapy is larotrectinib. entry url: https://civicdb.org/links/evidence_items/8930", "If a patient with nan cancer has nras q61k, one recommended therapy is trametinib. entry url: https://civicdb.org/links/evidence_items/8933", "If a patient with nan cancer has kiaa1549::braf fusion, one recommended therapy is selumetinib. entry url: https://civicdb.org/links/evidence_items/8943", "If a patient with nan cancer has kiaa1549::braf fusion, one recommended therapy is trametinib. entry url: https://civicdb.org/links/evidence_items/8944", "If a patient with papillary thyroid cancer has braf v600e, one recommended therapy is vemurafenib. entry url: https://civicdb.org/links/evidence_items/9018", "If a patient with Melanoma cancer has ano10::raf1 fusion, one recommended therapy is trametinib. entry url: https://civicdb.org/links/evidence_items/9021", "If a patient with Cancer cancer has bcr::abl1 fusion, abl1 g250e, one recommended therapy is dasatinib. entry url: https://civicdb.org/links/evidence_items/9083", "If a patient with Cancer cancer has bcr::abl1 fusion, abl1 h396p, one recommended therapy is dasatinib. entry url: https://civicdb.org/links/evidence_items/9084", "If a patient with B-lymphoblastic Leukemia/lymphoma cancer has sfpq::abl1 fusion, one recommended therapy is imatinib + dasatinib. entry url: https://civicdb.org/links/evidence_items/9159", "If a patient with B-lymphoblastic Leukemia/lymphoma cancer has rcsd1::abl1 fusion, one recommended therapy is dasatinib. entry url: https://civicdb.org/links/evidence_items/9164", "If a patient with B-lymphoblastic Leukemia/lymphoma cancer has rcsd1::abl1 fusion, one recommended therapy is dasatinib. entry url: https://civicdb.org/links/evidence_items/9165", "If a patient with B-lymphoblastic Leukemia/lymphoma cancer has rcsd1::abl1 fusion, one recommended therapy is dasatinib. entry url: https://civicdb.org/links/evidence_items/9168", "If a patient with nan cancer has rcsd1::abl1 fusion, one recommended therapy is tyrosine kinase inhibitor. entry url: https://civicdb.org/links/evidence_items/9169", "If a patient with B-lymphoblastic Leukemia/lymphoma cancer has etv6::abl1 fusion, one recommended therapy is imatinib. entry url: https://civicdb.org/links/evidence_items/9171", "If a patient with nan cancer has ranbp2::abl1 fusion, one recommended therapy is dasatinib. entry url: https://civicdb.org/links/evidence_items/9211", "If a patient with B-lymphoblastic Leukemia/lymphoma cancer has rcsd1::abl1 fusion, one recommended therapy is ponatinib. entry url: https://civicdb.org/links/evidence_items/9213", "If a patient with Non-Small Cell Lung Cancer cancer has egfr a767_v769dupasv, one recommended therapy is osimertinib. entry url: https://civicdb.org/links/evidence_items/9220", "If a patient with Non-Small Cell Lung Cancer cancer has egfr n771_p772insl, one recommended therapy is osimertinib. entry url: https://civicdb.org/links/evidence_items/9221", "If a patient with Non-Small Cell Lung Cancer cancer has egfr d770_n771insg, one recommended therapy is osimertinib. entry url: https://civicdb.org/links/evidence_items/9223", "If a patient with Non-Small Cell Lung Cancer cancer has egfr s768_d770dup, one recommended therapy is osimertinib. entry url: https://civicdb.org/links/evidence_items/9224", "If a patient with Non-Small Cell Lung Cancer cancer has egfr a763_y764insfqea, one recommended therapy is osimertinib. entry url: https://civicdb.org/links/evidence_items/9225", "If a patient with nan cancer has eml4::alk fusion, one recommended therapy is alectinib. entry url: https://civicdb.org/links/evidence_items/9228", "If a patient with Cancer cancer has atrx deletion, one recommended therapy is fluorouracil + cisplatin. entry url: https://civicdb.org/links/evidence_items/9239", "If a patient with Colorectal Cancer cancer has kdr r1032q, one recommended therapy is axitinib + dovitinib + lenvatinib + cabozantinib. entry url: https://civicdb.org/links/evidence_items/9339", "If a patient with nan cancer has mef2d::csf1r fusion, one recommended therapy is imatinib. entry url: https://civicdb.org/links/evidence_items/9360", "If a patient with diffuse large b-cell lymphoma cancer has ezh2 y646h, one recommended therapy is tazemetostat. entry url: https://civicdb.org/links/evidence_items/9377", "If a patient with Neuroblastoma cancer has alk i1171t, one recommended therapy is ceritinib. entry url: https://civicdb.org/links/evidence_items/9404", "If a patient with Non-Small Cell Lung Cancer cancer has kras g12c, one recommended therapy is sotorasib. entry url: https://civicdb.org/links/evidence_items/9431", "If a patient with Solid Tumor cancer has lmna::ntrk1 fusion, one recommended therapy is larotrectinib. entry url: https://civicdb.org/links/evidence_items/9588", "If a patient with Bladder Urothelial Carcinoma cancer has hras mutation, one recommended therapy is tipifarnib. entry url: https://civicdb.org/links/evidence_items/9632", "If a patient with Head And Neck Squamous Cell Carcinoma cancer has hras mutation, one recommended therapy is tipifarnib. entry url: https://civicdb.org/links/evidence_items/9633", "If a patient with Cancer cancer has erbb2 v777l, one recommended therapy is lapatinib. entry url: https://civicdb.org/links/evidence_items/9697", "If a patient with Follicular Lymphoma cancer has ezh2 activating mutation, one recommended therapy is tazemetostat. entry url: https://civicdb.org/links/evidence_items/9709", "If a patient with nan cancer has erbb2 amplification, one recommended therapy is lapatinib. entry url: https://civicdb.org/links/evidence_items/9778", "If a patient with Colorectal Cancer cancer has braf v600e, one recommended therapy is encorafenib + cetuximab. entry url: https://civicdb.org/links/evidence_items/9851", "If a patient with Cancer cancer has egfr g598v, one recommended therapy is erlotinib. entry url: https://civicdb.org/links/evidence_items/10066", "If a patient with Cancer cancer has tpm3::ntrk1 fusion, one recommended therapy is entrectinib. entry url: https://civicdb.org/links/evidence_items/10094", "If a patient with Cancer cancer has lmna::ntrk1 fusion, one recommended therapy is entrectinib. entry url: https://civicdb.org/links/evidence_items/10095", "If a patient with Cancer cancer has etv6::ntrk1 fusion, one recommended therapy is entrectinib. entry url: https://civicdb.org/links/evidence_items/10096", "If a patient with Cancer cancer has vcl::ntrk2 fusion, one recommended therapy is entrectinib. entry url: https://civicdb.org/links/evidence_items/10097", "If a patient with Cancer cancer has afap1::ntrk2 fusion, one recommended therapy is entrectinib. entry url: https://civicdb.org/links/evidence_items/10098", "If a patient with Cancer cancer has etv6::ntrk2 fusion, one recommended therapy is entrectinib. entry url: https://civicdb.org/links/evidence_items/10099", "If a patient with Renal Cell Carcinoma cancer has flcn c.1285dupc, one recommended therapy is everolimus. entry url: https://civicdb.org/links/evidence_items/10137", "If a patient with Breast Cancer cancer has igf1r overexpression, one recommended therapy is exemestane + metformin. entry url: https://civicdb.org/links/evidence_items/10138", "If a patient with Leukemia cancer has sf3b1 k700e, one recommended therapy is etoposide + olaparib. entry url: https://civicdb.org/links/evidence_items/10139", "If a patient with Non-Small Cell Lung Cancer cancer has erbb2 exon 20 insertion, one recommended therapy is trastuzumab deruxtecan. entry url: https://civicdb.org/links/evidence_items/10140", "If a patient with Non-Small Cell Lung Cancer cancer has ercc1 underexpression, one recommended therapy is gemcitabine + carboplatin. entry url: https://civicdb.org/links/evidence_items/10142", "If a patient with Non-Small Cell Lung Cancer cancer has rrm1 underexpression, one recommended therapy is carboplatin + gemcitabine. entry url: https://civicdb.org/links/evidence_items/10143", "If a patient with Cancer cancer has idh1 r132c, one recommended therapy is olaparib. entry url: https://civicdb.org/links/evidence_items/10144", "If a patient with Pancreatic Adenocarcinoma cancer has slc29a1 overexpression, one recommended therapy is gemcitabine. entry url: https://civicdb.org/links/evidence_items/10145", "If a patient with nan cancer has ercc1 underexpression, one recommended therapy is platinum compound. entry url: https://civicdb.org/links/evidence_items/10146", "If a patient with Solid Tumor cancer has ntrk1 amplification, one recommended therapy is larotrectinib. entry url: https://civicdb.org/links/evidence_items/10170", "If a patient with Glioblastoma cancer has kit expression, one recommended therapy is sunitinib. entry url: https://civicdb.org/links/evidence_items/10180", "If a patient with nan cancer has sstr5 expression, one recommended therapy is pasireotide. entry url: https://civicdb.org/links/evidence_items/10193", "If a patient with Pilocytic Astrocytoma cancer has fgfr1 n546k, one recommended therapy is pemigatinib. entry url: https://civicdb.org/links/evidence_items/10325", "If a patient with spindle cell sarcoma cancer has qki::raf1 fusion, one recommended therapy is trametinib. entry url: https://civicdb.org/links/evidence_items/10326", "If a patient with nan cancer has kank4::alk fusion, one recommended therapy is alectinib. entry url: https://civicdb.org/links/evidence_items/10327", "If a patient with Cancer cancer has fgfr3 overexpression, one recommended therapy is r3mab. entry url: https://civicdb.org/links/evidence_items/10352", "If a patient with Anaplastic Ependymoma cancer has kank1::ntrk2 fusion, one recommended therapy is larotrectinib. entry url: https://civicdb.org/links/evidence_items/10360", "If a patient with Glioblastoma cancer has kank1::ntrk2 fusion, one recommended therapy is larotrectinib. entry url: https://civicdb.org/links/evidence_items/10361", "If a patient with Solid Tumor cancer has v::ntrk2 fusion, one recommended therapy is larotrectinib. entry url: https://civicdb.org/links/evidence_items/10392", "If a patient with papillary thyroid cancer has eml4::ntrk3 fusion, one recommended therapy is entrectinib. entry url: https://civicdb.org/links/evidence_items/10635", "If a patient with Non-Small Cell Lung Cancer cancer has eml4::ntrk3 fusion, one recommended therapy is entrectinib. entry url: https://civicdb.org/links/evidence_items/10636", "If a patient with nan cancer has etv6::ntrk3 fusion, one recommended therapy is larotrectinib. entry url: https://civicdb.org/links/evidence_items/10840", "If a patient with Cholangiocarcinoma cancer has idh1 r132, one recommended therapy is ivosidenib. entry url: https://civicdb.org/links/evidence_items/10886", "If a patient with Colon Adenocarcinoma cancer has egfr amplification, egfr::septin14 fusion, one recommended therapy is erlotinib. entry url: https://civicdb.org/links/evidence_items/10913", "If a patient with Lung Adenocarcinoma cancer has egfr::purb fusion, one recommended therapy is erlotinib. entry url: https://civicdb.org/links/evidence_items/10996", "If a patient with Lung Adenocarcinoma cancer has egfr::rad51 fusion, one recommended therapy is erlotinib. entry url: https://civicdb.org/links/evidence_items/11015", "If a patient with Lung Adenocarcinoma cancer has egfr::rad51 fusion, one recommended therapy is osimertinib. entry url: https://civicdb.org/links/evidence_items/11021", "If a patient with Lung Adenocarcinoma cancer has kif5b::egfr fusion, one recommended therapy is afatinib. entry url: https://civicdb.org/links/evidence_items/11026", "If a patient with Myeloid Neoplasm cancer has srsf2 p95l, one recommended therapy is ctx-712. entry url: https://civicdb.org/links/evidence_items/11027", "If a patient with Myeloid Neoplasm cancer has srsf2 p95h, one recommended therapy is ctx-712. entry url: https://civicdb.org/links/evidence_items/11028", "If a patient with Lung Adenocarcinoma cancer has eml4::ntrk3 fusion, one recommended therapy is entrectinib. entry url: https://civicdb.org/links/evidence_items/11099", "If a patient with nan cancer has eml4::ntrk3 fusion, one recommended therapy is larotrectinib. entry url: https://civicdb.org/links/evidence_items/11100", "If a patient with Follicular Lymphoma cancer has ezh2 activating mutation, one recommended therapy is tazemetostat. entry url: https://civicdb.org/links/evidence_items/11107", "If a patient with nan cancer has ezh2 expression, one recommended therapy is tazemetostat. entry url: https://civicdb.org/links/evidence_items/11108", "If a patient with Follicular Lymphoma cancer has ezh2 y646s, one recommended therapy is tazemetostat. entry url: https://civicdb.org/links/evidence_items/11109", "If a patient with Follicular Lymphoma cancer has ezh2 y646f, one recommended therapy is tazemetostat. entry url: https://civicdb.org/links/evidence_items/11109", "If a patient with Follicular Lymphoma cancer has ezh2 y646h, one recommended therapy is tazemetostat. entry url: https://civicdb.org/links/evidence_items/11109", "If a patient with Follicular Lymphoma cancer has ezh2 y646c, one recommended therapy is tazemetostat. entry url: https://civicdb.org/links/evidence_items/11109", "If a patient with Follicular Lymphoma cancer has ezh2 y646n, one recommended therapy is tazemetostat. entry url: https://civicdb.org/links/evidence_items/11109", "If a patient with Follicular Lymphoma cancer has ezh2 a692v, one recommended therapy is tazemetostat. entry url: https://civicdb.org/links/evidence_items/11109", "If a patient with Follicular Lymphoma cancer has ezh2 a682g, one recommended therapy is tazemetostat. entry url: https://civicdb.org/links/evidence_items/11109", "If a patient with nan cancer has eml4::alk fusion, alk i1171n, alk l1196m, one recommended therapy is lorlatinib. entry url: https://civicdb.org/links/evidence_items/11113", "If a patient with Non-Small Cell Lung Cancer cancer has v::alk fusion, one recommended therapy is brigatinib. entry url: https://civicdb.org/links/evidence_items/11121", "If a patient with Inflammatory Myofibroblastic Tumor cancer has v::alk fusion, one recommended therapy is crizotinib. entry url: https://civicdb.org/links/evidence_items/11122", "If a patient with Non-Small Cell Lung Cancer cancer has v::ros1 fusion, one recommended therapy is entrectinib. entry url: https://civicdb.org/links/evidence_items/11123", "If a patient with Solid Tumor cancer has v::ntrk1 fusion, one recommended therapy is entrectinib. entry url: https://civicdb.org/links/evidence_items/11124", "If a patient with Solid Tumor cancer has v::ntrk3 fusion, one recommended therapy is entrectinib. entry url: https://civicdb.org/links/evidence_items/11125", "If a patient with Ovarian Cancer cancer has brca1 mutation, one recommended therapy is rucaparib. entry url: https://civicdb.org/links/evidence_items/11136", "If a patient with Ovarian Cancer cancer has brca2 mutation, one recommended therapy is rucaparib. entry url: https://civicdb.org/links/evidence_items/11137", "If a patient with Ovarian Cancer cancer has brca1 mutation, one recommended therapy is rucaparib. entry url: https://civicdb.org/links/evidence_items/11138", "If a patient with Ovarian Cancer cancer has brca2 mutation, one recommended therapy is rucaparib. entry url: https://civicdb.org/links/evidence_items/11139", "If a patient with Systemic Mastocytosis cancer has not kit d816v, one recommended therapy is imatinib mesylate. entry url: https://civicdb.org/links/evidence_items/11158", "If a patient with nan cancer has brca1 loss-of-function, one recommended therapy is olaparib. entry url: https://civicdb.org/links/evidence_items/11201", "If a patient with nan cancer has brca2 loss-of-function, one recommended therapy is olaparib. entry url: https://civicdb.org/links/evidence_items/11202", "If a patient with nan cancer has brca1 mutation, one recommended therapy is olaparib. entry url: https://civicdb.org/links/evidence_items/11203", "If a patient with nan cancer has cdk12 mutation, one recommended therapy is olaparib. entry url: https://civicdb.org/links/evidence_items/11204", "If a patient with nan cancer has chek2 mutation, one recommended therapy is olaparib. entry url: https://civicdb.org/links/evidence_items/11205", "If a patient with nan cancer has rad54l mutation, one recommended therapy is olaparib. entry url: https://civicdb.org/links/evidence_items/11207", "If a patient with nan cancer has brip1 mutation, one recommended therapy is olaparib. entry url: https://civicdb.org/links/evidence_items/11208", "If a patient with nan cancer has bard1 mutation, one recommended therapy is olaparib. entry url: https://civicdb.org/links/evidence_items/11209", "If a patient with nan cancer has chek1 mutation, one recommended therapy is olaparib. entry url: https://civicdb.org/links/evidence_items/11210", "If a patient with nan cancer has rad51b mutation, one recommended therapy is olaparib. entry url: https://civicdb.org/links/evidence_items/11212", "If a patient with nan cancer has rad51d mutation, one recommended therapy is olaparib. entry url: https://civicdb.org/links/evidence_items/11214", "If a patient with nan cancer has brca1 loss-of-function, one recommended therapy is olaparib. entry url: https://civicdb.org/links/evidence_items/11216", "If a patient with nan cancer has brca2 loss-of-function, one recommended therapy is olaparib. entry url: https://civicdb.org/links/evidence_items/11217", "If a patient with Anaplastic Large Cell Lymphoma cancer has v::alk fusion, one recommended therapy is crizotinib. entry url: https://civicdb.org/links/evidence_items/11218", "If a patient with Non-Small Cell Lung Cancer cancer has egfr l858r, one recommended therapy is osimertinib. entry url: https://civicdb.org/links/evidence_items/11219", "If a patient with Non-Small Cell Lung Cancer cancer has egfr exon 19 deletion, one recommended therapy is osimertinib. entry url: https://civicdb.org/links/evidence_items/11219", "If a patient with Solid Tumor cancer has v::ntrk2 fusion, one recommended therapy is entrectinib. entry url: https://civicdb.org/links/evidence_items/11222", "If a patient with Non-Small Cell Lung Cancer cancer has egfr exon 20 insertion, one recommended therapy is amivantamab. entry url: https://civicdb.org/links/evidence_items/11227", "If a patient with Non-Small Cell Lung Cancer cancer has egfr exon 20 insertion, one recommended therapy is mobocertinib. entry url: https://civicdb.org/links/evidence_items/11228", "If a patient with Non-Small Cell Lung Cancer cancer has egfr s768i, one recommended therapy is afatinib. entry url: https://civicdb.org/links/evidence_items/11229", "If a patient with Non-Small Cell Lung Cancer cancer has egfr g719a, one recommended therapy is afatinib. entry url: https://civicdb.org/links/evidence_items/11229", "If a patient with Non-Small Cell Lung Cancer cancer has egfr l861q, one recommended therapy is afatinib. entry url: https://civicdb.org/links/evidence_items/11229", "If a patient with Cholangiocarcinoma cancer has fgfr2::v fusion, one recommended therapy is infigratinib. entry url: https://civicdb.org/links/evidence_items/11230", "If a patient with Cholangiocarcinoma cancer has fgfr2::? fusion, one recommended therapy is infigratinib. entry url: https://civicdb.org/links/evidence_items/11230", "If a patient with Non-Small Cell Lung Cancer cancer has v::ret fusion, one recommended therapy is pralsetinib. entry url: https://civicdb.org/links/evidence_items/11233", "If a patient with Thyroid Cancer cancer has v::ret fusion, one recommended therapy is pralsetinib. entry url: https://civicdb.org/links/evidence_items/11234", "If a patient with Melanoma cancer has braf v600, one recommended therapy is cobimetinib + atezolizumab + vemurafenib. entry url: https://civicdb.org/links/evidence_items/11238", "If a patient with Non-Small Cell Lung Cancer cancer has egfr l858r, one recommended therapy is dacomitinib. entry url: https://civicdb.org/links/evidence_items/11239", "If a patient with Non-Small Cell Lung Cancer cancer has egfr exon 19 deletion, one recommended therapy is dacomitinib. entry url: https://civicdb.org/links/evidence_items/11239", "If a patient with Non-Small Cell Lung Cancer cancer has egfr l858r, one recommended therapy is erlotinib + ramucirumab. entry url: https://civicdb.org/links/evidence_items/11240", "If a patient with Non-Small Cell Lung Cancer cancer has egfr exon 19 deletion, one recommended therapy is erlotinib + ramucirumab. entry url: https://civicdb.org/links/evidence_items/11240", "If a patient with Non-Small Cell Lung Cancer cancer has egfr l858r, one recommended therapy is gefitinib. entry url: https://civicdb.org/links/evidence_items/11241", "If a patient with Non-Small Cell Lung Cancer cancer has egfr exon 19 deletion, one recommended therapy is gefitinib. entry url: https://civicdb.org/links/evidence_items/11241", "If a patient with nan cancer has brca1 mutation, one recommended therapy is niraparib. entry url: https://civicdb.org/links/evidence_items/11243", "If a patient with nan cancer has brca2 mutation, one recommended therapy is niraparib. entry url: https://civicdb.org/links/evidence_items/11243", "If a patient with Breast Cancer cancer has erbb2 amplification, one recommended therapy is margetuximab. entry url: https://civicdb.org/links/evidence_items/11249", "If a patient with Breast Cancer cancer has pik3ca c420r, one recommended therapy is alpelisib + fulvestrant. entry url: https://civicdb.org/links/evidence_items/11275", "If a patient with Myeloid Neoplasm cancer has zmym2::fgfr1 fusion, one recommended therapy is pemigatinib. entry url: https://civicdb.org/links/evidence_items/11324", "If a patient with Myeloid Neoplasm cancer has bcr::fgfr1 fusion, one recommended therapy is pemigatinib. entry url: https://civicdb.org/links/evidence_items/11324", "If a patient with Myeloid Neoplasm cancer has cep43::fgfr1 fusion, one recommended therapy is pemigatinib. entry url: https://civicdb.org/links/evidence_items/11324", "If a patient with Myeloid Neoplasm cancer has trim24::fgfr1 fusion, one recommended therapy is pemigatinib. entry url: https://civicdb.org/links/evidence_items/11324", "If a patient with Myeloid Neoplasm cancer has fgfr1 translocation, one recommended therapy is pemigatinib. entry url: https://civicdb.org/links/evidence_items/11324", "If a patient with Cancer cancer has lmna::ntrk1 fusion, one recommended therapy is repotrectinib. entry url: https://civicdb.org/links/evidence_items/11346", "If a patient with Cancer cancer has lmna::ntrk1 fusion, ntrk1 g595r, one recommended therapy is repotrectinib. entry url: https://civicdb.org/links/evidence_items/11347", "If a patient with Cancer cancer has lmna::ntrk1 fusion, ntrk1 f589l, one recommended therapy is repotrectinib. entry url: https://civicdb.org/links/evidence_items/11348", "If a patient with Cancer cancer has lmna::ntrk1 fusion, one recommended therapy is larotrectinib. entry url: https://civicdb.org/links/evidence_items/11349", "If a patient with Cancer cancer has lmna::ntrk1 fusion, one recommended therapy is entrectinib. entry url: https://civicdb.org/links/evidence_items/11354", "If a patient with Cancer cancer has lmna::ntrk1 fusion, ntrk1 f589l, one recommended therapy is entrectinib. entry url: https://civicdb.org/links/evidence_items/11355", "If a patient with Breast Cancer cancer has esr1 mutation, one recommended therapy is elacestrant. entry url: https://civicdb.org/links/evidence_items/11443", "If a patient with Low-Grade Glioma, NOS cancer has idh1 r132c, one recommended therapy is vorasidenib. entry url: https://civicdb.org/links/evidence_items/11508", "If a patient with Low-Grade Glioma, NOS cancer has idh1 r132h, one recommended therapy is vorasidenib. entry url: https://civicdb.org/links/evidence_items/11508", "If a patient with Low-Grade Glioma, NOS cancer has idh1 r132l, one recommended therapy is vorasidenib. entry url: https://civicdb.org/links/evidence_items/11508", "If a patient with Low-Grade Glioma, NOS cancer has idh1 r132g, one recommended therapy is vorasidenib. entry url: https://civicdb.org/links/evidence_items/11508", "If a patient with Low-Grade Glioma, NOS cancer has idh1 r132s, one recommended therapy is vorasidenib. entry url: https://civicdb.org/links/evidence_items/11508", "If a patient with Low-Grade Glioma, NOS cancer has idh2 r172k, one recommended therapy is vorasidenib. entry url: https://civicdb.org/links/evidence_items/11509", "If a patient with Low-Grade Glioma, NOS cancer has idh2 r172g, one recommended therapy is vorasidenib. entry url: https://civicdb.org/links/evidence_items/11509", "If a patient with Low-Grade Glioma, NOS cancer has idh2 r172w, one recommended therapy is vorasidenib. entry url: https://civicdb.org/links/evidence_items/11509", "If a patient with Non-Small Cell Lung Cancer cancer has ntrk3 g623r, eml4::ntrk3 fusion, one recommended therapy is repotrectinib. entry url: https://civicdb.org/links/evidence_items/11516", "If a patient with Lung Adenocarcinoma cancer has sqstm1::ntrk1 fusion, one recommended therapy is larotrectinib. entry url: https://civicdb.org/links/evidence_items/11574", "If a patient with papillary thyroid cancer has sqstm1::ntrk1 fusion, one recommended therapy is larotrectinib. entry url: https://civicdb.org/links/evidence_items/11575", "If a patient with nan cancer has lmna::ntrk1 fusion, one recommended therapy is entrectinib. entry url: https://civicdb.org/links/evidence_items/11578", "If a patient with Non-Small Cell Lung Cancer cancer has kras g12c, one recommended therapy is divarasib. entry url: https://civicdb.org/links/evidence_items/11652", "If a patient with Non-Small Cell Lung Cancer cancer has rb1 wildtype, ( cdkn2a loss, one recommended therapy is palbociclib. entry url: https://civicdb.org/links/evidence_items/11665", "If a patient with Non-Small Cell Lung Cancer cancer has cdkn2a mutation ), one recommended therapy is palbociclib. entry url: https://civicdb.org/links/evidence_items/11665", "If a patient with Prostate Cancer cancer has brca1 mutation, one recommended therapy is olaparib. entry url: https://civicdb.org/links/evidence_items/11666", "If a patient with Prostate Cancer cancer has brca2 mutation, one recommended therapy is olaparib. entry url: https://civicdb.org/links/evidence_items/11666", "If a patient with Colorectal Cancer cancer has erbb2 amplification, one recommended therapy is pertuzumab + trastuzumab. entry url: https://civicdb.org/links/evidence_items/11668", "If a patient with Colorectal Cancer cancer has braf v600e, one recommended therapy is vemurafenib + cobimetinib. entry url: https://civicdb.org/links/evidence_items/11670", "If a patient with Colorectal Cancer cancer has braf k601e, one recommended therapy is vemurafenib + cobimetinib. entry url: https://civicdb.org/links/evidence_items/11670", "If a patient with Cancer cancer has v::alk fusion, one recommended therapy is crizotinib. entry url: https://civicdb.org/links/evidence_items/11671", "If a patient with Cancer cancer has v::ros1 fusion, one recommended therapy is crizotinib. entry url: https://civicdb.org/links/evidence_items/11671", "If a patient with Cancer cancer has braf v600e, one recommended therapy is trametinib + dabrafenib. entry url: https://civicdb.org/links/evidence_items/11672", "If a patient with Cancer cancer has msh2 loss, one recommended therapy is nivolumab. entry url: https://civicdb.org/links/evidence_items/11677", "If a patient with Cancer cancer has mlh1 loss, one recommended therapy is nivolumab. entry url: https://civicdb.org/links/evidence_items/11677", "If a patient with Cancer cancer has pik3ca mutation, one recommended therapy is copanlisib. entry url: https://civicdb.org/links/evidence_items/11678", "If a patient with Extramammary Paget Disease cancer has erbb2 d769y, one recommended therapy is afatinib. entry url: https://civicdb.org/links/evidence_items/11688", "If a patient with nan cancer has erbb2 d769y, one recommended therapy is afatinib. entry url: https://civicdb.org/links/evidence_items/11689", "If a patient with Breast Cancer cancer has erbb2 v777l, one recommended therapy is afatinib. entry url: https://civicdb.org/links/evidence_items/11690", "If a patient with Breast Cancer cancer has erbb2 s310f, one recommended therapy is afatinib. entry url: https://civicdb.org/links/evidence_items/11691", "If a patient with lung cancer has tpm3::ntrk1 fusion, one recommended therapy is larotrectinib. entry url: https://civicdb.org/links/evidence_items/11692", "If a patient with Solid Tumor cancer has tpm3::ntrk1 fusion, one recommended therapy is larotrectinib regimen. entry url: https://civicdb.org/links/evidence_items/11703", "If a patient with Colorectal Cancer cancer has tpr::ntrk1 fusion, one recommended therapy is larotrectinib. entry url: https://civicdb.org/links/evidence_items/11706", "If a patient with Glioma cancer has idh2 mutation, one recommended therapy is vorasidenib. entry url: https://civicdb.org/links/evidence_items/11708", "If a patient with Glioma cancer has idh1 mutation, one recommended therapy is vorasidenib. entry url: https://civicdb.org/links/evidence_items/11708", "If a patient with Cancer cancer has tp53 mutation, one recommended therapy is vegf/vegfr inhibitors. entry url: https://civicdb.org/links/evidence_items/11709", "If a patient with Non-Small Cell Lung Cancer cancer has erbb2 mutation, one recommended therapy is trastuzumab deruxtecan. entry url: https://civicdb.org/links/evidence_items/11731", "If a patient with nan cancer has brca1 loss-of-function, one recommended therapy is rucaparib. entry url: https://civicdb.org/links/evidence_items/11739", "If a patient with nan cancer has bap1 loss-of-function, one recommended therapy is rucaparib. entry url: https://civicdb.org/links/evidence_items/11739", "If a patient with Non-Small Cell Lung Cancer cancer has tpr::ntrk1 fusion, one recommended therapy is larotrectinib. entry url: https://civicdb.org/links/evidence_items/11744", "If a patient with papillary thyroid cancer has tpr::ntrk1 fusion, one recommended therapy is larotrectinib. entry url: https://civicdb.org/links/evidence_items/11747", "If a patient with Non-Small Cell Lung Cancer cancer has erbb2 s310f, one recommended therapy is trastuzumab deruxtecan. entry url: https://civicdb.org/links/evidence_items/11751", "If a patient with Non-Small Cell Lung Cancer cancer has erbb2 l755a, one recommended therapy is trastuzumab deruxtecan. entry url: https://civicdb.org/links/evidence_items/11752", "If a patient with Non-Small Cell Lung Cancer cancer has erbb2 l755m, one recommended therapy is trastuzumab deruxtecan. entry url: https://civicdb.org/links/evidence_items/11753", "If a patient with Non-Small Cell Lung Cancer cancer has erbb2 l755p, one recommended therapy is trastuzumab deruxtecan. entry url: https://civicdb.org/links/evidence_items/11754", "If a patient with Non-Small Cell Lung Cancer cancer has erbb2 a775_g776instvma, one recommended therapy is trastuzumab deruxtecan. entry url: https://civicdb.org/links/evidence_items/11755", "If a patient with Non-Small Cell Lung Cancer cancer has erbb2 a775_g776insv, one recommended therapy is trastuzumab deruxtecan. entry url: https://civicdb.org/links/evidence_items/11756", "If a patient with Non-Small Cell Lung Cancer cancer has erbb2 a775_g776insvvma, one recommended therapy is trastuzumab deruxtecan. entry url: https://civicdb.org/links/evidence_items/11757", "If a patient with Non-Small Cell Lung Cancer cancer has erbb2 g776_v777delinsvcd, one recommended therapy is trastuzumab deruxtecan. entry url: https://civicdb.org/links/evidence_items/11758", "If a patient with Non-Small Cell Lung Cancer cancer has erbb2 g776delinscv, one recommended therapy is trastuzumab deruxtecan. entry url: https://civicdb.org/links/evidence_items/11759", "If a patient with Non-Small Cell Lung Cancer cancer has erbb2 g776delinslc, one recommended therapy is trastuzumab deruxtecan. entry url: https://civicdb.org/links/evidence_items/11760", "If a patient with Non-Small Cell Lung Cancer cancer has erbb2 g776delinsvc, one recommended therapy is trastuzumab deruxtecan. entry url: https://civicdb.org/links/evidence_items/11761", "If a patient with Non-Small Cell Lung Cancer cancer has erbb2 g778_p780dup, one recommended therapy is trastuzumab deruxtecan. entry url: https://civicdb.org/links/evidence_items/11762", "If a patient with Non-Small Cell Lung Cancer cancer has erbb2 g778_s779inslps, one recommended therapy is trastuzumab deruxtecan. entry url: https://civicdb.org/links/evidence_items/11763", "If a patient with Non-Small Cell Lung Cancer cancer has erbb2 y772_a775dup, one recommended therapy is trastuzumab deruxtecan. entry url: https://civicdb.org/links/evidence_items/11764", "If a patient with Non-Small Cell Lung Cancer cancer has erbb2 exon 20 insertion, one recommended therapy is trastuzumab deruxtecan. entry url: https://civicdb.org/links/evidence_items/11765", "If a patient with Low-Grade Glioma, NOS cancer has braf v600e, one recommended therapy is vemurafenib. entry url: https://civicdb.org/links/evidence_items/11770", "If a patient with Non-Small Cell Lung Cancer cancer has v::alk fusion, one recommended therapy is alectinib. entry url: https://civicdb.org/links/evidence_items/12012", "If a patient with Solid Tumor cancer has erbb2 overexpression, one recommended therapy is trastuzumab deruxtecan. entry url: https://civicdb.org/links/evidence_items/12013", "If a patient with Non-Small Cell Lung Cancer cancer has egfr exon 20 insertion, one recommended therapy is chemotherapy + amivantamab. entry url: https://civicdb.org/links/evidence_items/12014", "If a patient with Non-Small Cell Lung Cancer cancer has egfr l858r, one recommended therapy is osimertinib + chemotherapy. entry url: https://civicdb.org/links/evidence_items/12015", "If a patient with Non-Small Cell Lung Cancer cancer has egfr exon 19 deletion, one recommended therapy is osimertinib + chemotherapy. entry url: https://civicdb.org/links/evidence_items/12015", "If a patient with nan cancer has braf v600e, one recommended therapy is tovorafenib. entry url: https://civicdb.org/links/evidence_items/12016", "If a patient with nan cancer has kiaa1549::braf fusion, one recommended therapy is tovorafenib. entry url: https://civicdb.org/links/evidence_items/12016", "If a patient with Breast Cancer cancer has pik3ca mutation, one recommended therapy is capivasertib + fulvestrant. entry url: https://civicdb.org/links/evidence_items/12020", "If a patient with Breast Cancer cancer has pten mutation, one recommended therapy is capivasertib + fulvestrant. entry url: https://civicdb.org/links/evidence_items/12020", "If a patient with Breast Cancer cancer has akt1 mutation, one recommended therapy is capivasertib + fulvestrant. entry url: https://civicdb.org/links/evidence_items/12020", "If a patient with nan cancer has braf v600, one recommended therapy is tovorafenib. entry url: https://civicdb.org/links/evidence_items/12028", "If a patient with nan cancer has v::braf fusion, one recommended therapy is tovorafenib. entry url: https://civicdb.org/links/evidence_items/12028", "If a patient with nan cancer has tp53 mutation, one recommended therapy is eprenetapopt + azacitidine. entry url: https://civicdb.org/links/evidence_items/12029", "If a patient with nan cancer has pik3ca r88q, one recommended therapy is capivasertib + fulvestrant. entry url: https://civicdb.org/links/evidence_items/12034", "If a patient with nan cancer has bcr::ntrk2 fusion, one recommended therapy is entrectinib. entry url: https://civicdb.org/links/evidence_items/12035", "If a patient with Solid Tumor cancer has v::ret fusion, one recommended therapy is selpercatinib. entry url: https://civicdb.org/links/evidence_items/12056", "If a patient with Solid Tumor cancer has ret mutation, one recommended therapy is selpercatinib. entry url: https://civicdb.org/links/evidence_items/12056", "If a patient with Colorectal Cancer cancer has kras g12c, one recommended therapy is adagrasib + cetuximab. entry url: https://civicdb.org/links/evidence_items/12063", "If a patient with Solid Tumor cancer has mtor mutation, one recommended therapy is sapanisertib. entry url: https://civicdb.org/links/evidence_items/12075", "If a patient with Solid Tumor cancer has pik3ca mutation, one recommended therapy is sapanisertib. entry url: https://civicdb.org/links/evidence_items/12075", "If a patient with Solid Tumor cancer has pten mutation, one recommended therapy is sapanisertib. entry url: https://civicdb.org/links/evidence_items/12075", "If a patient with Solid Tumor cancer has akt1 mutation, one recommended therapy is sapanisertib. entry url: https://civicdb.org/links/evidence_items/12075", "If a patient with Solid Tumor cancer has akt2 mutation, one recommended therapy is sapanisertib. entry url: https://civicdb.org/links/evidence_items/12075", "If a patient with Non-Small Cell Lung Cancer cancer has tmb high, one recommended therapy is pembrolizumab. entry url: https://civicdb.org/links/evidence_items/12083", "If a patient with nut midline cancer has brd4::nutm1 fusion, one recommended therapy is panobinostat. entry url: https://civicdb.org/links/evidence_items/12099", "If a patient with esophageal cancer has ntrk1 amplification, one recommended therapy is larotrectinib. entry url: https://civicdb.org/links/evidence_items/12120", "If a patient with Non-Small Cell Lung Cancer cancer has egfr l858r, one recommended therapy is lazertinib + amivantamab. entry url: https://civicdb.org/links/evidence_items/12131", "If a patient with Non-Small Cell Lung Cancer cancer has egfr exon 19 deletion, one recommended therapy is lazertinib + amivantamab. entry url: https://civicdb.org/links/evidence_items/12131", "If a patient with Melanoma cancer has gopc::ros1 fusion, one recommended therapy is entrectinib. entry url: https://civicdb.org/links/evidence_items/12140", "If a patient with Colorectal Cancer cancer has top1 amplification, one recommended therapy is cetuximab + folfiri regimen. entry url: https://civicdb.org/links/evidence_items/12143", "If a patient with Non-Small Cell Lung Cancer cancer has egfr l858r, one recommended therapy is amivantamab + carboplatin + pemetrexed. entry url: https://civicdb.org/links/evidence_items/12156", "If a patient with Non-Small Cell Lung Cancer cancer has egfr exon 19 deletion, one recommended therapy is amivantamab + carboplatin + pemetrexed. entry url: https://civicdb.org/links/evidence_items/12156", "If a patient with medullary thyroid cancer has ret mutation, one recommended therapy is selpercatinib. entry url: https://civicdb.org/links/evidence_items/12157", "If a patient with Solid Tumor cancer has mtap deletion, one recommended therapy is anvumetostat. entry url: https://civicdb.org/links/evidence_items/12158", "If a patient with Solid Tumor cancer has braf v600e, one recommended therapy is trametinib + dabrafenib. entry url: https://civicdb.org/links/evidence_items/12161", "If a patient with Low-Grade Glioma, NOS cancer has braf v600e, one recommended therapy is dabrafenib + trametinib. entry url: https://civicdb.org/links/evidence_items/12162", "If a patient with B-lymphoblastic Leukemia/lymphoma cancer has nup214::abl1 fusion, one recommended therapy is imatinib mesylate. entry url: https://civicdb.org/links/evidence_items/12218", "If a patient with Non-Small Cell Lung Cancer cancer has v::nrg1 fusion, one recommended therapy is zenocutuzumab-zbco. entry url: https://civicdb.org/links/evidence_items/12246", "If a patient with Pancreatic Adenocarcinoma cancer has v::nrg1 fusion, one recommended therapy is zenocutuzumab-zbco. entry url: https://civicdb.org/links/evidence_items/12247", "If a patient with Solid Tumor cancer has lrp1b loss-of-function, one recommended therapy is immune checkpoint inhibitor. entry url: https://civicdb.org/links/evidence_items/12252", "If a patient with Colorectal Cancer cancer has kras g12c, one recommended therapy is sotorasib + panitumumab. entry url: https://civicdb.org/links/evidence_items/12264", "If a patient with Non-Small Cell Lung Cancer cancer has egfr::rad51 e24::e4, one recommended therapy is erlotinib. entry url: https://civicdb.org/links/evidence_items/12360", "If a patient with Lung Adenocarcinoma cancer has egfr::rad51 e24::e4, one recommended therapy is afatinib. entry url: https://civicdb.org/links/evidence_items/12369", "If a patient with Lung Adenocarcinoma cancer has egfr::rad51 fusion, one recommended therapy is erlotinib + osimertinib. entry url: https://civicdb.org/links/evidence_items/12370", "If a patient with Non-Small Cell Lung Cancer cancer has egfr::rad51 fusion, one recommended therapy is gefitinib. entry url: https://civicdb.org/links/evidence_items/12371", "If a patient with Lung Adenocarcinoma cancer has egfr::rad51 fusion, one recommended therapy is osimertinib. entry url: https://civicdb.org/links/evidence_items/12372", "If a patient with Spindle Cell Rhabdomyosarcoma cancer has fus::tfcp2 fusion, alk exon 2-18 deletion, one recommended therapy is alectinib. entry url: https://civicdb.org/links/evidence_items/12406", "If a patient with Breast Cancer cancer has fgfr1 amplification, one recommended therapy is erdafitinib. entry url: https://civicdb.org/links/evidence_items/12469", "If a patient with Breast Cancer cancer has fgfr1 amplification, one recommended therapy is dovitinib. entry url: https://civicdb.org/links/evidence_items/12478"]